the Final Program Book

Transcription

SHEASPRING.ORG | #SHEA2016
SHEA Spring 2016 Conference
SCIENCE GUIDING PREVENTION
FINAL PROGRAM
May 18-21
ATLANTA, GEORGIA
Westin Peachtree Hotel
Dear Colleagues,
On behalf of the Society for Healthcare Epidemiology of America (SHEA),
the Planning Committee, and the Board of Trustees, welcome to the
SHEA Spring 2016 Conference: Science Guiding Prevention in Atlanta, GA.
CONTENTS
Accreditation Information, 1-2
Financial Disclosures, 3
Instructions to Acquire Your
Certificate(s), 4-5
Networking Events, 6-7
General Information, 7
SHEA Awards, 8-9
Schedule at a Glance, 10-13
Westin Peachtree Hotel
Floor Plan, 14-15
We are all excited to welcome you for the next few days to immerse yourself
in education and training related to infection prevention, healthcare epi and
antibiotic stewardship in many different settings. We are very proud of the
sessions and speakers taking part in this conference. We feel strongly that all
attendees will leave Atlanta with new ideas and methods to implement at your
own institutions. SHEA believes education is the basis for fulfilling our vision
statement – safe healthcare for all – and is proud to sponsor educational efforts
that so closely align with this mission. We understand you have many choices
when it comes to meeting your educational needs for the year and are thankful
you selected SHEA as one of those meetings.
SHEA Spring 2016 Conference highlights you will not want to miss include:
•
Focused scientific abstracts related to healthcare epidemiology,
surveillance, implementation science and patient safety, and prevention
strategies in poster form during breakfast and lunch breaks and a limited
number of oral presentations
•
All the educational sessions in the general conference and specialized
tracks but especially the plenaries, which are open to ALL attendees
•
Expanded networking opportunities during breaks
•
The Women in Epi Networking Reception on Wednesday, May 18
•
Mentorship Networking Breakfast on Thursday, May 19 (by invitation only)
•
SHEA Education & Research Foundation Dinner on Thursday, May 19
(extra ticket purchase)
•
International Meet and Greet Breakfast on Friday, May 20 (by invitation only)
Wednesday, May 18, 16-20
Thursday, May 19, 21-36
Friday, May 20, 37-54
Saturday, May 21, 53-54
The next few days are jam-packed with education from experts in the field.
If you have a spare moment, find us or another member of the planning
committee or board and let us know how we are doing, we would love to have
your feedback in real time. Please do not forget to submit your evaluations
after the meeting as well.
Thank you again for joining us. Enjoy the conference!
Sincerely,
Co-Chairs, Scientific Program
Silvia Munoz-Price, MD
Institute for Health and Society/Department of Medicine Froedtert
and the Medical College of Wisconsin Health Research Center
Milwaukee, WI
ENDORSING PARTNERS
The Society for Post-Acute and
Long-Term Care Medicine (AMDA)
Pediatric Infectious Disease
Society (PIDS)
Society of Infectious Diseases
Pharmacists (SIDP)
Thomas R. Talbot, MD
Vanderbilt University
Nashville, TN
CME, CEU, CPE &
EVALUATION
INFORMATION
The overall goal for SHEA Spring
2016 is for participants to gain
valuable knowledge about the latest
research and science in healthcare
epidemiology, practical skills
and strategies to implement this
knowledge, and ongoing connections
with other professionals in the field of
healthcare epidemiology and infection
prevention.
At the conclusion of the course,
learners should be able to:
• Review and critique new scientific
evidence related to epidemiologic
methods and prevention of
healthcare-associated infections
(HAIs)
• Identify evolving public policy
developments and their impact on
HAI prevention
• Compare and contrast differing
approaches to controversial aspects
of HAI prevention
• Translate best methods in
healthcare epidemiology, antibiotic
stewardship, surveillance,
prevention, and research into
practice
• Apply and evaluate appropriate
antibiotic stewardship practices in
acute and non-acute healthcare
settings
• Discuss current best practices in
HAI prevention in individual clinical
settings including pediatrics and
long-term care
SHEA/CDC TRAINING
CERTIFICATE COURSE
IN HEALTHCARE
EPIDEMIOLOGY
At the conclusion of this activity,
participants should be able to:
• Describe the process of surveillance
for healthcare-associated infections
and how to apply surveillance
techniques and methods
INFORMATION
• Define trends in transmission
and control of healthcareassociated infections and drug
resistant-pathogens, as well as
other emerging infections in the
healthcare setting
• Apply and define outbreak
investigation techniques and
evidence-based infection prevention
strategies
• Evaluate the unique approaches to
infection prevention among special
populations
• Describe the role of leadership
and clinical education in infection
prevention efforts
• Gain a working knowledge of the
role of the healthcare epidemiologist
in antibiotic stewardship,
epidemiology research, the
microbiology laboratory, and
emergency preparedness
SHEA ANTIBIOTIC
STEWARDSHIP TRAINING
COURSE
• Identify the rationale for antibiotic
stewardship programs in healthcare
institutions and communicate
this rationale to other healthcare
providers
• Evaluate components of effective
antibiotic stewardship programs
and implement interventions in their
healthcare setting
• Apply strategies for and measuring
both process and outcomes
measures
• Assess available data, including
pharmacy and microbiology data,
and the informatics strategies
needed to support antibiotic
stewardship in their institution
• Identify concepts from improvement
science and change theory to
enhance implementation of
antibiotic stewardship activities
SHEA/CDC/AMDA
INFECTION PREVENTION IN
POST-ACUTE & LONG-TERM
CARE CERTIFICATE
COURSE
• Describe surveillance definitions
and recognize differences in
applying them in the post-acute and
long-term care settings
• Identify opportunities for infection
prevention, including those caused
by multi-drug resistant organisms, in
the post-acute and long-term care
settings
• Discuss recognition and response
to common outbreaks in the
post-acute and long-term care
settings
• Apply principles of occupational
health and safety to healthcare
workers and staff in the post-acute
and long-term care settings
• Recognize the need for and
opportunities to practice antibiotic
stewardship in the post-acute and
SCIENCE GUIDING PREVENTION 1
ACCREDITATION INFORMATION
ACCREDITATION
ACCREDITATION INFORMATION
ACCREDITATION
TARGET AUDIENCE
NURSES
This conference is designed for
physicians, infection preventionists,
pediatricians, healthcare epidemiologists, infectious disease specialists,
microbiologists, nurses, pharmacists,
and other healthcare professionals
interested in healthcare epidemiology,
infection prevention, surveillance,
research methods, patient safety, and
quality improvement.
This continuing
nursing education activity was
approved by the
Virginia Nurses Association, an accredited approver by the American Nurses
Credentialing Center’s Commission on
Accreditation.
ACCREDITATION
STATEMENT
The Society for Healthcare
Epidemiology of America is accredited by the Accreditation Council for
Continuing Medical Education to
provide continuing medical education
for physicians.
PHYSICIANS
The Society
for Healthcare
Epidemiology of
America designates this live activity
for a maximum of 27.5 AMA PRA
Category 1 Credit(s)™. Physicians
should claim only the credit commensurate with the extent of their
participation in the activity.
INTERNATIONAL
PHYSICIANS
The American Medical Association
has determined that physicians not
licensed in the United States who
participate in this continuing medical
education activity are eligible for
AMA PRA Category 1 Credit(s)™.
2
INFORMATION
Nurses who complete this activity
will be awarded a maximum of 27.5
contact hours.
PHARMACISTS
(Credits only available
for the SHEA Antibiotic
Stewardship Training
Course)
The continuing education
activities for pharmacists
have been developed
through a joint providership of ProCE, Inc. and
SHEA. ProCE is accredited by the Accreditation Council for
Pharmacy Education as a provider of
continuing pharmacy education (CPE).
Participants attending the conference
CPE activities may earn a maximum
of eleven and one half (11.50) contact
hours of CPE credit. Note: some of the
CPE sessions are being held concurrently. The sessions offering ACPE
credit are designated in the Program
brochure with a UAN (Universal Activity
Number) and hours of CPE credit. The
release date for these CPE activities
is May 18, 2016. Conference registration fees cover the cost of CPE
credit. Statements of completion will
be issued at www.ProCE.com upon
successful completion of the online
CPE activity learning assessment(s)
and activity evaluation(s). All learning
assessment(s) and activity evaluation(s)
must be completed no later than June
24, 2016. No partial credit will be given
for any individual session. Conflict of
interest disclosures are required of
all faculty and shall be provided to all
participants at the conference.
SUCCESSFUL
COMPLETION STATEMENT
Participants are expected to claim only
those hours spent in the educational
activity approved for continuing education credit. Certificates of Attendance
are provided to registered attendees
based upon completion of the online
evaluation. On May 18, attendees
will receive a link from Confex to
complete the assessment and evaluation online. Once your evaluation is
completed, you may print your certificate automatically. Please refer to
page 4 for additional information on
the evaluation.
CONTENT VALIDATION
STATEMENT
The Society for Healthcare Epidemiology
of America accepts the following content
validation statements and expects all
persons involved in its professional
education activities to abide by these
statements with regard to any recommendations for clinical care.
• All recommendations involving
clinical medicine are based on
evidence accepted within the
profession of medicine as adequate
justification for their indications
and contradictions in the care of
patients; AND/OR
• All scientific research referred to or
reported in support or justification
of a patient care recommendation
conforms to generally accepted
standards of experimental design,
data collection, and analysis.
DISCLOSURES
In accordance with the Accreditation Council for Continuing Medical
Education’s (ACCME) Standards for Commercial Support for Continuing
Medical Education, all faculty and planning partners must disclose
any financial relationship(s) or other relationship(s) held within the past
12 months relevant to the content presented. SHEA identifies and
manages all conflicts of interest prior to delivering the educational
activity to learners.
PLANNING
COMMITTEE &
SPEAKERS
Silvia Munoz-Price, MD
(Planning Co-Chair)
Scientific Advisor: Xenex, Clorox
Speaker’s Bureau: Ecolab
Thomas R. Talbot, MD
(Planning Co-Chair)
Research Support: Sanofi Pasteur,
Medimmune, Gilead
Scientific Advisor: Novartis
Deverick J. Anderson, MD
Disclosed no relevant financial
relationships
Laurie Conway, PhD
relationships
Susan Huang, MD
Provides Product: Sage, Molnlycke,
3M, Clorox
John Jernigan, MD
Mary Ellen Nepps, Esq.
Michael Calderwood, MD
relationships
relationships
Marion Kainer, MD
Eric Pamer, MD
relationships
relationships
Michael Klompas, MD
Trish Perl, MD
relationships
Scientific Advisor: Merck, Zurec,
Clorox
Ebbing Lautenbach, MD
Peter Pronovost, MD
Research Grant: bioMerieux
relationships
relationships
Curtis Donskey, MD
Belinda Ostrowsky, MD
relationships
Eli Perencevich, MD
Investigator Grant: Merck
Christopher Pfeiffer, MD
relationships
Kari Simonsen, MD
Research Funding: The Medicines
Company, Merck, Cempra
Pharmaceuticals, Astellas
Nimalie D. Stone, MD
relationships
Kavita Trivedi, MD
(AS Track Co-Chair)
Speaker’s Bureau: Premier
Jessica Johnson (Staff)
relationships
Kimberly Mace (Staff)
relationships
SPEAKERS
Hilary Babcock, MD
relationships
Raymond Chinn, MD
relationships
Louise Dembry, MD
Stock Options: ReadyDock (West
Hartford, CT)
Daniel Diekema, MD
Simon Lax, PhD
Daniel Raymond, MD
Scientific Advisor: 3M, Seres Health
Research Grant: 3M, EcoLab, GOJO,
Merck, Cepheid
relationships
relationships
Grace Lee, MD
Nasia Safdar, MD
Shira Doron, MD
relationships
relationships
Tammy Lundstrom, MD
Thomas Sandora, MD
relationships
relationships
Conan MacDougall,
PharmD
Emily Sickbert-Bennett,
PhD
Consultant: Actavis Pharmaceuticals,
Cubist Pharmaceuticals
relationships
Maryn McKenna, MSJ
Arjun Srinivasan, MD
relationships
relationships
Leonard Mermel, DO
James Steinberg, MD
Consultant: Catheter Connections,
EndoVene, CareFusion, Elcam,
PuraCath
relationships
Aaron Milstone, MD
Research Grant: Sage, MITRE
Corporation
Research Grant: GSK, Sanofi-Pasteur
Honorarium: 3M
Travel Support: Johnson and Johnson
Lona Mody, MD
Ermira Tartari, MSc
relationships
relationships
Daniel Morgan, MD
Robert Weinstein, MD
relationships
relationships
Stephen Muething, MD
Deborah S. Yokoe, MD
relationships
relationships
Scientific Advisor: Allergan, Durata
Speaker’s Bureau: Allergan, Merck
Frank Drews, MD
relationships
Erik Dubberke, MD
Consultant: Sanofi Pasteur, Merck
Scientific Advisor: Sanofi Pasteur,
Pfizer, Summit, Merck, Daiichi,
Valneva
Maggie Dudeck, MPH
relationships
Jonathan Edwards, MStat
relationships
relationships
Sean Barnes, MD
Mohamad Fakih, MD
Jeffrey Gerber, MD
Alex Kallen, MD
relationships
relationships
Beth Bell, MD
Carolyn Gould, MD
Matthew Linam, MD
relationships
relationships
relationships
Gonzalo Bearman, MD
relationships
Victoria Nahum
relationships
Armando Nahum
Research Funding: Pfizer
Sarah L. Krein, PhD
Gerald Hickson, MD
relationships
relationships
relationships
relationships
Joost Hopman, MD
relationships
Robin Jump, MD
(LTC Co-Track Chair)
Jerod Nagel, PharmD
relationships
Grant recipient for SCORE study
(administered by The Joint
Commission): Pfizer Grants for
Learning and Change
Kerri Thom, MD
Sarah Haessler, MD
(SHEA/CDC Healthcare
Epidemiology Track Chair)
Lauri Hicks, DO
Whitney Buckel, PharmD
Sara Cosgrove, MD (AS Track Liaison)
Scientific Advisor: Hospital
Association of NY
Faculty: NY State Council of Health
Systems Pharmacists
Consultant: University of Rochester
relationships
relationships
(LTC Track Co-Chair)
relationships
Elizabeth Dodds-Ashley,
PharmD, MHS David Nace, MD
Investigator: Clorox, Sage
Reserach: Molnyke
Latania Logan, MD
relationships
(AS Track Co-Chair)
relationships
Mary Hayden, MD
relationships
relationships
Michael Bell, MD
Anthony Harris, MD
relationships
relationships
Paul Tambyah, MD
FINANCIAL DISCLOSURES
FINANCIAL
INSTRUCTIONSCONTINUING
TO ACQUIRE YOUR
CERTIFICATE(S)
EDUCATION
CREDITS
ACQUIRING
PHYSICIANS AND NURSES
CME, CNE, and Attendance
Certificates are provided to all registered attendees based upon the
completion of the online evaluation. You will receive an email on
Wednesday, May 18 with a link to your
evaluation. The email will include your
registration number which is needed to
access your evaluation.
All attendees will be asked if they
participated any of the three Single
Training Course during the conference:
• SHEA/CDC Training Certificate
Course in Healthcare Epidemiology
• SHEA Antibiotic Stewardship
Training Course
• SHEA/CDC/AMDA Infection
Prevention in Post-Acute &
Long-Term Care Certificate Course
Once selected, your printed Training
Course Certificate of completion will be
mailed within the next few weeks.
You will be able to print your certificate
once you have completed the evaluation. To obtain AMA PRA Category 1
Credit™ or CEU credits, participants
must:
1. Evaluate all sessions attended,
2. Complete the Attestation/
Evaluation statement at the end of
the evaluation.
YOUR
CERTIFICATES
PHARMACISTS
CE ACTIVITY EVALUATION
AND CREDIT
INSTRUCTIONS
ATTENDEE PORTAL
SHEA 2016 ‐ Guiding Science Prevention
The Conference Attendee Portal includes:
May 18 - 21, 2016, Atlanta, Georgia
• All Full Conference and Track Session
Information and PDF Presentations
• Oral Abstract Presentations
• Poster Abstract Presentations
• Presenter/Speaker Information
• A Daily Agenda for you to create
your own schedule
• Listing of all Special Events during
the conference
• Floor Plans to locate all sessions and
events
• General Conference Information
• Access and complete your Conference
Evaluation to download your CME,
CNE, and Attendance Certificates.
• Everything you need to know about
the meeting, at your fingertips!
View the SHEA Spring 2016
Attendee Portal online today at www.
sheaspring.org/attendeeportal.
1.To receive CE credit for the activities at this conference, you must
complete the activity post-tests
and evaluations online no later than
Friday, June 24, 2016.
2.Visit www.ProCE.com/evaluation.
3.Click on the Evaluation button,
which is listed with the SHEA Spring
2016 Conference - May 18-21,
2016 CE activity.
4.Login to the ProCE CE Center.
NOTE: You will need to register as a
new user if you have not previously
used the ProCE CE Center.
5.Enter the Attendance Codes for all
of the CE sessions you attended.
NOTE: Each session has a unique
attendance code.
6. Follow the online instructions to
complete the activity post-tests and
evaluations, and to receive CE credit.
NOTE: Complete the activity post-tests
and evaluations, and claim CE credit
only for the sessions you attended.
7.If you need assistance or have
questions, please contact ProCE
at 630-540-2848 or via email at
[email protected].
ACCESS PRESENTATIONS
ONLINE
As a registrant, you will be able to
access all presentations online through
the attendee portal at www.sheaspring.
org/attendeeportal. Please note:
Presentations will be uploaded as they
are available. In some cases, this will be
after the conference.
C R E D I T T R A C K E R SHEA Antibiotic Stewardship Training Course CE
Time
4:15 - 4:45 p.m.
Thursday, May 19
Antibiotic Stewardship in Skilled Nursing Facilities and Long-Term Care
Breakout Session: Beginning Antibiotic Stewardship
Breakout Session: Advanced Antibiotic Stewardship
What Every Steward Should Know About Pharmacokinetics - Pharmacodynamics
Allergies, Interactions and Adverse Events
An Update on Duration of Therapy and Therapeutic Monitoring: Our Role as Stewards
Antibiotic Stewardship: Navigating the Liability Risks
Case Study #1: Using Benchmarking to Enhance Antibiotic Stewardship
Friday, May 20
Integration of the Microbiology Lab & Antibiotic Stewardship
Rapid Diagnostic Tests and How to Implement their Use: Mini-lecture & Case
Study #2
Update on the National Stewardship Activities
How to Find Resources at your Institution or Health System
Art of Antibiotic Stewardship
Informatics and Stewardship
Management of Resistant Gram Positive Infections
Management of Resistant Gram Negative Infections
4:45 - 5:45 p.m.
Case Study #3: Stewardship and C. difficile Infection
11:00 - 12:00 p.m.
1:00 - 2:30 p.m.
2:45 - 3:15 p.m.
3:15 - 3:45 p.m.
3:45 - 4:15 p.m.
4:30 - 5:00 p.m.
5:00 - 5:45 p.m.
8:00 - 8:45 a.m.
8:45 - 9:30 a.m.
10:00 - 10:30 a.m.
10:30 - 11:30 a.m.
11:30 - 12:00 p.m.
2:45 - 3:30 p.m.
3:30 - 4:00 p.m.
4
Title
CPE/CME/
CNE Credit
ACPE UAN
1
0221-9999-16-079-L04-P
Attendance Credits
Code
Earned
0221-9999-16-080-L04-P
0221-9999-16-081-L04-P
0.5
0221-9999-16-082-L01-P
0.5
0221-9999-16-083-L05-P
0.5
0221-9999-16-084-L05-P
0.5
0221-9999-16-085-L03-P
0.75
0221-9999-16-086-L04-P
0.75
0221-9999-16-087-L01-P
0.75
0221-9999-16-088-L04-P
0.5
0221-9999-16-089-L04-P
1
0221-9999-16-090-L04-P
0.5
0221-9999-16-091-L04-P
0.75
0221-9999-16-092-L04-P
0.5
0221-9999-16-093-L01-P
0.5
0221-9999-16-094-L01-P
1
0221-9999-16-095-L05-P
1.5
CREDIT
TRACKER
SHEA/CDC/AMDA Infection Prevention in Post-Acute &
Long-Term Care Certificate Course
Full Conference Sessions
Time
CME /CNE
Credit
Title
CME /CNE
Credit
Credits
Earned
Time
10:15 – 11:15 a.m. Joint Session: Introduction to Healthcare Epidemiology
Title
Wednesday, May 18
Wednesday, May 18
8:00 - 9:30 a.m.
Opening Plenary: CDC and Healthcare
Associated Infections - Prevention in the Past,
Present, and the Future
10:00 - 12:00 p.m. Creating a Level Playing Field with Publically
1.5
11:15 – 12:00 p.m. Joint Session: Transmission of Infectious
2
1
Reprocessing Methods?
11:00 - 12:00 p.m. The Possibilities of Innovation Automated
1
Implementation Academy: Turning Science
into Improved Practice
1.5
1:00 -2:15 p.m.
Managing Outbreaks
1.25
2:30 – 4:00 p.m.
Changing Approaches in Surveillance
1.5
4:15 – 5:30 p.m.
Strategies to Prevent Infections and MDROs
1.25
Thursday, May 19
Tools in Hand Hygiene Compliance
Measurement
1:00 - 2:30 p.m.
1
0.75
Agents in Healthcare Settings
Reported HAI Data
10:00 - 11:00 a.m. Are there Global Standards for Endoscope
Credits
Earned
8:00 – 8:45 a.m.
Occupational Health & Safety
0.75
8:45 – 9:30 a.m.
CDI Management
0.75
10:00 – 11:00 a.m. Challenging Situations
1
1
0.75
2:45 - 4:00 p.m.
Pediatric Infection Prevention: Focus on
Guideline Implementation
1.25
11:00 – 12:00 p.m. Joint Session: Antibiotic Stewardship in
4:15 - 5:45 p.m.
Choosing Wisely
1.5
2:45 – 3:30 p.m.
8:00 - 9:30 a.m.
Environmental Disinfection
1.5
SHEA/CDC Training Course in Healthcare Epidemiology
8:00 - 9:30 a.m.
Selling Your Results: To Suits, Scientists &
Society
1.5
Time
2
Thursday, May 19
10:00 - 12:00 p.m. Surgical Site Infection Prevention–Where Do
We SCIP & HOP From Here
10:00 - 12:00 p.m. Practical Consideration in HAI Research
2
1:00 - 2:30 p.m.
Plenary: Reaching out to New Partners
1.5
2:45 - 4:00 p.m.
Pro/Con: To Wash or Rub Off C. difficile &
Making the Most of C. difficile PCR
1.25
Updates from the CDC Prevention
Epicenters Program: A Public Health/
Academic Research Partnership
1.5
Is there Quality in Quality Metrics?
1.5
4:15 - 5:45 p.m.
4:15 - 5:45 p.m.
Skilled Nursing Facilities & Long-Term Care
Joint Session: PAC&LTC: Changing the
National Landscape & Infection Prevention
CME /CNE
Credit
Title
Credits
Earned
Wednesday, May 18
10:15 – 11:15 a.m. Joint Session: Introduction to Healthcare
1
11:15 – 12:00 p.m. Joint Session: Transmission of Infectious
0.75
Epidemiology
Agents in Healthcare Settings
1:00 – 1:45 p.m.
Practical Strategies for Surveillance
0.75
1:45 – 2:30 p.m.
The Compendium Strategies for Preventing HAIs
0.75
2:45 – 3:45 p.m.
Change Management & the Science of Safety
3:45 – 4:15 p.m.
Root Cause Analysis Practical Session
4:30 – 5:30 p.m.
Overview of Antibiotic Stewardship
Friday, May 20
1
0.5
1
Thursday, May 19
8:00 - 9:30 a.m.
Research Methods in Healthcare
Epidemiology – Practical Considerations
1.5
8:00 - 9:30 a.m.
Novel Engineering Solutions to Environmental
Hygiene
1.5
10:00 - 12:00 p.m. Regional Approach to MDRO Prevention
2
10:00 - 12:00 p.m. Challenging Cases and Issues in Infection
2
0.5
1.5
2:45 – 3:30 p.m.
Joint Session: PAC&LTC: Changing the
National Landscape & Infection Prevention
0.75
1
3:30 – 4:15 p.m.
Environment, Sterilization, & Disinfection
0.75
4:30 – 5:30 p.m.
Special Populations: Immunocompromised,
ICU, Dialysis & Burn Patients
1
8:00 – 8:45 a.m.
Leadership & Communication Skills
0.75
8:45 – 9:30 a.m.
The Hospital Epidemiologist as a Clinical Educator
0.75
1
Prevention
1:00 - 2:30 p.m.
Plenary: Telling Stories: Using Narrative to
Expand Awareness of Infection Prevention
2:45 - 3:45 p.m.
Role of One Microbiome in Resistance
Against Healthcare Associated Infections
2:45 - 4:00 p.m.
Device-Associated Infections: Can Science
Bring us to Zero?
1.25
4:15 - 5:45 p.m.
A Human Factors & Systems Engineering
Approach to Infection Prevention
1.5
8:00 – 8:45 a.m.
CDC Problem Sessions: Device Associated
Infections
0.75
8:45 – 9:30 a.m.
CDC Problem Sessions: Procedure Infections
0.75
10:00 – 10:45 a.m. Unique Aspects of Pediatric Infection Control
0.75
10:45 – 11:30 a.m. Approach to Epidemic/Outbreak Investigation
0.75
11:30 – 12:00 p.m. Problem Session: Outbreak in the OR
Friday, May 20
Saturday, May 21
8:00 - 9:30 a.m.
Pro/Con: Universal PPE
1.5
8:00 - 9:30 a.m.
Crossing the Stewardship Continuum
1.5
10:00 - 12:00 p.m
Closing Plenary: Creating a Culture of
Accountability & Professionalism to Drive
Improvement
2
10:00 – 11:00 a.m. Occupational Health Issues
11:00 – 12:00 p.m. Regulatory & Emergency Preparedness
1
2:45 – 3:30 p.m.
How to Read a Study and Perform Research
0.75
3:30 – 4:10 p.m.
Business of Infection Prevention: Promoting
Growth of a Program
0.75
4:15 – 5:00 p.m.
The Role of the Laboratory in Healthcare
Epidemiology
0.75
5:00 – 5:45 p.m.
Putting it all Together: Leading Your Healthcare
Facility through a Massive Exposure Situation
0.75
NETWORKING EVENTS
NETWORKING
LUNCH WITH POSTER
VIEWING
SHEA MENTORSHIP
BREAKFAST
7th Floor: Augusta Ballroom(s)
Thursday, May 19, 7:00 – 7:50 a.m.
Peachtree Room
First Poster Viewing Session
Poster Display Hours
Wednesday, May 18
Thursday, May 19
7:00 a.m. – 6:00 p.m.
7:00 a.m. – 1:00 p.m.
Extended Poster Viewing Hours
Wednesday, May 18
6:00 p.m. – 7:00 p.m.
Author Presentation Hour
Thursday, May 19
SHEA WOMEN IN EPI
RECEPTION
Wednesday, May 18, 6:00 – 8:00 p.m.,
Peachtree Ballroom CD
Women in the field of Healthcare
Epidemiology are encouraged to
attend a women’s only reception.
Women are increasingly entering the
field of hospital epidemiology, but have
had few opportunities to meet and
discuss the challenges. This reception
is designed to facilitate networking
and mentoring among women who
have succeeded in healthcare hospital
epidemiology and those who are still in
training or are junior in the field.
LONGER BREAK SESSIONS
The break sessions throughout the
meeting have been extended to allow
more time to meet and mingle with
other attendees in your field as well
as faculty and leadership. Networking
Breaks are May 18-21 from 9:30 to
10:00 a.m. in the 7th Floor: Augusta
Ballroom(s).
12:00 p.m. – 1:00 p.m.
Second Poster Viewing Session
Poster Display Hours
Thursday, May 19
Friday, May 20
Saturday, May 21
4:30 p.m. – 6:00 p.m.
7:00 a.m. – 6:00 p.m.
7:00 a.m. – 10:00 a.m.
Extended Poster Viewing Hours
Friday, May 20
6:00 p.m. – 7:00 p.m.
Author Presentation Hour
Friday, May 20
12:00 p.m. – 1:00 p.m.
MEET WITH THE AUTHORS
Thursday, May 19, 12:00 – 1:00 p.m.
Friday, May 20, 12:00 – 1:00 p.m.
Selected abstract posters will be
presented during lunch Thursday and
Friday. There will be time during these
lunch session to visit and explore the
posters and meet with the authors.
Posters may also be viewed during
lunch on Wednesday, May 18 from
12:00 – 1:00 p.m. but will not have
presentations at this time. The top
twenty three abstracts will be presented
with “SHEA Abstract Award” ribbons.
Thursday Poster Topics:
VAE, CAUTI, CLABSI, Disinfection/
Sterilization, Environmental Cleaning,
Hand Hygiene, Pediatrics, Respiratory
Viruses, and SSI
Friday Poster Topics:
Antibiotic Stewardship, C.
difficile, Diagnostic/Microbiology,
Implementation Science, Long-Term
Care, and MDR GNR
6
EVENTS
SHEA Mentors and Mentees will gather
to discuss the newly implemented
SHEA Mentorship Program. This
Program is designed to create a strong
networking community; providing and
enhancing the SHEA membership
experience at all levels (e.g. student,
fellow, junior faculty and practitioners).
The goal is to form relationships that
can be carried forward beyond this
meeting. The mentoring Program seeks
to cultivate supportive and mutually
rewarding relationships between the
mentee and the mentor. As the mentee
seeks advice and support with career
development, and goal achievement,
the mentor will provide guidance and
help the mentee set and attain goals, as
well as offer encouragement. Mentors
have the satisfaction of sharing their
experience & wisdom. As in any
teaching relationship, the teacher often
benefits from new insights and rejuvenated enthusiasm. This breakfast is
open only to SHEA Mentors, SHEA
Mentees, and SHEA Leaders.
Mentors
Aneesa Afroze
Mayar Al Mohajer
Jaffar Al-Tawfiq
Kumar Angamuthu
Edward Chapnick
Teena Chopra
Marci Drees
Ozlem Equils
Judy Guzman-Cottrill
Jesse Jacob
Susan Jain
Waleed Javaid
Marion Kainer
Zeina Kanafani
Sheetal Kandiah
Aaron Milstone
Venkat Minnaganti
Lona Mody
Nathanael Napolitano
Michael Oji
Belinda Ostrowsky
Ravi Pallipamu
Chistopher Pfeiffer
Aurora Pop-Vicas
Michael Rubin
Matt Seymour
Mark Shelly
Arjun Srinvasan
Paul Tambyah
Kerri Thom
David Woodard
Sharon Wright
Mentees
Sujit Suchindran
Andre Rossi
Mohamed Badawi
Sarit Sharma
Nagakrishnal Nachimuthu
Jerry Jacob
Geehan Suleyman
Holly Sweet
Jonathan Crews
Lovisa Olafsdottir
Savitha Nagaraj
Shambhu Dutta Joshi
Ana Carla Silva
Caline Matter
Priya Nori
Matthew Washam
Ratna Rao
Colleen Roberts
Marissa Valentine
Oscar Gutierrez-Aguirre
Marybeth Sexton
Caitlyn Ngam
Hajime Kanamori
Ana Bardossy
Carlos Figueroa Castro
Anna Barker
Deborah Kupferwasser
Elise Martin
Norihisa Yamamoto
Rishi Parikh
Karen Brust
Amy Lane
GENERAL INFORMATION
SPEAKER READY ROOM
Chastain A
Hours of Operation:
Tuesday, May 17, 2:30 – 5:30 p.m.
Wednesday, May 18, 6:30 a.m. – 6:00 p.m
Friday, May 20, 6:30 a.m. – 6:00 p.m.
Saturday, May 21, 6:30 – 10:00 a.m.
SHEA INTERNATIONAL
BREAKFAST
Friday, May 20, 7:00 – 7:50 a.m.
Peachtree Room
All International attendees & SHEA
Leadership are invited to attend this international networking opportunity. This is a
time for International members to share
and actively participate in conversations
on implementing infection prevention
best practices and knowledge. This
networking event serves as a vehicle for
international members to work together
to identify the gaps in meeting the needs
of infection preventionists and other
healthcare professionals outside of the
United States. This breakfast is open
only to International attendees and
SHEA Leaders.
FOUNDATION DONATION
INFORMATION
SHEA is committed to providing
members what they need to be leaders
in their facilities — now and into the
future. Membership dues cover only
a small percentage of what SHEA
needs to provide these valuable tools
and opportunities. We need the help
and commitment from all members to
continue to recruit and transform SHEA
members into SHEA leaders, and to
help train the next generation of healthcare epidemiologists. We are asking
each SHEA member to ‘Double their
Dues’ in 2016.
Please visit www.shea-online.org/
Foundation/Donate.aspx
to find out how to make an online tax
deductible donation or email
[email protected] to make
your donation. As a thank you, you
will receive a “Keep Calm and
Let the Epidemiologist Handle It” t-shirt.
2ND ANNUAL SHEA
EDUCATION AND
RESEARCH FOUNDATION
DINNER (Ticketed Event)
Thursday, May 19, 6
:00 p.m.
Georgia Aquarium, located down
the street from the Westin Peachtree
hotel. Transportation to the Aquarium
will not be provided.
The SHEA Education and Research
Foundation is hosting its 2nd annual
foundation dinner. Speakers this year
include David Henderson, MD, and
Julie Gerberding, MD, MPH.
If you did not purchase a ticket
in advance, a limited number of
tickets are available for purchase
at Registration until 5:00 p.m.
Wednesday, May 18.
Please note: No transportation will be
provided as the Georgia Aquarium is
within walking distance to the Westin
Peachtree Plaza.
SHEA Staff and Atlanta Volunteers will be
available as guides for walking groups.
Guides will depart from the hotel lobby at
5:30 p.m. to take you to the aquarium.
If you are walking on your own, the
aquarium’s Oceans Ballroom is located on
the first level of the parking deck. If parking
at the aquarium, take the elevator to level
one and follow the signs to the Oceans
Ballroom.
Chastain A serves as the speaker ready
room for presenters to review and update
presentations as well as check for any
last-minute issues. Professional audiovisual staff will be available in the speaker
ready room to provide assistance.
Speakers are required to arrive at the
room they are presenting in 15 minutes
before their session starts in order to meet
with the moderator of the session.
REGISTRATION AND
MEMBERSHIP BOOTH
Peachtree Ballroom Foyer
Tuesday, May 17, 2:30 p.m. – 5:30 p.m.
Wednesday, May 18 , 6:30 a.m. – 6:00 p.m.
Thursday, May 19, 6:30 a.m. – 6:00 p.m.
Friday, May 20, 6:30 a.m. – 6:00 p.m.
Saturday, May 21, 6:30 – 10:00 a.m.
HOTEL INFORMATION
SHEA Spring 2016 is being held at the
Westin Peachtree in Atlanta, Georgia.
A map of the hotel and location of all
activities is provided on pages 14-15 of
this program.
INTERNET CONNECTION
Wireless Internet connection will
not be provided in meeting rooms.
Complimentary WiFi connection will be
available in the hotel lobby and guest
sleeping rooms.
SESSION CHANGES
SHEA will display a message board in
the registration area (Peachtree Ballroom
Foyer), which will display any daily
session changes.
Julie Gerberding, MD, MPH
David Henderson, MD
SHEA AWARDS
SHEA
AWARDS
JOHNATHAN FREEMAN
SCHOLARSHIP AWARDEES
BILL RUTALA SCHOLARSHIP GINA PUGLIESE
AWARDEES
SCHOLARSHIP AWARDEES
The Jonathan Freeman Scholarship was
established by SHEA to promote the
training of outstanding infectious disease
fellows who demonstrate interest in the
field of healthcare epidemiology. The
society established this scholarship in
the memory of Jonathan Freeman, MD,
MPH, a teacher and researcher in
the field of healthcare epidemiology
dedicated to improving the delivery of
healthcare through the prevention of
nosocomial infections. Dr. Freeman was
a founding faculty member who for a
decade taught the epidemiology and
statistics track of the course.
The Bill Rutala Scholarship was
training of a non-physician interested
in the research of healthcare-associated infections. SHEA established this
scholarship in honor of William Rutala,
MS, MPH, PhD a prominent SHEA
leader the field of healthcare epidemiology research. Dr. Rutala was the
SHEA Lectureship awardee in 2012
and has worked tirelessly researching
areas such as disinfection, sterilization,
cross-infection, healthcare-associated
infections, outbreaks, and antibiotic-resistant pathogens.
The Gina Pugliese Scholarship was
training of a non-physician infection
preventionist (IP) who has shown
outstanding interest and leadership
in the field or works in a resource
limited setting. SHEA established
this scholarship in honor of Gina
Pugliese, RN, MS, a prominent IP
and leader in the field of healthcare
epidemiology. Ms. Pugliese was
a founding faculty member of the
SHEA/CDC Training Course and
co-chair for 15 years.
Laura Kate Tyner, RN
Nebraska Infection
Control Assessment and
Promotion Program
J. Bradford
Bertumen, MD Duke University
Medical Center
Kazuaki Jindai, MD
Oregon Health &
Science University
Rachael Lee, MD
University of
Alabama at
Birmingham
Lovisa Bjork
Olafsdottir, MD Beth Israel Deaconess
Medical Center
Nicole Poole, MD
Seattle Children’s
Hospital
Hiroki Saito, MD
University of
California Irvine
Michelle S.
Toleman University of
Cambridge
8
Nicholas M.
Moore, MS
Rush University
Medical Center
Rajeshwari Nair,
MBBS The University
of Iowa
INTERNATIONAL
AMBASSADORS
INTERNATIONAL AMBASSADORS PROGRAM WINNERS
In its eighth year, the International Ambassadors Program (IAP) builds collaborative
relationships between U.S. and international healthcare professionals with expertise in
healthcare epidemiology and infection prevention. Since 2009, SHEA has partnered
with 3M to benefit the international community of healthcare professionals dedicated
to infection prevention through our International Ambassadors Program. To date
SHEA has welcomed 62 Ambassadors representing 35 countries.
Wensen Chen, MPH
China
Jiangsu Province
Hospital
Elie K. Kabululu, RN
Democratic
Republic of Congo
Centre Medical
Evangelique De
Nyankunde A Beni
Joost Hopman, MD
The Netherlands
Radboud University
Medical Center
Aamer Ikram, PhD
Pakistan
Armed Forces
Institute of
Pathology
Sujan B. Marahatta,
PhD
Nepal
Manmohan
Memorial Institute of
Health Sciences
Nathlee McMorris,
MD
Jamaica
National Public
Health Laboratory
Vandana K.
Eshwara, MD
India
Kasturba Medical
College
Corey Forde, DM
Barbados
Queen Elizabeth
Hospital
Susan Jain, MN
Australia
Prince of Wales
Hospital
Uday Kelkar, MD
India
Central Government
Health Scheme
Mbogori M.
Murugu, BSN
Kenya
Infection Prevention
Network, Kenya
Philip O. Oshun,
MPH
Nigeria
Lagos University
Teaching Hospital
Jan Gralton, PhD
Australia
Clinical Excellence
Commission
Ahmed M.
Hakawi, MD
Saudi Arabia
King Fahad
Medical City
Thana
Khawcharoenporn,
MD
Thailand
Thammasat
University
Reginaldo A. de
Luz, MSc
Brazil
School of Nursing,
University of São
Paulo
Fu Qiao, MD
China
West China
Hospital, Sichuan
University
Ratna Rao, MD
India
Apollo Hopsital,
Hyderabad
SHEA INTERNATIONAL AMASSADORS
SHEA
SCHEDULE AT A GLANCE
SCHEDULE
AT
A
GLANCE
WEDNESDAY, MAY 18
l
7:00 – 7:50 a.m. Continental Breakfast
8:00 - 9:30 a.m. Opening Plenary: CDC and Healthcare Associated Infections —Prevention in
the Past, the Present, and the Future
9:30 – 10:00 a.m.
l
l
l
10:00 – 10:15 a.m. Joint Session: Course Overview
Chastain F
10:00 – 12:00 p.m. Creating a Level Playing Field with Publicly Reported HAI Data
Savannah Ballroom
10:00 – 11:00 a.m. Are there Global Standards for Endoscope Reprocessing Methods?
Chastain Room
10:15 – 11:15 a.m. Joint Session: Introduction to Healthcare Epidemiology
Chastain F
11:00 – 12:00 p.m. The Possibilities of Innovation Automated Tools in Hand Hygiene Compliance
Chastain Room
11:15 – 12:00 p.m. Joint Session: Transmission of Infectious Agents in Healthcare Settings
Chastain F
Measurement
12:00 – 1:00 p.m.
l
l
l
l
l
l
l
l
l
l
l
l
l
l
Networking Break
Lunch with Poster Viewing
1:00 – 1:45 p.m. Practical Strategies for Surveillance
1:00 -2:15 p.m. Managing Outbreaks
Chastain F
Chastain E
1:00 – 2:30 p.m. Implementation Academy: Turning Science into Improved Practice
Savannah Ballroom
1:00 – 2:30 p.m. Oral Abstract Session: MDROs
Chastain Room
1:45 – 2:30 p.m. The Compendium Strategies for Preventing HAIs
Chastain F
2:30 – 4:00 p.m. Changing Approaches in Surveillance
Chastain E
2:45 – 3:45 p.m. Change Management & the Science of Safety
Chastain F
2:45 – 4:00 p.m. Pediatric Infection Prevention: Focus on Guideline Implementation
Savannah Ballroom
2:45 – 3:30 p.m. Oral Abstract Session: Outbreaks
Chastain Room
3:45 – 4:15 p.m. Root Cause Analysis Practical Session
Chastain F
4:15 – 5:30 p.m. Strategies to Prevent Infections & MDROs
Chastain E
4:15 – 5:30 p.m. Oral Abstract Session: Innovation In Infection Prevention
Chastain Room
4:15 – 5:45 p.m. Choosing Wisely
Savannah Ballroom
4:30 – 5:30 p.m. Overview of Antibiotic Stewardship
Chastain F
6:00 – 8:00 p.m. Women in Epi Reception
l Plenaries
l Oral Abstract Sessions
l Full Conference Sessions
l SHEA/CDC Training Certificate Course in Healthcare Epidemiology
l SHEA/CDC/AMDA Infection Prevention in Post-Acute & Long-Term Care Certificate Course
l SHEA Antibiotic Stewardship Training Course
Joint Session for Both Tracks
10
AT
A
GLANCE
(continued)
THURSDAY, MAY 19
l
l
l
l
l
l
7:00 – 7:50 a.m. Mentorship Breakfast
Peachtree Room
8:00 – 8:45 a.m. Occupational Health & Safety
Chastain E
8:00 – 8:45 a.m. CDC Problem Session: Device Associated Infections
Chastain F
8:00 – 9:30 a.m. Environmental Disinfection
Chastain Room
8:00 – 9:30 a.m. Selling Your Results: To Suits, Scientists & Society
Savannah Ballroom
8:45 – 9:30 a.m. CDC Problem Session: Procedure Infections
Chastain F
8:45 – 9:30 a.m. CDI Management
Chastain E
9:30 – 10:00 a.m.
l
l
l
l
l
Networking Break
10:00 – 10:45 a.m. Unique Aspects of Pediatric Infection Control
Chastain F
10:00 – 11:00 a.m. Challenging Situations
Chastain E
10:00 – 12:00 p.m. Surgical Site Infection Prevention–Where Do We SCIP & HOP From Here
Chastain Room
10:00 – 12:00 p.m. Practical Consideration in HAI Research
Savannah Ballroom
10:45 – 11:30 a.m. Approach to Epidemic/Outbreak Investigation
Chastain F
11:00 – 12:00 p.m. Joint Session: Antibiotic Stewardship in Skilled Nursing Facilities &
Chastain E
11:30 – 12:00 p.m. Problem Session: Outbreak in the OR
Chastain F
Long-Term Care
l
12:00 – 1:00 p.m.
l
l
l
l
Lunch With Poster Presentations
1:00 – 2:30 p.m. Breakout: Beginning Antibiotic Stewardship
Chastain E
1:00 – 2:30 p.m. Breakout: Advanced Antibiotic Stewardship
Chastain F
1:00 – 2:30 p.m. Plenary: Reaching out to New Partners
2:45 – 3:15 p.m. What Every Steward Should Know About Pharmacokinetics
Chastain E
2:45 – 3:30 p.m. Joint Session: PAC&LTC: Changing the National Landscape & Infection
Chastain F
l
l
l
l
l
2:45 – 4:00 p.m. Oral Abstract Session: HAI Surveillance
Chastain Room
2:45 – 4:00 p.m. Pro/Con: To Wash or Rub Off C. difficile & Making the Most of C. difficile PCR
Savannah Ballroom
3:15 – 3:45 p.m. Allergies, Interactions and Adverse Events
Chastain E
3:30 – 4:15 p.m. Environment, Sterilization, & Disinfection
Chastain F
3:45 – 4:15 p.m. An Update on Duration of Therapy and Therapeutic Monitoring: Our Role as
Chastain E
l
4:15 – 5:45 p.m. Updates from the CDC Prevention Epicenters Program: A Public Health/
Chastain Room
l
l
l
l
4:15 – 5:45 p.m. Is There Quality in Quality Metrics?
Savannah Ballroom
4:30 – 5:00 p.m. Antibiotic Stewardship: Navigating the Liability Risks
Chastain E
4:30 – 5:30 p.m. Special Populations: Immunocompromised, ICU, Dialysis & Burn Patients
Chastain F
5:00 – 5:45 p.m. Case Study #1: Using Benchmarking to Enhance Antibiotic Stewardship
Chastain E
6:00 – 9:00 p.m. 2nd Annual SHEA Education and Research Foundation Dinner
Georgia Aquarium
– Pharmacodynamics
Prevention
Stewards
Academic Research Partnership
(Advance Ticket Purchase Required)
SCHEDULE
SCHEDULE
AT
A
GLANCE
FRIDAY, MAY 20
7:00 – 7:50 a.m.
International Meet and Greet Breakfast
7th Floor: Augusta Ballroom
Peachtree Room
l
l
8:00 – 8:45 a.m. Leadership & Communication Skills
Chastain F
8:00 – 8:45 a.m. Integration of the Microbiology Lab & Antibiotic Stewardship:
Chastain E
l
l
l
l
8:00 – 9:30 a.m. Research Methods in Healthcare Epidemiology – Practical Considerations
Savannah Ballroom
8:00 – 9:30 a.m. Novel Engineering Solutions to Environmental Hygiene
Chastain Room
8:45 – 9:30 a.m. The Hospital Epidemiologist as a Clinical Educator
Chastain F
8:45 – 9:30 a.m. Rapid Diagnostic Tests and How to Implement their Use: Mini-lecture &
Chastain E
Beginning Concepts
Case Study #2
9:30 – 10:00 a.m.
l
l
l
l
l
l
l
Networking Break
10:00 – 10:30 a.m. Update on National Stewardship Activities
Chastain E
10:00 – 11:00 a.m. Occupational Health Issues
Chastain F
10:00 – 12:00 p.m. Regional Approach to MDRO Prevention
Savannah Ballroom
10:00 – 12:00 p.m. Challenging Cases and Issues in Infection Prevention
Chastain Room
10:30 – 11:30 a.m. How to find Resources at your Institution of Health System
Chastain E
11:00 – 12:00 p.m. Regulatory & Emergency Preparedness
Chastain F
11:30 – 12:00 p.m. Art of Antibiotic Stewardship
Chastain E
12:00 – 1:00 p.m.
Lunch With Poster Presentations
l
1:00 – 2:30 p.m. Plenary: Telling Stories: Using Narrative to Expand Awareness of
l
l
l
l
l
l
l
l
l
l
l
l
2:45 – 3:30 p.m. How to Read a Study and Perform Research
Chastain F
2:45 – 3:30 p.m. Informatics and Stewardship
Chastain E
2:45 – 3:45 p.m. Role of one Microbiome in Resistance Against Healthcare Associated Infections
Chastain Room
2:45 – 4:00 p.m. Device-Associated Infections: Can Science Bring us to Zero?
Savannah Ballroom
3:30 – 4:00 p.m. Management of Resistant Gram Positive Infections
Chastain E
3:30 – 4:10 p.m. Business of Infection Prevention: Promoting Growth of a Program
Chastain F
4:15 – 4:45 p.m. Management of Resistant Gram Negative Infections
Chastain E
4:15 – 5:00 p.m. The Role of the Laboratory in Healthcare Epidemiology
Chastain F
4:15 – 5:45 p.m. A Human Factors & Systems Engineering Approach to Infection Prevention
Savannah Ballroom
4:15 – 5:45 p.m. Top Oral Abstract Session
Chastain Room
4:45 – 5:45 p.m. Case Study #3: Stewardship and C. difficile Infection
Chastain E
5:00 – 5:45 p.m. Putting it all Together: Leading your Healthcare Facility through a
Chastain F
12
Massive Exposure Situation
A
GLANCE
(continued)
SATURDAY, MAY 21
l
l
l
8:00 – 9:30 a.m. Pro/Con: Universal PPE
Savannah Ballroom
8:00 – 9:30 a.m. Crossing the Stewardship Continuum
Chastain F
8:00 – 9:30 a.m. Oral Abstract Session: Antibiotic and Test Stewardship
Chastain Room
9:30 – 10:00 a.m. Networking Break
l
10:00 – 12:00 p.m. Closing Plenary: Creating a Culture of Accountability & Professionalism
to Drive Improvement
l Plenaries
l Oral Abstract Sessions
l Full Conference Sessions
l SHEA/CDC Training Certificate Course in Healthcare Epidemiology
l SHEA/CDC/AMDA Infection Prevention in Post-Acute & Long-Term Care Certificate Course
l SHEA Antibiotic Stewardship Training Course
AT
WESTIN PEACHTREE HOTEL FLOOR PLAN
SCHEDULE
CHASTAIN
F
POSTER
PICKUP
CHASTAIN
E
CHASTAIN
A
CHASTAIN
ROOM
6TH FLOOR
Chastain Room:
Abstract Presentations,
Full Conference Track Sessions
Chastain A:
Speaker Ready Room
AUGUSTA LEVEL, SEVENTH FLOOR
Chastain
E:
SHEA/CDC/AMDA Infection Prevention in Post-Acute & Long-Term Care Certificate Course,
SHEA Antibiotic Stewardship Training Course
Chastain F:
SHEA/CDC Training Certificate Course in Healthcare Epidemiology,
Breakout and Joint Sessions
ACCESS TO 200 PEACHTREE
AUGUSTA ROOM
AUGUSTA BALLROOM
7TH FLOOR
Augusta Ballroom(s):
Breakfast, Networking Breaks, and Lunch with Posters
14
PEACHTREE
ROOM
PEACHTREE BALLROOM
8TH FLOOR
Peachtree Ballroom Foyer:
Registration, Membership Booth
Peachtree Room:
Mentorship Breakfast
VANNAH LEVEL, TENTH FLOOR
International Meet and Greet Breakfast
Peachtree Ballroom CD:
Plenary Sessions
Women in Epi Reception
10TH FLOOR
(Escalator access from the 9th Floor)
Savannah Ballroom:
Full Conference Sessions
SAVANNAH BALLROOM
FOYER
WEDNESDAY, MAY 18
W E S T I N P E A C H T R E E H O T E L F L O O R P L A N (continued)
WEDNESDAY, May 18
SCIENTIFIC
PROGRAM
CONTINENTAL BREAKFAST
7:00 – 7:50 a.m.
OPENING PLENARY:
CDC AND HEALTHCARE ASSOCIATED
INFECTIONS: PREVENTION IN THE PAST,
THE PRESENT, AND THE FUTURE
8:00 – 9:30 a.m.
Moderator: Beth Bell, MD
Speakers:
Introduction: What is happening at the CDC? Beth Bell, MD
Public Health and HAI Prevention: A Changing Paradigm Mike Bell, MD
Expanding the Reach: Federal/State Partnership in HAI
Prevention - Marion Kainer, MD
Exploring the Cutting Edge of HAI Prevention Science:
What’s New, What’s Next, What’s on the Horizon John Jernigan, MD
Learning Objectives:
• Assess the overview of the internal CDC process for dealing
with emergent infectious diseases
• Discuss the state level perspective on interactions and collaboration with CDC
• Describe the long-term vision of CDC and how it affects
hospital epidemiologists and infection preventionists
NETWORKING BREAK
9:30 – 10:00 a.m.
SCHEDULE
ARE THERE GLOBAL STANDARDS FOR
ENDOSCOPE REPROCESSING METHODS?
10:00 – 11:00 p.m.
Chastain Room
Moderators: John Boyce, MD and Carolyn Gould, MD
Speakers:
MDRO Outbreaks Linked with Endoscopes Alexander Kallen, MD
Does One Size Fit All? Global Guidelines for Endoscope
Reprocessing - Paul Tambyah, MD
• Review the implications associated with inadequately decontaminated endoscopes as they relate to several outbreaks
across countries.
• Evaluate measures for successful decontamination processing
of endoscopes.
• Identifying produced guidelines and necessary quality controls
for endoscope reprocessing practices
THE POSSIBILITIES OF INNOVATIVE
AUTOMATED TOOLS FOR HAND HYGIENE
COMPLIANCE MEASUREMENT
11:00 – 12:00 p.m.
Chastain Room
Moderators: John Boyce, MD and Susan Huang, MD
Speakers:
The Evidence behind Unique Methods and Newly
Discovered Electronic Tools to Improve Hand Hygiene Joost Hopman, MD
Does Real Time Automated Hand Hygiene Compliance
Measurement Improve Practice? - Ermira Tartarim, MSc
FULL CONFERENCE
CREATING A LEVEL PLAYING FIELD WITH
PUBLICALLY-REPORTED HAI DATA
10:00 – 12:00 p.m.
Savannah Ballroom
Moderators: Anthony H
arris, MD and
Daniel Diekema, MD
Speakers:
The Next Steps for Risk Stratification of HAI Data Anthony Harris, MD
Analyzing Reported HAI Data for Variation in Definition
Application - Emily Sickbert-Bennett, PhD
Moving to Objective Surveillance Outcomes to Level the
Playing Field: Hospital - Onset Bacteremia Aaron Milstone, MD
• Discuss challenges with currently reported HAI metrics
• Assess variations in reported HAI data and potential issues
with selection and reporting biases
• Examine alternative metrics and methods to ensure a more
level playing field with regards to reported HAI metrics
16
• Identify quantitative and qualitative research evaluation and
identifying the challenges in adopting unique electronic
methods to measure hand hygiene compliance
• Assess the ability of currently available electronic tools in
providing adequate hand hygiene actions
• Identify the differences in behavioral science linked to the
human review process versus automated process in improving
hand hygiene compliance
PROGRAM
JOINT SESSIONS
FULL CONFERENCE
COURSE OVERVIEW
10:00 - 10:15 a.m.
Chastain F
Speakers: Sarah Haessler, MD and Nimalie Stone, MD
• Orientation to course materials
• Overview of course structure
INTRODUCTION TO HEALTHCARE
EPIDEMIOLOGY
10:15 - 11:15 a.m.
Chastain F
Speaker: Trish Perl, MD
• Obtain a broad overview of the importance of basic concepts
in infection prevention, including hand hygiene and asepsis,
isolation precautions, disinfection and sterilization, device
reprocessing, and environmental cleaning
• Define occupational health-related issues and procedures
• Examine immunization of HCW and patients
• Review infected HCW assessment
• Discuss blood borne pathogen and communicable disease
exposure management
• Explain environmental infection control, air handling and water
• Classify infection control issues related to construction in
healthcare facilities
• Define the role of healthcare epidemiology across the
continuum of care
• Define the role of epidemiology beyond infection control
• Define the hospital epidemiologist’s role in regulatory
compliance
TRANSMISSION OF INFECTIOUS AGENTS
IN HEALTHCARE SETTINGS 11:15 - 12:00 p.m.
Chastain F
Speaker: Curtis Donskey, MD
• Discuss modes of transmission for important healthcare
pathogens
• Evaluate methods for interruption of transmission of pathogens
in healthcare settings
• Discuss how to implement effective methods to prevent
transmission
LUNCH WITH POSTER VIEWING
12:00 – 1:00 p.m.
SCHEDULE
Posters may be viewed during this lunch period with no
presentations.
IMPLEMENTATION ACADEMY: TURNING
SCIENCE INTO IMPROVED PRACTICE
1:00 – 2:30 p.m.
Savannah Ballroom
Moderators: Jennifer Meddings, MD and
Sarah Krein, PhD
Speakers:
Implementation Methods: Understanding the Models and
Methods - Sarah Krein, PhD
CAUTI Prevention in Post-Acute and Long-Term Care:
Applying Principles of Implementation Science Lona Mody, MD
Real-Life Case Examples: Discussing Implementation
Challenges in the Trenches - Silvia Munoz-Price, MD
A couple of case examples will be presented in this session.
• Identify key models and methods in the field of implementation
science
• Discuss implementation focused strategies and approaches
for preventing MDROs
• Describe the application of implementation principles as part of
a large-scale collaborative focusing on preventing CAUTI in the
long-term care setting
ORAL ABSTRACT SESSION: MDROS
1:00 – 2:30 p.m.
Chastain Room
Moderators: Alex Kallen, MD and Brooke Decker, MD
7967All-Cause Mortality, Among Hospitalized Patients, With
Carbapenem-Resistant Enterobacteriaceae (CRE)
Sandra N. Bulens, MPH1, Uzma Ansari, MS1, Tatiana Travis, BS1,
Kelly McCormick, MSPH2, David Kleinbaum, PhD1, Valerie S. Albrecht,
MPH1, Maroya Walters, PhD ScM1, Jesse Jacob, MD3,4, Christopher
Bower, MPH4,5,6, Lucy Wilson, MD7, Elisabeth Vaeth, MPH8, Ruth
Lynfield, MD9, Kristin Shaw, MPH9, Paula M. Snippes Vagnone,
MT9, Wendy Bamberg, MD10, Sarah Janelle10, Ghinwa Dumyati, MD,
FSHEA11,12, Cathleen Concannon, MPH11,13, Erin C Phipps, DVM,
MPH14, Nicole Kenslow, MPH14, Zintars Beldavs, MS15, P. Maureen
Cassidy, MPH15, Marion A. Kainer, MD, MPH16, Jacquelyn Mounsey,
BSN, RN17, Maria Karlsson, PhD1 and Alexander J. Kallen, MD,
MPH1, (1)Centers for Disease Control and Prevention, Atlanta, GA,
(2)Division of Healthcare Quality Promotion, CDC, Atlanta, GA, (3)
Emory University School of Medicine, Division of Infectious Diseases,
Atlanta, GA, (4)Georgia Emerging Infections Program, Decatur, GA, (5)
Atlanta Research and Education Foundation, Atlanta, GA, (6)Atlanta
Veterans Affairs Medical Center, Decatur, GA, (7)Department of Health
& Mental Hygiene, Baltimore, MD, (8)6Maryland Department of Health
and Mental Hygiene, Baltimore, MD, (9)Minnesota Department of
Health, Saint Paul, MN, (10)Colorado Department of Public Health
& Environment, Denver, CO, (11)New York Emerging Infections
Program, Rochester, NY, (12)University of Rochester Medical Center
- Center for Community Health, Rochester, NY, (13)University of
Rochester Medical Center, Rochester, NY, (14)University of New
Mexico, New Mexico Emerging Infections Program, Albuquerque,
NM, (15)Oregon Health Authority, Portland, OR, (16)Tennessee
Department of Health, Nashville, TN, (17)Tennessee Emerging
Infections Program, Vanderbilt University, Nashville, TN
(Continued to page 18)
WEDNESDAY, May 18
SCIENTIFIC
WEDNESDAY, May 18
SCIENTIFIC
PROGRAM
8110Genomic and Epidemiological Analysis Identifies
EMRSA-15 Transmission In the UK Community
Michelle S Toleman1, Emmeline R Watkins2, Tom Williams1, Francesc
Coll1, Bernadette Nazareth2, Belinda Sadler3, Nick Brown4, Julian
Parkhill5 and Sharon J Peacock1,6, (1)University of Cambridge,
Cambridge, United Kingdom, (2)Health Protection Team, PHE East of
England, Thetford, United Kingdom, (3)Infection Prevention & Control
Cambridgeshire & Peterborough CCG, Cambridgeshire, United
Kingdom, (4)PHE Clinical Microbiology and Public Health Laboratory,
Cambridge, United Kingdom, (5)Wellcome Trust Sanger Institute,
Cambridge, United Kingdom, (6)LSHTM, London, United Kingdom
8144 Factors Leading to Transmission Risk of Acinetobacter
baumannii
Kerri Thom, MD, MS1, Clare Rock, MD, MS2, Sarah S Jackson,
MPH1, J. Kristie Johnson, PhD3, Laurence S. Magder, PhD1, Robert
A. Bonomo, MD4 and Anthony Harris, MD, MPH1, (1)Department
of Epidemiology and Public Health, University of Maryland School
of Medicine, Baltimore, MD, (2)Department of Medicine, Division of
Infectious Diseases, Johns Hopkins University, Baltimore, MD, (3)
University of Maryland, Baltimore, MD, (4)Louis Stokes Cleveland VA
Medical Center, Cleveland, OH
8125Prevalence of Multi Drug Resistant Organism (MDRO)
Contamination in Nursing Homes
Michael Bolaris, MD1,2,3, James A McKinnell, MD2, Bryn Launer,
BS2, Kyle Ramsay, BS2, Raveena Singh, MS4, Tabitha Dutciuc, MPH4,
Marlene Estevez, BA4, Tom Tjoa, MS MPH4, Ellena Peterson, PhD5,
Kaye Evans, BS6, Susan S. Huang, MD, MPH4 and Loren Miller, MD,
MPH7,8, (1)Department of Pediatrics, Harbor UCLA Medical Center,
David Geffen School of Medicine at UCLA, Torrance, CA, (2)Infectious
Disease Clinical Outcomes Research Unit (ID-CORE), Division of
Infectious Disease, Los Angeles Biomedical Research Institute at
Harbor-University of California Los Angeles (UCLA) Medical Center,
Torrance, CA, (3)Los Angeles Biomedical Research Institute at Harbor
UCLA Medical Center, Torrance, CA, (4)Division of Infectious Diseases
and Health Policy Research Institute, University of California, Irvine
School of Medicine, Irvine, CA, (5)Department of Pathology and
Laboratory Medicine, University of California School of Medicine,
Irvine, CA, (6)Department of Pathology and Laboratory Medicine,
University of California, Irvine School of Medicine, Irvine, CA, (7)Los
Angeles Biomedical Research Institute at Harbor UCLA Medical
Center, Torrance, CA, CA, (8)Department of Medicine, Division of
Infectious Disease, Harbor-UCLA Medical Center, David Geffen
School of Medicine, Torrance, CA
7787SAVE’M STAT: Staph Aureus Vancomycin Evaluation of
MIC: A Semi-Automated Tool for Analyzing Trends
Robert Clifford, PhD1, Uzo Chukwuma2, Charlotte Neumann2, Paige
Waterman, MD3, Emma Milburn2, Jacob Moran-Gilad4, Michael
Julius, PMP1, Mary Hinkle, MD1 and Emil Lesho, DO1, (1)Walter Reed
Army Institute of Research, Silver Spring, MD, (2)Navy and Marine
Corps Public Health Center, Portsmouth, VA, (3)Armed Forces Health
Surveillance Center, Silver Spring, MD, (4)Ben-Gurion University of the
Negev, Be’er Sheva, Israel
7987Genomic Analysis of Transmission of KPC-Producing
Enterobacter and Klebsiella Species
Hajime Kanamori, MD, PhD, MPH1,2, Christian M. Parobek3,
Jonathan J. Juliano1, David Van Duin1, David J. Weber, MD, MPH1,4
and William A. Rutala, PhD, MPH1,4, (1)Division of Infectious Diseases,
University of North Carolina School of Medicine, Chapel Hill, NC, (2)
Hospital Epidemiology, University of North Carolina Health Care,
Chapel Hill, NC, (3)University of North Carolina School of Medicine,
Chapel Hill, NC, (4)Hospital Epidemiology, UNC Medical Center,
Chapel Hill, NC
18
SCHEDULE
PEDIATRIC INFECTION PREVENTION:
FOCUS ON GUIDELINE
2:45 – 4:00 p.m.
Savannah Ballroom
Moderators: Kari Simonsen, MD and Matthew Linam, MD
Speakers:
Isolation Precautions and Parents and Visitors Matthew Linam, MD
Animals, Healthcare and Children - Gonzalo Bearman, MD
Implementation of the CF Guidelines - Kari Simonsen, MD
• Discuss the role parents and visitors play in the transmission of pathogenic organisms Discuss the current evidence
supporting the use of isolation precautions and hand hygiene
by parents and visitors
• Discuss the role of animal-to-human transmission of infections
in healthcare settings Develop strategies to minimize the risks
associated with animals in healthcare settings
• Discuss the potential healthcare sources and modes of transmission of cystic fibrosis pathogens to children with cystic fibrosis
• Develop strategies to minimize the risk of transmission and acquisition of cystic fibrosis pathogens in patients with cystic fibrosis
ORAL ABSTRACT SESSION: OUTBREAKS
2:45 – 3:30 p.m.
Chastain Room
Moderators: Marion Kainer, MD and Michael Bell, MD
8164Outbreak of Mycobacterium chimaera Infections in
Cardiac Surgery Patients Linked to Heater-Coolers
Emily J Cooper, RN, MS, CIC, WellSpan Health, York, PA
8122Screening of Exposed Healthcare Workers During an
Outbreak of MERS in Saudi Arabia
Dr. Hanan Balkhy, MD1, Aiman El-Saed, MD, PHD2, Henry BaffoeBonnie, MD2, Thamer H Alenazi, MD2, Azzam Mohammed2, Nimfa
L. Dagunton, BSN, RN1, Fatimah Abdulkarim, PHN2, Sameera Al
Johani, MD3, Waseem Khan, MD2 and Dina Afurong, RN2, (1)King
Abdulaziz Medical City, Riyadh, Saudi Arabia, (2)King Abdulaziz
Medical City; Ministry of National Guard Health Affairs, Riyadh, Saudi
Arabia, (3)Pathology and Laboratory Medicine Department, King
Abdulaziz Medical City, Riyadh, Saudi Arabia
8232Rethinking Measles Exposures in Health Care Settings:
Missed Opportunities to Prevent Transmission
Emmanuel Mendoza, MPH, Dulmini Wilson, MPH, Chhandasi
Pamina Bagchi, MPH, Idriss Fassassi, MPH, Jon LaMori, MA,
Franklin Pratt, MD and Michelle T. Parra, PhD, Los Angeles County
Department of Public Health Immunization Program, Los Angeles, CA
PROGRAM
ORAL ABSTRACT SESSION: INNOVATION
IN INFECTION PREVENTION
4:15 – 5:30 p.m.
Chastain Room
Moderators: Belinda Ostrowsky, MD and
Rebekah Moehring, MD
8146Post-Discharge Central Line Management in the
Nursing Home
Shruti K. Gohil, MD, MPH1,2, Mohamad Al Sharif, MD3, Raveena
Singh, MS4 and Susan S. Huang, MD, MPH4,5, (1)University of
California, Irvine School of Medicine, Assistant Professor, Irvine, CA,
(2)UC Irvine Medical Center, Associate Medical Director, Epidemiology
& Infection Prevention, Irvine, CA, (3)University of California Irvine
School of Medicine, Division of Infectious Diseases, Orange, CA, (4)
Division of Infectious Diseases and Health Policy Research Institute,
University of California, Irvine School of Medicine, Irvine, CA, (5)
Epidemiology and Infection Prevention, UC Irvine Health, Orange, CA
7942Sustained Improvement in Hand Hygiene at 3 Sites
with Badge-based Monitoring and Individual Feedback
Liberty R. Dykehouse, MSN, RN, ACNS-BC, CIC1, Megan E. Read,
MPH, MLS, CIC2 and Jessica Buckner, MSN, RN3, (1)Mercy Health
Saint Mary’s, Grand Rapids, MI, (2)Dartmouth-Hitchcock Medical
Center, Lebanon, NH, (3)Annie Penn Hospital, Reidsville, NC
8235Cost-effectiveness of Infectious Diseases (ID)
Consultation for S. aureus Bacteremia in Hemodialysis
Thomas C. Rose1, Jesse Jacob, MD2,3 and Chad Robichaux,
MPH3,4, (1)Emory University School of Medicine, Atlanta, GA, (2)
Emory University School of Medicine, Division of Infectious Diseases,
Atlanta, GA, (3)Emory University, Atlanta, GA, (4)Emory Healthcare,
Decatur, GA
8018Optimizing Urine Culture Ordering Practices Using the
Electronic Medical Record: A Pilot Study
Daniel K. Shirley, MD, MS1, Harry Scholtz, DO1, Kurt Osterby,
BS2, Barry C. Fox, MD1 and Nasia Safdar, MD, PhD3,4, (1)University
of Wisconsin School of Medicine and Public Health, Madison, WI,
(2)UW Health, University Hospital, Madison, WI, (3)The William S.
Middleton Veterans Affairs Medical Center, Madison, WI, (4)University
of Wisconsin School of Medicine & Public Health, Madison, WI
7799Increasing the Uptake of Influenza Vaccination by
Family Members of Pediatric Ambulatory Patients
Su Jin Joo, MD1,2, Sandra Rojas-Honan, RN, BSN2 and Andi
Shane, MD, MPH, MSc2,3, (1)Division of Pediatric Infectious
Diseases, Emory University School of Medicine, Atlanta, GA, (2)
Children’s Healthcare of Atlanta, Atlanta, GA, (3)Emory University
School of Medicine, Atlanta, GA
SCHEDULE
CHOOSING WISELY
Co-Organized by The Society of Infectious
Diseases Pharmacists (SIDP)
4:15 – 5:45 p.m.
Savannah Ballroom
Moderators: Elizabeth Dodds-Ashley, PharmD and
Gonzalo Bearman, MD
Speakers:
Choosing Wisely Campaign - Daniel Morgan, MD
Improving the Culture of Culturing: Why the Urine Mohamad Fakih, MD
The Role of Up and Coming Antibiotics at the Local Level Conan MacDougall, PharmD
• Examine approaches to reduce patient harm related to
inappropriate utilization of diagnostic tests and treatments.
• Review the Choosing Wisely campaign and the new SHEA
Choosing Wisely metrics
• Describe strategies to improve urine culture utilization and as a
result reducing antibiotic use and false positive UTI diagnoses
• Describe the role of new and emerging anti-infective agents at
the local level
• List key factors in assessing whether new anti-infective agents
add significantly to the local antibiotic formulary
SHEA/CDC TRAINING CERTIFICATE COURSE
IN HEALTHCARE EPIDEMIOLOGY
Course Moderator: Sarah Haessler, MD
PRACTICAL STRATEGIES FOR
SURVEILLANCE
1:00 – 1:45 p.m.
Chastain F
Speaker: Laurie Conway, PhD
• Identify core components of an HAI surveillance program
• Select optimal methods for collection and analysis of surveillance data
• Correlate relationship between surveillance and prevention
activities
• Evaluate surveillance findings and incorporate into effective
intervention plans
THE COMPENDIUM STRATEGIES FOR
PREVENTING HAIs
1:45 – 2:30 p.m.
Chastain F
Speaker: Deborah S. Yokoe, MD
• Identify priority recommendations of Compendium of
Strategies to prevent healthcare-associated infections in
acute-care settings and associated resources
• Identify practical methods and tools to meet basic and
advanced recommendations
WEDNESDAY, May 18
SCIENTIFIC
WEDNESDAY, May 18
SCIENTIFIC
PROGRAM
SHEA/CDC TRAINING
C E RT I F I C AT E C O U R S E
CHANGE MANAGEMENT AND THE
SCIENCE OF SAFETY
2:45 – 3:45 p.m.
1:00 – 2:15 p.m.
Chastain F
Chastain E
Speaker: David Nace, MD
• Compare the differences between RCA and FMEA and when
to utilize each method in the setting of HAI
• Develop the infrastructure and team necessary to perform a
RCA or FMEA
• Identify the scoring methodology for individual failure modes in
a FMEA
• Justify the use of RCA and FMEA
• Evaluate how the patient safety/infection prevention Program
intersects with the institution’s strategic plan
• Review basic concepts regarding patient safety, quality
science, implementation science, human factor design, and
organizational change
ROOT CAUSE ANALYSIS PRACTICAL
SESSION
Chastain F
Speaker: Tammy Lundstrom, MD
•
•
•
•
SHEA/CDC/AMDA INFECTION PREVENTION IN
PAC & LTC CERTIFICATE COURSE
MANAGING OUTBREAKS
Speaker: Tammy Lundstrom, MD
3:45 – 4:15 p.m.
SCHEDULE
Perform an RCA related to HAI in a team setting
Evaluate process changes necessary for a thorough RCA
Evaluate RCA measures of success
Identify how accreditation bodies will evaluate an effective RCA
• Describe how the long-term care environment influences
outbreak risk and impacts outbreak detection and response
• Identify common causes of outbreaks in post-acute and
• Discuss strategies to manage outbreaks that occur in the
long-term care environment
CHANGING APPROACHES IN
SURVEILLANCE
2:30 – 4:00 p.m.
Chastain E
Speaker: Nimalie Stone, MD
• Review surveillance criteria used to define infections in
post-acute and long-term care settings
• Compare different methods for surveillance data collection in
post-acute and long-term care settings
• Identify how to use surveillance data to guide infection
prevention and antibiotic stewardship efforts in post-acute and
long-term care
STRATEGIES TO PREVENT INFECTIONS
AND MDROS
4:10 – 5:30 p.m.
Chastain E
OVERVIEW OF ANTIBIOTIC STEWARDSHIP
Speakers: Lona Mody, MD, and Shira Doron, MD
4:30 – 5:30 p.m.
Chastain F
Speaker: Sara Cosgrove, MD
• Discuss the rationale for antibiotic stewardship
• Discuss the elements and activities of a stewardship program
• Discuss approaches to help prescribers make good decisions
about antibiotics
• Translate emerging national initiatives to encourage and
enhance antibiotic stewardship
• Describe risk factors and interventions to prevent deviceassociated infections among residents in post-acute and
long-term care
• Review challenges in diagnosis of infection due to C. difficile
and MDROs in post-acute and long-term care
• Describe strategies for preventing the spread of Multidrug
Resistant Organisms in post-acute and long-term care
WOMEN IN EPI RECEPTION
6:00 – 8:00 p.m.
20
PROGRAM
7:00 – 7:50 a.m.
MENTORSHIP BREAKFAST
7:00 – 7:50 a.m.
Peachtree Room
This breakfast is open only to SHEA Mentors, SHEA
Mentees, and SHEA Leaders.
FULL CONFERENCE
ENVIRONMENTAL DISINFECTION
8:00 – 9:30 a.m.
Chastain Room
Moderators: Philip Carling, MD and
Emily Sickbert-Bennett, PhD
Speakers:
UV Light/Peroxide - Deverick Anderson, MD
Monitoring - Curtis Donskey, MD
Return on Investment and Robots - Trish Perl, MD
SCHEDULE
S H E A / C D C C E R T I F I C AT E C O U R S E I N
H O S P I TA L E P I D E M I O L O G Y C O U R S E
CDC PROBLEM SESSION:
DEVICE-ASSOCIATED INFECTIONS
8:00 – 8:45 a.m.
Chastain F
Speakers: Jonathan Edwards, MStat and
Maggie Dudeck, MPH
• Summarize decisions on how to prioritize surveillance efforts
• Identify analytical methods for assessing temporal changes in
infection rates
• Indicate the role of risk adjustment when analyzing infection rate
data
• Identify methods of analysis for assessing intervention
effectiveness
• Assess, interpret, and summarize data that are imprecise
• Using NHSN to understand and benchmark your hospital’s
data
CDC PROBLEM SESSION: PROCEDURE
INFECTIONS
• Discuss the current state of hospital cleaning and disinfection
• Discuss the pros and cons of alternative or enhanced strategies
for room cleaning and disinfection
8:45 – 9:30 a.m.
SELLING YOUR RESULTS: TO SUITS,
SCIENTISTS, AND SOCIETY
8:00 – 9:30 a.m.
Savannah Ballroom
Moderators: Daniel Diekema, MD and
Anthony Harris, MD
Speakers:
The VP of Quality Perspective - Louise Dembry, MD
Social Media - Eli Perencevich, MD
Selling into Broader Society - Arjun Srinivasan, MD
Chastain F
Speakers: Jonathan Edwards, MStat and
Maggie Dudeck, MPH
• Summarize decisions on how to prioritize surveillance efforts
• Identify analytical methods for assessing temporal changes in
infection rates
• Indicate the role of risk adjustment when analyzing infection rate
data
• Identify methods of analysis for assessing intervention
effectiveness
• Assess, interpret, and summarize data that are imprecise
• Identifying how NHSN can help you understand and benchmark your hospital’s data
• Assess key persuasion techniques when dealing with C level
administrators
• Recognize how to influence your peers using hospital
epidemiology data
• Identify the fundamental components of how to transform
societal perceptions related to infection control
THURSDAY, MAY 19
SCIENTIFIC
SCIENTIFIC
PROGRAM
SHEA/CDC/AMDA INFECTION PREVENTION
I N PA C & LT C C E R T I F I C AT E C O U R S E
OCCUPATIONAL HEALTH AND SAFETY
8:00 – 8:45 a.m.
Chastain E
FULL CONFERENCE
SURGICAL SITE INFECTION PREVENTION:
WHERE DO WE SCIP AND HOP FROM
HERE?
Speaker: David Nace, MD
10:00 – 12:00 p.m.
Moderators: Marci Drees, MD and
Deverick Anderson, MD
Speakers:
Pre-Op Screening and Choice of Prophylaxis Trish Perl, MD
Splish Splash I was Taking a Bath: The Case for Antibiotic
Surgical Washes and Other Antibiotic Delivery Systems Belinda Ostrowsky, MD
A Bundle of Bundles- Extending Bundled Infection
Prevention and ASP Approach Across Surgical Procedures Jerod Nagel, PharmD
• Review common occupational health issues in the long-term
care setting
• Identify how to manage common occupation health issues in
• Identify regulatory requirements pertaining to occupational
health issues in long-term care
THURSDAY, MAY 19
SCHEDULE
CDI MANAGEMENT
8:45 – 9:30 a.m.
Chastain E
Speaker: Robin Jump, MD
• Define the management and prevention of CDI in post acute
care.
NETWORKING BREAK
9:30 – 10:00 a.m.
Chastain Room
• Review infection prevention and stewardship processes and
interventions in the post SCIP and HOP Era to prevent SSIs
• Discuss data and implementation of more proactive screening
to guide prophylaxis for surgical procedures (including
screening from MRSA or other MDRO pathogens or for
specific high risk procedures)
• Describe the data (or lack thereof) and practices for a series
of washes (chlorhexidine, antibiotic solutions, impregnated
beads) that are used in surgical procedures
• Describe” bundles” that address both prescribing and infection
prevention strategies; these would address a series of surgery
types and locations
PRACTICAL CONSIDERATIONS IN HAI
RESEARCH
10:00 – 12:00 p.m.
Savannah Ballroom
Moderators: Ann-Christine Nyquist, MD and
Shruti Gohil, MD
Speakers:
Ethics of QI and QI Research: The Blurring of the Lines Susan Huang, MD
Engaging Patients and other Stakeholders in your Research
- Jeffrey Gerber, MD
HAI/AS Research on a Shoestring - Leonard Mermel, DO
Is Something Better than Nothing? Gauging the Level of
Evidence for Implementation - Eli Perencevich, MD
• Describe critical elements of ethics and stakeholders in developing HAI research
• Discuss how to maximize opportunities to conduct HAI
research when funds are limited
• Assess the level of evidence for various interventions as a
critical step prior to implementation
22
PROGRAM
S H E A / C D C T R A I N I N G C E R T I F I C AT E
C O U R S E I N H E A LT H C A R E E P I D E M I O L O G Y
UNIQUE ASPECTS OF PEDIATRIC
INFECTION CONTROL
10:00 – 10:45 a.m.
SCHEDULE
SHEA/CDC/AMDA INFECTION PREVENTION
I N PA C & LT C C E R T I F I C AT E C O U R S E
CHALLENGING SITUATIONS
10:00 – 11:00 a.m.
Chastain F
Chastain E
Speaker: Thomas Sandora, MD
Panelists: David Nace, MD, Robin Jump, MD,
Shira Doron, MD, and Silvia Munoz-Price, MD
• Identify risk factors for healthcare-associated infections that
are unique to children
• Discuss common pediatric infections and how to prevent them
• Define unique aspects of infection control in special populations, including neonatal intensive care units
• Describe pediatric modifications to typical infection prevention
strategies
• Discuss challenging infection control situations that might arise
in post-acute and long-term care such as outbreaks, healthcare personnel vaccination, and antibiotic overuse
APPROACH TO EPIDEMIC/OUTBREAKS
INVESTIGATION
10:45 – 11:30 a.m.
Chastain F
Speaker: Arjun Srinivasan, MD
JOINT SESSIONS
ANTIBIOTIC STEWARDSHIP IN SKILLED
NURSING FACILITIES AND LONG-TERM
CARE
11:00 – 12:00 p.m.
Chastain E
Speaker: Kavita Trivedi, MD
•
•
•
•
Identify and define an outbreak
Illustrate how to perform an outbreak analysis
Analyze how to manage and control an outbreak
Indicate methods to find and investigate cases in an outbreak
investigation
• Recognize when a formal risk factor study is needed and how
to select the appropriate study design (e.g., case control vs.
cohort) for an outbreak investigation
• Recognize when and how to communicate with facility administrators, risk management, public affairs, clinical staff and
patients/families about the need for, progress of, and outcome
of an outbreak investigation
• Review the potential role of molecular typing of microbial
isolates in an outbreak investigation
• Define the unique challenges for resources, team development
and measurement in long-term care settings
• Identify starter strategies for implementing effective antibiotic
stewardship in long-term care settings
• Describe collaborations between acute care and long-term
care to create effect antibiotic stewardship programs
CPE Number: 0221-9999-16-079-L04-P
PROBLEM SESSION:
OUTBREAK IN THE OR
11:30 – 12:00 p.m.
Chastain F
• Apply the lessons of outbreak investigation to a real world
example
• Identify some of the practical issues that arise when doing an
outbreak investigation
THURSDAY, MAY 19
SCIENTIFIC
POSTER PRESENTATIONS: THURSDAY, MAY 19
SCIENTIFIC
PROGRAM
POSTER LUNCH PRESENTATIONS
12:00 – 1:00 p.m.
501 Adherence to the Ventilator Bundle and Risk of
Ventilator-Associated Events
Bryan D Harris, MD1, Gale A Thomas2, Michael S Chaikowski2
and Thomas Talbot III, MD, MPH1, (1)Vanderbilt University School
of Medicine, Nashville, TN, (2)Vanderbilt University Medical Center,
Nashville, TN
502 Preventing CAUTI in the ICUs: Why Culturing Practices
Trump the Effect of Device Care
Ana C Bardossy, MD1, Takiah Williams, RN2, Karen Jones, RN3,
Susan Szpunar, MPH, DrPH3, Yuan Xin, MPH1, Marcus Zervos, MD1,
George Alangaden, MD4, Katherine Reyes, MD, MPH1 and Mohamad
Fakih, MD, MPH5, (1)Henry Ford Health System, Detroit, MI, (2)St.
John Hospital and Medical Center, Grosse Pointe, MI, (3)St John
Hospital & Medical Center, Grosse Pointe Woods, MI, (4)Wayne State
University, Detroit, MI, (5)Care Excellence, Ascension Health, Grosse
Pointe Woods, MI
503 Barriers to Implement Prevention Strategies for
Catheter Associated Urinary Tract Infections (CAUTI)
Adriana Jimenez, MPH, BSMT.1,2, Dennise De Pascale, BSMT.2,
Jose Guillermo Castro, MD.3, Ronda Sinkowitz-Cochran, MPH.4,
Carolyn Gould, MD, MSCR4, Katie Coutts, MPH4, Matthew J.
Hagan5, Esther I. Diaz, MD5 and Valeria Bagley, MD, MPH5, (1)Florida
International University Robert Stempel College of Public Health &
Social Work, Miami, FL, (2)Jackson Memorial Hospital - Department
of Infection Prevention and Control, Miami, FL, (3)Division of Infectious
Diseases University of Miami Miller School of Medicine, Miami, FL, (4)
Division of Healthcare Quality Promotion, Centers for Disease Control
and Prevention, Atlanta, GA, (5)University of Miami, Miami, FL
504 The Placement of an Indwelling Urinary Catheter: Art
or Science?
Lovisa B Olafsdottir, MD, Sharon B. Wright, MD, MPH, FIDSA,
FSHEA, Michael N. Cocci, MD and Graham M. Snyder, MD, SM, Beth
Israel Deaconess Medical Center, Boston, MA
505 Standardizing Urine Culture Practices Reduces
Misclassification of Catheter Associated Urinary Tract
Lisa Reif, MSN, RN, APRN-CCNS1, Esther Baker, MSN, RN, CIC2,
William Asbury, PharmD2, Owen Samuels, MD3, Sujan C. Reddy, MD
MS4, Nathan Spell, MD3 and Jay Varkey, MD3, (1)Emory University,
Atlanta, GA, (2)Emory Healthcare, Atlanta, GA, (3)Emory University
School of Medicine, Atlanta, GA, (4)Emory University School of
Medicine, Division of Infectious Diseases, Atlanta, GA
506 Urinary Catheter Awareness, Orders and Indications in
ICUs
Jennifer Meddings, MD, MSc1, Latoya Kuhn, MPH2 and Heidi
Reichert, MA1, (1)University of Michigan, Ann Arbor, MI, (2)VA Ann
Arbor Health System, Ann Arbor, MI
507 Catheter Associated Urinary Tract Infections Reduced
by 79% through a Bundled Approach
Priya Sampathkumar, MD1, Rodney L. Thompson, MD2 and Tamara
Buechler, MD2, (1)Mayo Clinic College of Medicine, Rochester, MN, (2)
Mayo Clinic, Rochester, MN
SCHEDULE
508 Knowledge Survey in Nursing Homes Reveals
Actionable Gaps in Knowledge of Infection Control
Barbara Trautner, MD, PhD1,2, Todd Greene, PhD3,4, Andrew Rolle,
MPH5, Barbara Edson, RN, MBA, MHA5, Sara McNamara, MPH4,
Heidi Wald, MD, MPH6, Sarah Krein, PhD, RN3,4, Sanjay Saint, MD,
MPH3,4 and Lona Mody, MD, MSc3,4, (1)Baylor College of Medicine,
Houston, TX, (2)Center for Innovations in Quality, Effectiveness
and Safety, Houston, TX, (3)VA Ann Arbor Healthcare System,
Ann Arbor, MI, (4)University of Michigan, Ann Arbor, MI, (5)Health
Research & Educational Trust in partnership with the American
Hospital Association, Chicago, IL, (6)University of Colorado, School of
Medicine, Aurora, CO
509 How Good Are We at Maintaining Our Devices in the
ICUs? A View of Two Tertiary Care Teaching Centers
Ana C Bardossy, MD1, Takiah Williams, RN2, Karen Jones, RN3,
Susan Szpunar, MPH, DrPH3, Yuan Xin, MPH1, Marcus Zervos, MD1,4,
George Alangaden, MD1,4, Katherine Reyes, MD, MPH1 and
Mohamad Fakih, MD, MPH5, (1)Henry Ford Health System, Detroit,
MI, (2)St. John Hospital and Medical Center, Grosse Pointe, MI, (3)St
John Hospital & Medical Center, Grosse Pointe Woods, MI, (4)Wayne
State University, Detroit, MI, (5)Care Excellence, Ascension Health,
Grosse Pointe Woods, MI
510 Reliability Testing of a New Decision Support Tool That
Promotes the Appropriate Use of Urinary Cath
Jan J Gralton, BSc (Hons), PhD1,2, Alistair Henry, BA (Hons)1,3 and
Paul Curtis, MBBS1, (1)Clinical Excellence Commission, Sydney NSW
2000, Australia, (2)University of New South Wales, Sydney NSW
2052, Australia, (3)Macquarie University, Sydney NSW 2109, Australia
511 Developing a User-Friendly Report for ElectronicallyAssisted CAUTI Surveillance
Felicia Skelton, MD1,2, Bryan Campbell, PhD1, Deborah Horwitz, PA2,
Sanjay Saint, MD, MPH3,4, Sarah Krein, PhD, RN3,4, Anne Sales, PhD,
RN3,4 and Barbara Trautner, MD, PhD1,2, (1)Center for Innovations in
Quality, Effectiveness and Safety, Houston, TX, (2)Baylor College of
Medicine, Houston, TX, (3)University of Michigan, Ann Arbor, MI, (4)VA
Ann Arbor Healthcare System, Ann Arbor, MI
512 Implementing Best Practices for CAUTI Reduction
Maureen A. Seckel, APRN, Kathy M. Wroten, MS, BSN, RN, CIC,
Denise French, MSN, RN, APN, GCNS-BC, Tamekia Thomas, MSN,
RN, PCCN, ACNS-BC, Gwen Ebbert, RN, MSN, BA, RN-BC, Craig
Martine, MSN, RN, CCRN, Nancy Davis, BSN, RN, CIC, Lorraine
Adkins, BSN, RN, CIC, Janice Gibson-Gerrity, MS, BSN, RN, Brian
Stephan, BA, Maureen Berry, Patricia Curtin, MD, Linda LaskowskiJones, MS, APRN, ACNS-BC, Emily Penman, MD and Marci
Drees, MD, MS, Christiana Care Health System, Newark, DE
513 A Look at the Indications Selected for Urinary Catheter
Insertion in the Emergency Department
Anthony Baffoe-Bonnie, MD1, Jim Wong, MD2, Fatima Wong,
DO3 and Shikha Vasudeva, MD4, (1)Carilion Clinic-VTC-School of
Medicine, Roanoke, VA, (2)Carilion Clinic, Roanoke, VA, (3)Carilion
Clinic/VTC- School of Medicine, Roanoke, VA, (4)Carilion Clinic-VTCSchool of Medicine, Roanoke, VA
514 Clinical Decision Support Interventions to Reduce
CAUTI: Pitfalls of Implementation
Zachary N Gordon, MD, Julie Mangino, MD, Daniel S Eiferman, MD,
Iahn Gonsenhauser, MD and Susan D Moffatt-Bruce, MD, PhD, The
Ohio State University Wexner Medical Center, Columbus, OH
515 A Sustained Process Improvement-Reduction of
Catheter-Associated Urinary Track Infections by 71%
Maureen Bunch, MSN, RN CIC, Vibra Hospital, Thornton, CO
Top Poster
Abstract
24
PROGRAM
516 Physicians are Unaware of Presence of Peripheral
Intravenous Catheters in Medical Inpatients
Shimontini Mitra, MD, Elizabeth Targan, MD, Alexandra Rose, MD,
Megan Ritter, MD, Mary T. LaSalvia, MD, MPH and Sharon B.
Wright, MD, MPH, FIDSA, FSHEA, Beth Israel Deaconess Medical
Center, Boston, MA
517 How Can Leadership Line Care Rounds Prevent
Central Line Associated Bloodstream Infections?
Hana Hakim, MD, MS, Angie Owings, MSN, RN, CIC, Sherry
Johnson, MSN, CCRN, CPON, NE-BC, JoBeth McBee, MSN, APN,
NE-BC, PPCNP-BC, BMTCN and Mike Gipson, BS, MBA, St. Jude
Children’s Research Hospital, Memphis, TN
518 Insertion Site Inflammation, CLABSI, and
Readmissions Due to Outpatient Central Lines
Hiroki Saito, MD, MPH1, Mohamad Al Sharif, MD1, Bardia Bahadori1,
Li Chen, BA1, Tara E. Seery, MD2, Jennifer Yim, RN, BSN, CIC3,
Linda Dickey, RN, MPH, CIC3, Susan S. Huang, MD, MPH1,3 and
Shruti K. Gohil, MD, MPH1,3, (1)University of California Irvine School of
Medicine, Division of Infectious Diseases, Orange, CA, (2)University of
California Irvine School of Medicine, Division of Hematology Oncology,
Orange, CA, (3)Epidemiology and Infection Prevention, UC Irvine
Health, Orange, CA
519 Complications of Central Venous Catheters in the Home
Sara Keller, MD1, Deborah Williams, BSN, MPH2, Dawn Hohl, PhD,
RN2, Amanda Krosche, BS1, Ayse Gurses, PhD, MS, MPH3, John
Adamovich, MHA2, Mitra Gavgani, PharmD2, Mary Myers, RN, MSN2,
David Hirsch, RN, MSN, MBA2, Trish Perl, MD, MSc1 and Sara
Cosgrove, MD, MS1, (1)Johns Hopkins University School of Medicine,
Baltimore, MD, (2)Johns Hopkins Home Care Group and Pharmaquip
Infusion Pharmacy, Baltimore, MD, (3)Johns Hopkins University
Armstrong Institute for Patient Safety, Baltimore, MD
520 CAUTIon CAUTI: How Changing Your Definition May
Create a CLABSI Epidemic
Mohamad Fakih, MD, MPH, Clariecia Groves, MS, Angelo Bufalino,
PhD, Michelle Heavens, MHA, RN and Ann Hendrich, PhD, RN, Care
Excellence, Ascension Health, St. Louis, MO
521 Review of Strategies to Reduce CLABSI and CAUTI in
Adult ICUs with Persistently High Infection Rates
Payal K Patel, MD, MPH1, Jennifer Meddings, MD, MSc1, Ashwin
Gupta, MD1, Valerie Vaughn, MD1 and Jason D. Mann, MSA2, (1)
University of Michigan, Ann Arbor, MI, (2)Ann Arbor VA Healthcare
System, Ann Arbor, MI
522 Impact of the CMS Healthcare-Acquired Conditions
Policy on Billing Rates of Two Targeted Conditions
Alison Kawai, ScD1, Michael S. Calderwood, MD, MPH2,3, Robert
Jin, MS4 and Grace Lee, MD, MPH4,5, (1)Harvard Medical School and
Harvard Pilgrim Health Care Institute, Boston, MA, (2)Harvard Medical
School and Harvard Pilgrim Health Care Institute, Department of
Population Medicine, Boston, MA, (3)Brigham and Women’s Hospital,
Boston, MA, (4)Department of Population Medicine, Harvard Medical
School and Harvard Pilgrim Health Care Institute, Boston, MA, (5)
Children’s Hospital Boston, Harvard Medical School and Harvard
Pilgrim Healthcare Institute, Boston, MA
523 CMS HAC Policy for CLABSI and CAUTI had Minimal
Impact on Hospital Reimbursement
Michael S. Calderwood, MD, MPH1, Alison Tse Kawai, ScD2,
Robert Jin, MS2 and Grace Lee, MD, MPH2, (1)Brigham and Women’s
Hospital, Boston, MA, (2)Department of Population Medicine, Harvard
Medical School and Harvard Pilgrim Health Care Institute, Boston, MA
SCHEDULE
524 Knowledge vs Practice: A cross-Sectional Survey on
Healthcare Workers Regarding Infection Control
Imran Hasanoglu, M.D1, Rahmet Guner, Prof. Dr2, Fatma Yekta
Korkmaz, M.D2, Bircan Kayaaslan, M.D2, Gul Ruhsar Yilmaz,
Associate Professor1, Zeliha Kocak Tufan, Associate Professor2,
Tumer Guven, Associate Professor2, Turan Buzgan, Associate
Professor2 and Mehmet A. Tasyaran, Prof.Dr2, (1)Ankara Ataturk
Training and Research Hospital, Ankara, Turkey, (2)Yildirim Beyazit
University Faculty of Medicine, Ankara, Turkey
525 Psychological Safety and Non-adherence to the
Central Line Bundle Interventions in the VHA
Heather M. Gilmartin, PhD, NP1, Paula Langner, MS1, Katerine
Osatuke, PhD2, Rachael Hasselbeck, MSN, MBA, RN3 and Catherine
Battaglia, PhD, RN1, (1)Denver VA Medical Center, Denver, CO, (2)
Veterans Health Administration, National Center for Organizational
Development, Cincinnati, OH, (3)Veterans Health Administration
Inpatient Evaluation Center, Cincinnati, OH
526 Implementation of Multiple Interventions to Decrease
Central Line Associated Bloodstream Infections
Susan C. Bleasdale, MD, Margaret Newman, MD and Monica K.
Sikka, MD, University of Illinois at Chicago, Chicago, IL
527 The Impact on CLABSIs with the Implementation of
Chlorhexidine Dressings for Post-Insertion Care
Kapil Vyas, D.O.1 and Aneesa Afroze, M.D.2, (1)Internal Medicine
Residency at Mercy Medical Center, Des Moines, IA, (2)Chest,
Infectious Diseases and Critical Care Associates, P.C., Clive, IA
528 Total House Surveillance of CLABSI in Large Tertiary
Care Hospital in Saudi Arabia
Joseph Boutros Tannous, BS, MT, CIC1, Aiman El-Saed
Ramadan, MD, PHD1, Henry Baffoe Bonnie, MD, PHD1, Bassem
Abukhzam, BS1, Nimfa L. Dagunton, BSN, RN1, Bassema Shadfan,
BS1, Kassem Zehri1, Marissa Alarcon, BSN, RN2, Khawla Salman,
BS1, Ahmad Ibrahim, BS1, Tamer Abu Areshih, BS1, Ohaila Slim,
BS1, Hisham Eid, BS1, Azzam Mohammed1, Tereza Portugal1 and Dr.
Hanan Balkhy, MD1, (1)King Abdulaziz Medical City, Riyadh, Saudi
Arabia, (2)King Abdulaziz Medical City Ministry of National Guard,
Riyadh, Saudi Arabia
529 Evaluation of a Far Ultraviolet Light Device for
Decontamination of Gloves
Myreen E. Tomas, MD1, Jennifer Cadnum, BS1,2, Annette Jencson,
BSMT, CIC3 and Curtis J. Donskey, MD1, (1)Geriatric Research
Education and Clinical Center, Louis Stokes Cleveland VA Medical
Center, Cleveland, OH, (2)Case Western Reserve University,
Cleveland, OH, (3)Cleveland VA Medical Center, Cleveland, OH
530 Adenosine Triphosphate Quantification Correlates
Poorly with Microbial Contamination of Duodenoscope
Lovisa B Olafsdottir, MD1, Sharon B. Wright, MD, MPH, FIDSA,
FSHEA1, Anne Smithey1, Alice Chen1,2, Elizabeth B. Hirsch,
PharmD1,2, Benjamin V. Lane, BS1 and Graham M. Snyder, MD,
SM1, (1)Beth Israel Deaconess Medical Center, Boston, MA, (2)
Northeastern University, Boston, MA
531 Evaluation of a Spray Disinfectant for Decontamination
of PPE Prior to Removal
Sreelatha Koganti, MD1, Heba Alhmidi, MD1, Myreen E. Tomas, MD2,
Jennifer Cadnum, BS2,3, Christopher Sass, BS4, Annette Jencson,
BSMT, CIC4 and Curtis J. Donskey, MD2,3, (1)Louis Stokes Cleveland
VA Medical Center, Cleveland, OH, (2)Geriatric Research Education
and Clinical Center, Louis Stokes Cleveland VA Medical Center,
Cleveland, OH, (3)Case Western Reserve University, Cleveland, OH,
(4)Cleveland VA Medical Center, Cleveland, OH
SCIENTIFIC
SCIENTIFIC
PROGRAM
532 Comparison of Far-UV and UV-C Light for Inactivation
of Bacteriophage MS2 on PPE
Annette Jencson, BSMT, CIC1, Myreen E. Tomas, MD2, Jennifer L.
Cadnum, BS2,3 and Curtis J. Donskey, MD2,3, (1)Cleveland VA Medical
Center, Cleveland, OH, (2)Geriatric Research Education and Clinical
Center, Louis Stokes Cleveland VA Medical Center, Cleveland, OH, (3)
Case Western Reserve University, Cleveland, OH
533 Prospective Randomized Trial Comparing Three
Duodenoscope High-Level Disinfection and
Sterilization
Graham M. Snyder, MD, SM , Sharon B. Wright, MD, MPH, FIDSA,
FSHEA1, Anne Smithey1, Meir Mizrahi, MD1, Michelle Sheppard, RN,
BS1, Elizabeth B. Hirsch, PharmD1,2 and Mandeep Sawhney, MBBS,
Ms1, (1)Beth Israel Deaconess Medical Center, Boston, MA, (2)
Northeastern University, Boston, MA
1
534 Evaluation of a Novel Alcohol-Based Surface
Disinfectant for Disinfection of Hard and Soft Surfaces
Heba Alhmidi, MD1, Sreelatha Koganti, MD1, Jennifer Cadnum, BS2,3
and Curtis J. Donskey, MD2,3, (1)Louis Stokes Cleveland VA Medical
Center, Cleveland, OH, (2)Geriatric Research Education and Clinical
535 Incorporation of an Ultraviolet Light Room
Decontamination Device in a Transplant Unit
Abhishek Deshpande, MD PhD , Justin Hartlej, BS , Jennifer
L. Cadnum, BS3,4, Thriveen Sankar Chittoor Mana, MS, MBA3,4,
Annette Jencson, BSMT, CIC4, Thomas G. Fraser, MD2 and Curtis
J. Donskey, MD3,4, (1)Medicine Institute Center for Value Based
Care Research, Cleveland Clinic, Cleveland, OH, (2)Department of
Infectious Diseases, Cleveland Clinic, Cleveland, OH, (3)Case Western
Reserve University, Cleveland, OH, (4)Geriatric Research, Education,
Cleveland, OH
1,2
1
536 Endoscopic Retrograde Cholangiopancreatography
(ERCP) Procedures and Infections
Susan C. Bleasdale, MD1,2, Kristen Crawford1 and Monica K.
Sikka, MD1,2, (1)University of Illinois at Chicago, Chicago, IL, (2)Jesse
Brown Va Medical Center, Chicago, IL
537 RCA for Consistent High Water Cultures in Water from
Dialysis and RO Machines
Pallavi Yadav, MBBS, MHA, CQPA1, Dawn England, MPH2 and
Caprice Vanderkolk, RN, BS, MS, BC-NE2, (1)University Of Minnesota
Medical Center, Minneapolis, MN, (2)University of Minnesota Health,
Minneapolis, MN
538 Efficacy of a Visible Light Disinfection System Against
Healthcare-Associated Pathogens
Jennifer Cadnum, BS1,2, Christopher Sass, BS3 and Curtis
Donskey, MD4, (1)Geriatric Research Education and Clinical Center,
Louis Stokes Cleveland VA Medical Center, Cleveland, OH, (2)Case
Western Reserve University, Cleveland, OH, (3)Cleveland VA Medical
Center, Cleveland, OH, (4)Geriatric Research, Education, and Clinical
Center, Louis Stokes Cleveland VA Medical Center, Cleveland, OH
539 Effectiveness of an Environmental Cleaning
Management Plan Implemented by The Quality
Department
Derya Mahmutoglu, MD1, Javeria Haque, MD2, Mary Beth
Graham, MD2 and L. Silvia Munoz-Price, MD, PhD2, (1)Medical
College of Wisconsin, Milwaukee, WI, (2)Division of Infectious
Diseases, Medical College of Wisconsin, Milwaukee, WI
SCHEDULE
540 A Low-Intensity Ultraviolet-C Device for
Decontamination of High-Touch Common Use Objects
Sreelatha Koganti, MD1, Heba Alhmidi, MD1, Jennifer L. Cadnum,
BS2,3, Aaron Ali Sheikh, MSW2, Annette Jencson, BSMT, CIC4 and
Curtis J. Donskey, MD2,3, (1)Louis Stokes Cleveland VA Medical
Center, Cleveland, OH, (2)Case Western Reserve University,
Cleveland, OH, (3)Geriatric Research Education and Clinical Center,
Louis Stokes Cleveland VA Medical Center, Cleveland, OH, (4)
Cleveland VA Medical Center, Cleveland, OH
541 An Ultraviolet Device for Decontamination of Personal
Items of Long-Term Care Facility Residents
Heba Alhmidi, MD1, Sreelatha Koganti, MD1, Jennifer L. Cadnum,
BS2,3 and Curtis J. Donskey, MD2,3, (1)Louis Stokes Cleveland VA
Medical Center, Cleveland, OH, (2)Case Western Reserve University,
Louis Stokes Cleveland VA Medical Center, Cleveland, OH
542 Implementation of Upper Room Germicidal Irradiation
in a Closed Dementia Long-Term Care Unit
Cathy St. Pierre, Ph.D., APRN1, James J. McDevitt, Ph.D., APRN2,
Donald K. Milton, MD, DrPH3 and Richard A. Martinello, MD4, (1)
Edith Norse Rogers Memorial VA Medical Center, Bedford, MA,
(2)Harvard School of Public Health, Boston, MA, (3)University of
Maryland, College Park, MD, (4)Yale University, New Haven, CT
543 Evaluation of an Automated Room Decontamination
Device using Aerosolized Peracetic Acid
Thriveen Sankar Chittoor Mana, MS, MBA1, Jennifer Cadnum,
BS1,2, Annette Jencson, BSMT, CIC2, Brett M. Sitzlar, BS3 and Curtis
Donskey, MD3, (1)Case Western Reserve University, Cleveland, OH,
(2)Cleveland VA Medical Center, Cleveland, OH, (3)Geriatric Research,
Education, and Clinical Center, Louis Stokes Cleveland VA Medical
Center, Cleveland, OH
544 Variation in Practices to Clean and Disinfect Surfaces
in SHEA Research Network Facilities
Sujan C. Reddy, MD MS1, Philip C. Carling, M.D.2, Daniel
Morgan, MD, MS3 and Jesse Jacob, MD1, (1)Emory University School
of Medicine, Division of Infectious Diseases, Atlanta, GA, (2)Boston
University School of Medicine, Boston, MA, (3)University of Maryland
School of Medicine, Baltimore, MD
545 Briefly Intervening to Affect Cleaning Outcomes: No
Good Deed Goes Unpunished
Robert Clifford, PhD1, Eve Hosford, MS1, Ana Ong, BS1, Douglas
Richesson1, Susan Fraser2, Yoon I Kwak, MS1, Sonia Miller2, Michael
Julius, PMP1, Patrick McGann, PhD1 and Emil Lesho, DO1, (1)Walter
Reed Army Institute of Research, Silver Spring, MD, (2)Ft. Belvoir
Community Hospital, Ft. Belvoir, VA
546 Evaluation of a Novel Silver Based Laundry Treatment
to Reduce Bacterial Contamination of Textiles
John J Openshaw, MD1, Bill Morris2, Gregory V Lowry, PhD3 and
Aydin Nazmi, PhD4, (1)Stanford University, Stanford, CA, (2)Applied
Silver, Hayward, CA, (3)Carnegie Mellon University, Pittsburgh, PA,
(4)California Polytechnic State University, San Luis Obispo, San Luis
Obispo, CA
547 Can Using Active UV-C Technology to Treat the Air
Reduce Surface Pathogens in a Healthcare Setting?
Linda Lee, DrPH, MBA, American Green Technology, South Bend,
IN, DNV-GL, Milford, OH
Top Poster
Abstract
26
PROGRAM
SCHEDULE
548 Portable, Affordable, and Adjustable: Evaluation of a
Novel Ultraviolet Light Decontamination Device
556 A Randomized Trial to Determine the Impact of a
Patient Hand Hygiene Intervention
549 Effectiveness of an Ultraviolet Light Decontamination
Device in Reducing Hospital Room Contamination
557 Use of Targeted Solutions Tool and Electronic
Monitoring to Improve Hand Hygiene Performance
Jennifer Cadnum, BS1,2, Sreelatha Koganti, MD3, Heba
Alhmidi, MD3, Annette Jencson, BSMT, CIC4, J. Itty Mathew, MLS2
and Curtis J. Donskey, MD1,2, (1)Geriatric Research Education and
Clinical Center, Louis Stokes Cleveland VA Medical Center, Cleveland,
OH, (2)Case Western Reserve University, Cleveland, OH, (3)Louis
Stokes Cleveland VA Medical Center, Cleveland, OH, (4)Cleveland VA
Abhishek Deshpande, MD PhD1,2, Justin Hartlej, BS2, Jennifer
Cadnum, BS3,4, Annette Jencson, BSMT, CIC3, Thriveen Sankar
Chittoor Mana, MS, MBA3,4, Thomas G. Fraser, MD1 and Curtis J.
Donskey, MD3,4, (1)Department of Infectious Diseases, Cleveland
Clinic, Cleveland, OH, (2)Medicine Institute Center for Value Based
Care Research, Cleveland Clinic, Cleveland, OH, (3)Geriatric
Research, Education, and Clinical Center, Louis Stokes Cleveland VA
Cleveland, OH
550 UV Light Decontamination of CRE from High Touch
Surfaces in Patient Room
Clare Rock, MD, MS1, Melanie Curless, RN MPH CIC2, Karen
Carroll, MD3, Tracy Howard2, Elaine Nowakowski2, Kathryn A. Carson,
Sc.M.4, Polly Trexler, MS, CIC2 and Lisa L. Maragakis, MD MPH1,
(1)Department of Medicine, Division of Infectious Diseases, Johns
Hopkins University, Baltimore, MD, (2)The Johns Hopkins Hospital,
Baltimore, MD, (3)John Hopkins University, Baltimore, MD, (4)
Department of Epidemiology, Johns Hopkins Bloomberg School of
Public Health, Baltimore, MD
551 Hospital Air-Handler Shutdown Increases Airborne
Viable Particle Counts
Patricia L. Harris, M.S.N., R.N.1, Paul D. Wiser, BSN2, Diana L. Toy,
B.S.N., R.N.1, Shelia M. Cloud-Woods, M.S.N., R.N.1, Charles W.
Jennings1, Cornelius J. Clancy, M.D.1 and Brooke K. Decker, M.D.1,
(1)VA Pittsburgh Healthcare System, Pittsburgh, PA, (2)VA Pittsburgh
Healthcare System, Pittsburgh, PA
552 Barriers, Perceptions and Compliance: Hand Hygiene
in the Operating Room and Endoscopy Suite
Laura Pedersen, BS, Kimberly Elgin, BSN, Barbara Peace, RN,
Nadia Masroor, BS, Kakotan Sanogo, MS, Kaila Cooper, MSN, RN,
CIC, Michelle Doll, MD, Gene Peterson, MD, PhD, Mike Stevens, MD,
MPH and Gonzalo Bearman, MD, MPH, VCU Health, Richmond, VA
553 The Experience of Being a Hand Hygiene Auditor in
Australia
Susan Jain, Master of Nursing, PhD candidate1, Denise Edgar,
RN BN MPH2, Janine Bothe, DN RN MA3, Helen Newman, RN2,
Annmaree Wilson, RN RM BSc2, Beth Bint, RN2, Megan Brown, RN
BN MSc2, Suzanne Alexander, RN BSc2 and Joanna Harris, RN BSc
(Hons)2, (1)Prince of Wales Hospital, Randwick, Australia, (2)Illawarra
Shoalhaven Local Health District, Wollongong, Wollongong, Australia,
(3)St. George Hospital, Kogarah, Australia
555 Jumanji! Improving Hand Hygiene Compliance by Use
of a Code Word on Inpatient Medical Units
Ching Zhu, MD, Alok K. Tewari, MD, Erika Runge, MD, Alex
Carbo, MD and Sharon B. Wright, MD, MPH, FIDSA, FSHEA, Beth
Israel Deaconess Medical Center, Boston, MA
Venkata Sunkesula, MD, MS1,2, Sirisha Kundrapu, MD, MS1,2,
Jennifer Cadnum, BS1,2, Shanina Knighton, PhD(c), RN3 and Curtis
Donskey, MD4, (1)Case Western Reserve University, Cleveland,
OH, (2)Cleveland VA Medical Center, Cleveland, OH, (3)Cleveland
VA Medical Center, National VA Quality Scholars, Cleveland, OH, (4)
Geriatric Research, Education, and Clinical Center, Louis Stokes
J. William Kelly, MD1, Dawn Blackhurst, PhD2, Connie Steed, RN,
MSN, CIC2, Sue Boeker, BSN, RN, CIC2 and Wendy McAtee, BS2,
(1)Greenville Health Systems, Greenville, SC, (2)Greenville Health
System, Greenville, SC
558 Knowledge on the Moment of Hand Hygiene among
Nurses in the Acute Care Hospitals
Young Ji Kang, RN, MSN1, Jae Sim Jeong, RN, MPH, PhD2,
Hye Ran Choi, RN, MPH3, Eun Suk Park, RN, PhD4 and Sang-Ho
Choi, MD, PhD5, (1)Asan Medical Center, Seoul, Korea, The Republic
of, (2)Department of Nursing, University of Ulsan, Seoul, South Korea,
(3)University of Ulsan, Seoul, South Korea, (4)Severance Hospital,
Seoul, South Korea, (5)Department of Infectious Diseases, University
of Ulsan College of Medicine, Asan Medical Center, Seoul, South
Korea
559 Glove Use as a Contributing Factor to Non-compliance
With Hand Hygiene
Anjali Majumdar, MD1, Shana Burrowes, MPH2, Josephine Brumit,
DNP, RN1, Michelle H. Williams, RN, MSN, CIC1, Michael Anne Preas,
RN, BSN, CIC1 and Surbhi Leekha, MBBS, MPH3, (1)University of
Maryland Medical Center, Baltimore, MD, (2)University of Maryland,
Baltimore, MD, (3)University of Maryland School of Medicine,
Baltimore, MD
560 Does Changing Point-of-Use Reminder Signs More
Frequently Improve Hand Hygiene Compliance?
Heather Reisinger, PhD1, Mark Vander Weg, PhD2, Cassie
Cunningham Goedken, MPH3, Mary Vaughan Sarrazin, PhD2, Carrie
Franciscus, MA3 and Eli N Perencevich, MD, MS4,5, (1)CADRE - Iowa
City VAHCS and Carver College of Medicine, University of Iowa,
Iowa City, IA, (2)CADRE - Iowa City VAHCS; University of Iowa, Iowa
City, IA, (3)CADRE - Iowa City VAHCS, Iowa City, IA, (4)Iowa City VA
Medical Center, Iowa City, IA, (5)University of Iowa Carver College of
Medicine, Iowa City, IA
561 What Hand Hygiene Delivery Method is Preferred by
Patients in the Acute and Long-Term Care Settings?
Shanina Knighton, PhD(c), RN1,2, Curtis J. Donskey, MD3 and
Cherese McDowell, BSN4, (1)Case Western Reserve University
Frances Payne Bolton School of Nursing, Cleveland, OH, (2)Cleveland
VA Medical Center, National VA Quality Scholars, Cleveland, OH, (3)
Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland,
OH, (4)Cleveland VA Medical Center, Cleveland, OH
562 Using an Alternative to Real Time Locating System for
Electronic Hand Hygiene Monitoring at a VA Hos
Christopher Crnich, MD, PhD1, Linda McKinley, RN, MPH, CIC1,
Katherine Matteson, RN, MSN, CIC1, Catherine Stampfli, RN, MSN2,
Karen Hunt, BSN2, Theresa Landvoght, BSN2, Jane McCarthy, BSN,
MSN2, Lakeatia Phillips, BSN2 and Stacie Rhinehart, RN, MSN2, (1)
William S. Middleton Memorial VA Hospital, Madison, WI, (2)Wm. S.
Middleton Memorial VA Hospital, Madison, WI
563 Foam Soap is not as Effective as Liquid Soap in
Eliminating the Hand Flora
Nicolette Dixon1, Margie Morgan, PhD2 and Ozlem Equils, MD,
FAAP2,3, (1)Bainbridge High School, Bainbridge Island, WA, (2)
Cedars-Sinai Medical Center/UCLA School of Medicine, Los Angeles,
CA, (3)Pfizer Inc, New York, NY
SCIENTIFIC
SCIENTIFIC
PROGRAM
564 Hand Hygiene in the 21st Century: Can We Really
Improve?
Robert Brandon Hulette, Meharry Medical College, Nashville, TN
565 Real-time Feedback between Job Classes as an
Intervention for Hand Hygiene Compliance
Emily Sickbert-Bennett, PhD, MS1,2, Lauren M. DiBiase, MS1,2,
David J. Weber, MD, MPH1,2, Lisa Teal, BSN1, Elizabeth M. Walters,
BSN1, Rebecca H. Brooks, BSN1, Judie Bringhurst, BSN1, Katherine
Schultz, BSN, MPH1, Sherie Goldbach1 and William A. Rutala, PhD,
MPH1,2, (1)Hospital Epidemiology, UNC Medical Center, Chapel Hill,
NC, (2)Division of Infectious Diseases, University of North Carolina
School of Medicine, Chapel Hill, NC
566 Improved Visitor Hand Hygiene Reduces Respiratory
Viral Infections in a Neonatal Intensive Care Unit
Elizabeth M. Marrero, MSN, RN, CNOR(e)1, Audrey Echlin, RN1,
Lori Thorpe, BSN, RNC-NIC1, Anna Gaspar, MSN, RN, CCRN1,
Jacques de Marche’, MHA1, Michele Honeycutt, RN, BSN, CIC1
and Matthew Linam, MD, MS2, (1)Arkansas Children’s Hospital, Little
Rock, AR, (2)University of Arkansas for Medical Sciences, Division of
Pediatrics, Infectious Diseases Section, Little Rock, AR
567 Seasonal Variation in Bare Below the Elbow
Compliance
Nadia Masroor, BS1, Michelle Doll, MD1, Kakotan Sanogo, MS1,
Kaila Cooper, MSN, RN, CIC1, Mike Stevens, MD, MPH1, Michael
Edmond, MD2 and Gonzalo Bearman, MD, MPH1, (1)VCU Health,
Richmond, VA, (2)University of Iowa Hospitals and Clinics, Iowa
City, IA
568 Handrub and Soap Consumption as a Monitoring Tool
in a Dutch Teaching Hospital
Suzanne D. van der Werff, PhD1, Annie Kaiser, MSc1, Martine
Caris, MD1,2, Mireille Dekker1, Rosa van Mansfeld, MD, PhD1 and
Christina M.J.E. Vandenbroucke-Grauls, MD, PhD1, (1)Department
of Medical Microbiology and Infection Control, VU University Medical
Center, Amsterdam, Netherlands, (2)Department of Internal Medicine,
VU University Medical Center, Amsterdam, Netherlands
569 Mortality Associated with Candida Infections Among
Neonates: a Meta-Analysis
Marin L Schweizer, PhD1, Melissa Ward, MS1, Daniel Fulton, MD1,
Eli Perencevich, MD, MS1, Jennifer McDanel, PhD1, Rajeshwari
Nair, MBBS, PhD1, Richard E. Nelson, PhD2, Karim Khader, PhD3,
Matthew Samore, MD3, Loreen Herwaldt, MD1, Amy Blevins, MALS4
and Daniel Diekema, MD1, (1)University of Iowa Carver College of
Medicine, Iowa City, IA, (2)Division of Epidemiology, University of
Utah, Salt Lake City, UT, (3)University of Utah School of Medicine,
Salt Lake City, UT, (4)University of Iowa, Hardin Library for the Health
Sciences, Iowa City, IA
570 Incidence of Rotavirus,Norovirus,Adenovirus &
Clostridium difficile (CDI) in Intestinal Transplant
Luis F Guzman, MD1, Diana F Florescu, MD2, Andre Kalil, MD3,
Fang Qiu, PhD2, Lisa Hill, APRN2 and Heather Chambers, APRN2,
(1)UNMC, Omaha, NE, (2)University of Nebraska Medical Center,
Omaha, NE, (3)University of Nebraska Med Ctr, Omaha, NE
571 Evaluation of Chlorhexidine Bathing as Part of a
Bundled Approach to Reduce NICU CLABSIs
Andrea Green Hines, MD1, Donnetta Perkins, RN, BSN2, Brenda
Heybrock, RN, CIC2, Lynne Willett, MD2, Mel Hall2, Crista Latimer,
APRN-NNP2, Chelsey Phalen, APRN-NNP2 and Kari Simonsen, MD3,
(1)Section of Pediatric Infectious Diseases, University of Nebraska
Medical Center, Omaha, NE, (2)Children’s Hospital and Medical
Center, Omaha, NE, (3)University of Nebraska Medical Center,
Omaha, NE
SCHEDULE
572 Human Factors Approach to Disseminating an
Intervention for Improving Blood Culture Utilization
Anping Xie, PhD1, Anne F. King, BSN2, Charlotte Z. Woods-Hill, MD2,
Judy Ascenzi, DNP, RN, CCRN2, Ayse P. Gurses, PhD, MPH, MS1,
James C. Fackler, MD2 and Aaron M. Milstone, MD MHS2, (1)
Armstrong Institute for Patient Safety and Quality, Johns Hopkins
University, Baltimore, MD, (2)Johns Hopkins Medical Institutions,
Baltimore, MD
573 Epidemiology and Antimicrobial Susceptibility of
Pediatric Invasive Acinetobacter Infections
Ishminder Kaur, M.D., Jennifer Vodzak, M.D., Alan Evangelista, PhD,
Sarah S. Long, M.D. and Jane M. Gould, M.D., St. Christopher’s
Hospital for Children/ Drexel University College of Medicine,
Philadelphia, PA
574 Risk Factors for MRSA Colonization in the Neonatal
Intensive Care Unit: A Meta-Analysis
Matthew Washam, MD, MPH, Jon Woltmann, MD, Beth
Haberman, MD, David Haslam, MD and Mary Allen Staat, MD, MPH,
Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
576 Surgical Site Infections in Children Following VEPTR
Surgery
Jonathan Crews, MD, MS1,2, Marina Mina, BS2, Eric Johnson,
BS3, Janette Guillen, RN2, James W. Simmons, MD1,2 and Ajeya
Joshi, MD1,2, (1)Baylor College of Medicine, San Antonio, TX, (2)
Children’s Hospital of San Antonio, San Antonio, TX, (3)University of
Texas Health Sciences Center San Antonio, San Antonio, TX
577 Prolonged Rhinovirus Shedding in a Patient with
Hodgkin Disease
Andrew T. Dysangco, MD1, Amy Beth Kressel, MD, MS1, W. Allan
Nix2, Stephanie Dearth3, Reema Patel, MPH3 and Shawn Richards3,
(1)Indiana University School of Medicine, Indianapolis, IN, (2)Centers
for Disease Control and Prevention, Atlanta, GA, (3)Indiana State
Department of Health, Indianapolis, IN
578 Crude Mortality In Patients Hospitalized For Viral
Respiratory Infections
Lauren DiBiase, MS, CIC1,2, David Weber, MD, MPH1,2, Mellisa Miller,
PhD1,2, Hajime Kanamori, MD, PhD, MPH1,2, Emily Sickbert-Bennett,
PhD, MS1,2 and William Rutala, PhD, MPH1,2, (1)University of North
Carolina Health Care, Chapel Hill, NC, (2)UNC School of Medicine,
Chapel Hill, NC
579 Survival of an Enveloped Virus on Toys
Richard L Bearden II, MS, Georgia State University, Atlanta, GA
580 Trend of Flu and Respiratory syncytial virus in
Emergency Department discharges in U.S, 2009-2012
Chao Song, MPH, Emelline Liu, MSHS and Michele Schoonmaker,
PhD, Cepheid, Sunnyvale, CA
581 Predictors of MERS-CoV infection
Sameeh Ghazal, MD1, Saleh Alogael, MD1, Talal Altuwijri, MD1, Sarah
Alfaraj, MD1, Marzouka Alanazi, MD1, Fahad Bafaqeeh, MD1, Menwer
Almajnoni, MD1, Donna McClish, PHD2, Ahmed Alenezi, MD1, Ziad
Memish, MD1, Hamza Ghazal, MS3 and Hamza Hamdan, MD1, (1)
Prince Mohammed bin Abdulaziz Hospital, Riyadh, Saudi Arabia,
(2)Virginia Commonwealth University, Richmond, VA, (3)Alimam
Mohammed bin Saud university, Riyadh, Saudi Arabia
582 Door Openings in the Operating Room Associated
with Increased Environmental Contamination
Brian L Hollenbeck, MD, Susan Cohen, Riya Joshi, MPH, MBBS,
Priscilla Perez, Julia Holloway, Lucy Ehrenfeld and Linda Cunningham,
RN, New England Baptist Hospital, Boston, MA
Top Poster
Abstract
28
PROGRAM
583 Mortality Attributable to Periprosthetic Joint Infection
following Hip and Knee Arthroplasty
Sarah H. Yi, PhD, James Baggs, PhD and John Jernigan, MD, MS,
Centers for Disease Control and Prevention, Atlanta, GA
585 Zero SSI Infections After Knee Arthroplasty: One
Hospital’s Secret Sauce
Lynne Karanfil, RN, MA, CIC1, Shawn Mueller, RN, MSN, CIC2 and
Wayne Campbell, MD3, (1)MedStar Health, Columbia, MD, (2)MedStar
Union Memorial, Baltimore, MD, (3)Union Mem Hosp/Univ of MD,
Baltimore, MD
586 No Significant Correlation Between OR Traffic and
Surgical Site Infections in a Multicenter Study
Shira Abeles, MD1, Frank Myers, MA2, Robert El-Kareh, MD2,
Rebecca Marmor, MD2, Mariya Kovryga Kornick3, Shruti Gohil, MD,
MPH4, Stuart Cohen, MD5, Nicole Mahr, RN, MS6, Amy Nichols,
RN, MBA7, Susan Garritson, PhD7, Catherine Liu, MD8, Zachary
Rubin, MD9, Alisa Trout, RN, BSN10, Paul R Allyn, MD10 and
Francesca J Torriani, MD2, (1)University of California San Diego,
La Jolla, CA, (2)UC San Diego Health, San Diego, CA, (3)UC Irvine
Health, Orange, CA, (4)UC Irvine Medical Center, Irvine, CA, (5)
University of California, Davis, Sacramento, CA, (6)UC Davis
Health System, Sacramento, CA, (7)UC San Francisco Health,
San Francisco, CA, (8)University of California, San Francisco, San
Francisco, CA, (9)David Geffen School of Medicine at UCLA, Los
Angeles, CA, (10)UCLA Health, Santa Monica, CA
587 Improving Risk Adjustment Above Current CDC
Methodology Using Electronically-Available
Comorbid Cond
Sarah S Jackson, MPH, Surbhi Leekha, MBBS, MPH, Lisa Pineles,
MA, Laurence S. Magder, PhD, Kerri Thom, MD, MS, Yuan Wang and
Anthony Harris, MD, MPH, Department of Epidemiology and Public
Health, University of Maryland School of Medicine, Baltimore, MD
588 Incidence and Risk Factors for Healthcare Associated
Infections After Hip Surgery
Amanda J Hessels, PhD, MPH, RN, CIC, CPHQ1,2 and Elaine L.
Larson, RN, PhD, FAAN, CIC1, (1)Columbia University, New York, NY,
(2)Meridian Health, Neptune, NJ
590 What’s the Risk? Differing Risk Adjustment Methods
for Colon SSI Between NHSN, CMS and NSQIP
Marci Drees, MD, MS, Carol Briody, MT (ASCP), CIC, Craig Martine,
MSN, RN, CCRN, Brian Stephan, BA, Dennis Witmer, MD and Gerard
Fulda, MD, Christiana Care Health System, Newark, DE
591 Reducing Colon Surgery-Related Surgical Site
Infection (SSI) Rates Using a Bundle
John M Boyce, MD1,2, Heidi Rillstone, RN1, Nicole Colandrea, MT1,
Robert W. Stout, MD1,2, Jeffrey Topal, MD1,2, Alan Ruskis, MD1,2,
Richard A. Martinello, MD1,2 and Kimberly A. Davis, MD1,2, (1)YaleNew Haven Hospital, New Haven, CT, (2)Yale University School of
Medicine, New Haven, CT
592 Identification of Patients with Increased Risk of
Mediastinitis Following Cardiac Surgery
Cheri Grigg, DVM, MPH , James Baggs, PhD , Rachel Slayton,
PhD, MPH1 and John Jernigan, MD, MS1, (1)Division of Healthcare
Quality Promotion, CDC, Atlanta, GA, (2)Epidemic Intelligence
Service, CDC, Atlanta, GA
1,2
1
593 Evaluation of Sterile Packaging Systems Using a
Dynamic Bioaerol Test Method
SCHEDULE
595 Rifampin Treatment and Time to Treatment Failure in
Staphylococcus aureus Prosthetic Joint Infection
Rajeshwari Nair, MBBS, PhD1,2,3, Eli N Perencevich, MD, MS1,2,3,
Daniel Diekema, MD2, Michihiko Goto, MD, MSCI1,2, Daniel J
Livorsi, MD, MSc1,2, James C Torner, PhD, MS3,4, Trudy L Burns,
PhD, MPH3,5, Joseph Cavanaugh, PhD, MS6, Lan Jiang, MS7,
Bruce Alexander, PharmD1, Kelly K Richardson, PhD1, Brice F
Beck, MA1, Jennifer S McDanel, PhD1,2,3 and Marin L Schweizer,
PhD1,2,3, (1)Iowa City VA Medical Center, Iowa City, IA, (2)University
of Iowa Carver College of Medicine, Iowa City, IA, (3)Department
of Epidemiology, University of Iowa College of Public Health, Iowa
City, IA, (4)Departments of Surgery and Neurosurgery, University of
Iowa Carver College of Medicine, Iowa City, IA, (5)Department of
Pediatrics, University of Iowa College of Public Health, Iowa City, IA,
(6)Department of Biostatistics, University of Iowa College of Public
Health, Iowa City, IA, (7)Providence VA Medical Center, Providence, RI
596 Propionibacterium Acnes Infection Complicating
Pediatric Spine Fusion
Ritika Coelho, MD1, Venkatraman Arakoni1, Ryan Goodwin, MD1 and
Charles Bartlett Foster, MD2, (1)Cleveland Clinic, Cleveland, OH, (2)
Cleveland Clinic Foundation, Cleveland, OH
597 Examining the Effect of Outpatient Facility Type on the
Risk of Surgical Site Infection
Rishi V. Parikh, MPH, Centers for Disease Control and Prevention,
Atlanta, GA
598 Not All Colon Procedures Are Equal: Implication for
Risk Adjustment in Publically Reported SSI Rates
Michael S. Calderwood, MD, MPH1, Ken Kleinman, ScD2, Michael
V. Murphy, BA3, Richard Platt, MD, MSc3 and Susan S. Huang, MD,
MPH4, (1)Brigham and Women’s Hospital, Boston, MA, (2)University
of Massachusetts Amherst School of Public Health and Health
Sciences, Amherst, MA, (3)Department of Population Medicine,
Harvard Medical School and Harvard Pilgrim Health Care Institute,
Boston, MA, (4)Division of Infectious Diseases and Health Policy
Research Institute, University of California, Irvine School of Medicine,
Irvine, CA
599 A Multicenter Study to Identify Risk Factors for
Infections Post-Craniotomy
Carlos E. F. Starling, MD1, Braulio R.G.M. Couto, PhD2, Gustavo
Palmer Irffi, Medical student3, Gabriel Bandeira Tofani, Medical
student3, Cynthia Cellina Mendes Silva4, Felipe Coelho Vieira5,
Gilberto Diniz Miranda, Medical student6 and Isabela Lorena Alfenas
Silva5, (1)Hospital da Baleia, Belo Horizonte, Brazil, (2)Centro
Universitário de Belo Horizonte / UNI-BH, Belo Horizonte, Brazil,
(3)Centro Universitário de Belo Horizonte - UniBH, Belo Horizonte,
Brazil, (4)Centro Universitário de Belo Horizonte - UniBH, Instituto
de Engenharia e Tecnologia – IET., Belo Horizonte -MG, Brazil,
(5)Centro Universitário de Belo Horizonte - UniBH, Instituto de
Engenharia e Tecnologia – IET., Belo Horizonte, Brazil, (6)Faculdade
de Ciências Médicas e da Saúde de Juiz de Fora - SUPREMA., Juiz
de Fora, Brazil
600 Utility of an Exposure Receipt Assessment: Evaluate
ICU Staff on Safety Interventions to Reduce VAE
Kisha Jezel Ali, MS, Nishi Rawat, MD, Ting Yang, PhD, MHS,
Kathleen Speck, MPH and Sean Berenholtz, MD, MHS, FCCM,
Johns Hopkins Medicine Armstrong Institute for Patient Safety and
Quality, Baltimore, MD
Brian Heimbuch, MS1, Del Harnish, MS1 and Harry Shaffer, MS2,
(1)Applied Research Associates, Panama City, FL, (2)Sterilization
Consulting Services LLC, Highlands Ranch, CO
SCIENTIFIC
SCIENTIFIC
12:00 – 1:00 p.m. PROGRAM
7th Floor: Augusta Room
601 Cluster Analysis Reveals Unexpected Patterns in
Pneumococcal Polysaccharide Vaccination Coverage
Brigid Wilson, PhD1, Richard Banks, AS1, Rebecca Carter, BA2,
Robin Jump, MD, PhD1,2 and Federico Perez, MD1,2, (1)Louis Stokes
Cleveland Veterans Aff Med Ctr, Cleveland, OH, (2)Case Western
Reserve University, Cleveland, OH
602 Prevalence of CT/NG and Trichomonas Vaginalis
Infection in U.S. Emergency Departments, 2009-2012
603 Cobweb Chart for Infection Rates
Braulio R.G.M. Couto, PhD1, Carlos E. F. Starling, MD2 and Joaquim
José Cunha Junior, MSc3, (1)Centro Universitário de Belo Horizonte /
UNI-BH, Belo Horizonte, Brazil, (2)Hospital da Baleia, Belo Horizonte,
Brazil, (3)Centro Universitário de Belo Horizonte – UniBH, Belo
Horizonte, Brazil
604 A Prospective Cohort Study: Intensive Care UnitAcquired Infections and Their Impact on Mortality
Bircan Kayaaslan, M.D1, Gul Ruhsar Yilmaz, Associate Professor2,
Imran Hasanoglu, M.D2, Fatma Yekta Korkmaz, M.D1, Rahmet
Guner, Prof. Dr1, Zeliha Kocak Tufan, Associate Professor1, Tumer
Guven, Associate Professor1, Seval Izdes, Proffesor3, Turan Buzgan,
Associate Professor1 and Mehmet Akin Tasyaran, Professor4, (1)
Yildirim Beyazit University Faculty of Medicine, Ankara, Turkey, (2)
Ankara Ataturk Training and Research Hospital, Ankara, Turkey,
(3)Yildirim Beyazit University Faculty of Medicine, Department of
Anesthesiology and Reanimation, Ankara, Turkey, (4)Yildirim Beyazit
University Faculty of Medicine, Department of Infectious Disease and
Clinical Microbiology, Ankara, Turkey
605 Outbreaks of Nosocomial Influenza Like Illness in
France, 2001-2015
Elodie Munier-Marion1, Thomas Bénet1,2, Sophan Soing-Altrach3,
Sylvie Maugat3, Sophie Vaux3 and Philippe Vanhems, MD, PhD2,4, (1)
Infection Control and Epidemiology Unit, Lyon, France, (2)Emerging
Pathogens Laboratory - Fondation Mérieux, Centre International de
Recherche en Infectiologie (CIRI) Inserm U1111, CNRS UMR5308,
Lyon, France, (3)French Institute of Public Health Surveillance, SaintMaurice, France, (4)Infection Control and Epidemiology Unit,
Lyon, France
606 Change in Epidemiological Characteristics of HealthCare Associated Infections in Five-Year Period
Hurrem Bodur, Fatmanur Pepe, Esragul Akıncı, Dilek Kanyilmaz,
Ahmet Sertcelik, Meltem Arzu Yetkin, Aliye Bastug, Ayse But, Halide
Arslaner, Adalet Aypak and Pinar Onguru, Ankara Numune Education
and Research Hospital, Ankara, Turkey
607 The Physician’s Role in Ebola Preparedness Planning
Costi D. Sifri, MD1, Kyle Enfield, MD, MS2, Trish Perl, MD, MSc3 and
Jessica D. Lewis, MD2, (1)University of Virginia, Charlottesville, VA,
(2)University of Virginia Health System, Charlottesville, VA, (3)Johns
Hopkins Medical Institutions and University, Baltimore, MD
SCHEDULE
608 Carbapenem-Resistant Klebsiella Pneumoniae
Isolated in Belo Horizonte, Brazil: a Multi-Centre Study
Braulio R.G.M. Couto, PhD1, Carlos E. F. Starling, MD2,3,4, Gustavo
Palmer Irffi, Medical student5, Gabriel Bandeira Tofani, Medical student5,
Gilberto Diniz Miranda, Medical student6, Daniela Santiago Dias
Araújo7, Lucas Felipe Silva8, Sandy Luiza Martins Oliveira9, Mariana C
Melo10 and Maria Izabella V Rocha11, (1)Centro Universitário de Belo
Horizonte / UNI-BH, Belo Horizonte, Brazil, (2)Hospital da Baleia, Belo
Horizonte, Brazil, (3)Hospital Vera Cruz, Belo Horizonte, Brazil, (4)
Vera Cruz Hospital, Belo Horizonte, MG, Brazil, (5)Centro Universitário
de Belo Horizonte - UniBH, Belo Horizonte, Brazil, (6)Faculdade de
Ciências Médicas e da Saúde de Juiz de Fora - SUPREMA., Juiz de
Fora, Brazil, (7)Centro Universitário de Belo Horizonte - UniBH, Instituto
de Engenharia e Tecnologia – IET., Belo Horioznte, Brazil, (8)Centro
Universitário de Belo Horizonte - UniBH, Instituto de Engenharia e
Tecnologia – IET., Belo Horizonte, Brazil, (9)Centro Universitário de
Belo Horizonte - UniBH, Instituto de Engenharia e Tecnologia – IET.,
Belo Horizonte -MG, Brazil, (10)Hospital Luxemburgo, Belo Horizonte,
BRAZIL, (11)Hospital da Baleia, Belo Horizont, Brazil
609 Improving Understanding of Publicly Reported
Healthcare-Associated Infection (HAI) Data
Max Masnick, PhD1, Daniel Morgan, MD, MS2,3, Mark D Macek,
DDS, DrPH4, John D. Sorkin, MD, PhD3,5, Jessica P. Brown,
PhD1, Penny Rheingans, PhD6 and Anthony Harris, MD, MPH1,
(1)Department of Epidemiology and Public Health, University of
Maryland School of Medicine, Baltimore, MD, (2)VA Maryland
Healthcare System, Baltimore, MD, (3)University of Maryland School
of Medicine, Baltimore, MD, (4)University of Maryland School of
Dentistry, Baltimore, MD, (5)Veterans Affairs Maryland Healthcare
System Geriatrics Research, Education, and Clinical Center,
Baltimore, MD, (6)Department of Computer Science and Electrical
Engineering, University of Maryland Baltimore County, Baltimore, MD
610 Ability of Healthcare-Associated Infection (HAI) Data
to Differentiate Hospitals Nationwide
Max Masnick, PhD1, Daniel Morgan, MD, MS2,3, John D. Sorkin, MD,
PhD4, Mark D Macek, DDS, DrPH5, Jessica P. Brown, PhD1, Penny
Rheingans, PhD6 and Anthony Harris, MD, MPH1, (1)Department
of Epidemiology and Public Health, University of Maryland School
of Medicine, Baltimore, MD, (2)VA Maryland Healthcare System,
Baltimore, MD, (4)Veterans Affairs Maryland Healthcare System
Geriatrics Research, Education, and Clinical Center, Baltimore, MD,
(5)University of Maryland School of Dentistry, Baltimore, MD, (6)
Department of Computer Science and Electrical Engineering,
University of Maryland Baltimore County, Baltimore, MD
611 Challenges for Epidemiological Nurses in Polish
Hospitals – After 20 Years of Modern IC in Poland
Jadwiga Wojkowska-Mach, dr1, Malgorzata Bulanda, Prof.1 and
Anna Rozanska, PhD2, (1)Jagiellonian University Medical School,
Kraków, Poland, (2)Chair of Microbiology Jagiellonian University
Medical College, Kraków, Poland
612 Development of Multidrug-Resistant Tuberculosis in a
Non-Adherent HIV-Infected Patient
Mohammad Hudeeb, M.D. and Mayar Al Mohajer, MD FACP,
University of Arizona, Tucson, AZ
Top Poster
Abstract
30
PROGRAM
613 The Impact of a Course on Healthcare Epidemiology
as Shown through a Before and After Analysis
Amanda Krosche, BS1, Victoria J. Fraser, MD2, Anthony Harris, MD,
MPH3, Jenna Los, MA1, Leonard Mermel, DO, ScM4, Jonathan Teter,
MS1, David Pegues, MD5, Trish Perl, MD, MSc6 and Kerri Thom, MD,
MS3, (1)Johns Hopkins University School of Medicine, Baltimore, MD,
(2)Washington University School of Medicine, St. Louis, MO, (3)
Department of Epidemiology and Public Health, University of
Maryland School of Medicine, Baltimore, MD, (4)Brown University,
Providence, RI, (5)University of Pennsylvania, Philadelphia, PA, (6)
Johns Hopkins Medical Institutions and University, Baltimore, MD
614 Repeated Prevalence Surveys of HealthcareAssociated Infections
Maija-Liisa Rummukainen, MD, PhD1, Maire Matsinen, RN1, Tiina
Tiitinen, RN1, Maija-Liisa Lauritsalo, RN1 and Hannu Kautiainen, MSc2,
(1)Central Finland Health Care District, Jyväskylä, Finland, (2)Medcare
Oy, Äänekoski, Finland
615 Teaching Healthcare Epidemiology including IP, and
ASP: Impact of a Face to Face Training Course
Amanda Krosche, BS1, Jonathan Teter, MS1, Trish M Perl, MD,
MSc1, David Pegues, MD2, Leonard Mermel, DO, ScM3, Jenna Los,
MA1, Anthony Harris, MD, MPH4, Victoria Fraser, MD5 and Kerri
Thom, MD, MS4, (1)Johns Hopkins University School of Medicine,
Baltimore, MD, (2)University of Pennsylvania, Philadelphia, PA, (3)
Brown University, Providence, RI, (4)Department of Epidemiology
and Public Health, University of Maryland School of Medicine,
Baltimore, MD, (5)Washington Univ School of Med, Saint Louis, MO
616 Consideration of Seasonality in Antimicrobial Use (AU)
Raphaelle H. Beard, MPH1, Jessica Vakili2, Ashley Fell, MPH1 and
Marion A. Kainer, MD, MPH1, (1)Tennessee Department of Health,
Nashville, TN, (2)Tennessee Dept of Health, Nashville, TN
617 A Web-Based Method for Tracking Calling Effort for a
Clostridium difficile Case-Control Study
Corinne M. Davis, MPH, MS and Marion A. Kainer, MD, MPH,
Tennessee Department of Health, Nashville, TN
618 Knowledge, Attitude and Practice of Medical Staff in
Collecting Blood Cultures: A Multi-Center Study
Archana Nair, MD1, Sean Elliott, MD2 and Mayar Al Mohajer, MD
FACP3, (1)University of Arizona Medical Center at South Campus,
Tucson, AZ, (2)Univ of Arizona Hlth Sci Ctr, Tucson, AZ, (3)University
of Arizona - Section of Infectious Disease, Tucson, AZ
619 Surveillance for ERCP Associated Infections
Nathan A. Pinsky1,2 and Mary Anderson, BS1, (1)Edward Hospital,
Naperville, IL, (2)University of Illinois, Urbana/Champaign, Urbana, IL
620 Delayed Processing of Simulated Duodenoscope and
Patient Cultures Yields Viable Bacteria
Alice Chen1,2, Benjamin V. Lane, BS2, Sharon B. Wright, MD,
MPH, FIDSA, FSHEA2, David S. Yassa, MD, MPH2, Graham
M. Snyder, MD, SM2 and Elizabeth B. Hirsch, PharmD1,2, (1)
Northeastern University, Boston, MA, (2)Beth Israel Deaconess
Medical Center, Boston, MA
621 2500 Genomes: A Cautionary Tale of Implementing
Genomic Epidemiology Across Healthcare Enterprises
Emil Lesho, DO1, Robert Clifford, PhD1, Fatma Onmus-Leone,
MS1, Lakshmi Appalla1, Erik C. Snesrud, MS1, Yoon I Kwak, MS1,
Ana Ong, BS1, Rosslyn Maybank1, Paige Waterman, MD2, Patricia
Rohrbeck2, Michael Julius, PMP1, Amanda Roth1, Joshua Martinez1,
Lindsey Nielsen, PhD3, Eric Steele3, Patrick McGann, PhD1 and
Mary Hinkle, MD1, (1)Walter Reed Army Institute of Research, Silver
Spring, MD, (2)Armed Forces Health Surveillance Center, Silver
Spring, MD, (3)San Antonio Military Medical Center, San Antonio, TX
SCHEDULE
622 Infection Prevention Needs Assessment of Nebraska
Acute, Long-Term, and Ambulatory Care Facilities
L. Kate Tyner, BSN1, Peg Gilbert, MS2, Margaret Drake, MT3,
Benjamin Scott, MS1, Mark Rupp4 and Shelly Schwedhelm, MSN1,
(1)Nebraska Medicine, Nebraska Infection Control Assessment &
Promotion Program (ICAP), Omaha, NE, (2)CIMRO of Nebraska,
Nebraska Medicine, Nebraska Infection Control Assessment &
Promotion Program (ICAP), Lincoln, NE, (3)Nebraska Medicine,
Nebraska Infection Control Assessment & Promotion Program (ICAP),
Nebraska DPH Epidemiology Unit, Omaha, NE, (4)University of
Nebraska Medical Center, Department of Internal Medicine, Omaha,
NE
623 Prevalence and Predictors of Multi Drug Resistance
(MDRO) Colonization in Nursing Homes
James A McKinnell, MD1,2, Loren Miller, MD, MPH2, Raveena Singh,
MS3, Ken Kleinman, ScD4, Ellena Peterson, PhD5, Kaye Evans, BS5,
Adrijana Gombosev, MS3, Lauren Heim, MPH3, Tabitha Dutciuc,
MPH3, Marlene Estevez, BA3, Bryn Launer, BS2, Tom Tjoa, MS MPH3,
Steven Tam, MD3, Michael Bolaris, MD2 and Susan S. Huang, MD,
MPH3, (1)Providence Little Company of Mary Hospital, Torrance, CA,
(2)Infectious Disease Clinical Outcomes Research Unit (ID-CORE),
Division of Infectious Disease, Los Angeles Biomedical Research
Institute at Harbor-University of California Los Angeles (UCLA) Medical
Center, Torrance, CA, (3)Division of Infectious Diseases and Health
Policy Research Institute, University of California, Irvine School of
Medicine, Irvine, CA, (4)Harvard Medical School and Harvard Pilgrim
Health Care Institute, Boston, MA, (5)Department of Pathology
and Laboratory Medicine, University of California, Irvine School of
Medicine, Irvine, CA
624 The Risk Factors for Acinetobacter Baumannii
Infections in Intensive Care Unit: A Prospective Study
Bircan Kayaaslan, M.D1, Gul Ruhsar Yilmaz, Associate Professor2,
Fatma Yekta Korkmaz, M.D1, Rahmet Guner, Prof. Dr1, Tumer Guven,
Associate Professor1, Zeliha Kocak Tufan, Associate Professor1, Seval
Izdes, Proffesor3, Imran Hasanoglu, M.D2, Turan Buzgan, Associate
Professor1 and Mehmet Akin Tasyaran, Professor4, (1)Yildirim
Beyazit University Faculty of Medicine, Ankara, Turkey, (2)Ankara
Ataturk Training and Research Hospital, Ankara, Turkey, (3)Yildirim
Beyazit University Faculty of Medicine, Deparment of Anesthesiology
and Reanimation, Ankara, Turkey, (4)Yildirim Beyazit University
Faculty of Medicine, Department of Infectious Disease and Clinical
Microbiology, Ankara, Turkey
625 Big Data Guiding Prevention: Improved Surveillance
with Large Scale Analytics
Uzo Chukwuma1, Trinka Coster2, Michelle LaCour2, Kathryn
McAuliffe1, Rosenie Thelus2, Charlotte Neumann1, Mary Hinkle, MD3,
Robert Clifford, PhD3, Michael Julius, PMP3, Paige Waterman, MD4
and Emil Lesho, DO3, (1)Navy and Marine Corps Public Health
Center, Portsmouth, VA, (2)U.S. Army Pharmacovigelance Center,
Falls Church, VA, (3)Walter Reed Army Institute of Research, Silver
Spring, MD, (4)Armed Forces Health Surveillance Center, Silver
Spring, MD
626 Burden of CRE in Veterans with Spinal Cord Injury
(SCI) and Impact of Varying Federal Definitions
Katie J. Suda, PharmD, MS1,2, Margaret Fitzpatrick, MD, MS1,3,
Martin E. Evans, MD4, Linda Poggensee, MS1, Swetha Ramanathan,
MPH1, Stephen Burns, MD5, Charlesnika T. Evans, PhD, MPH1,6 and
Makoto Jones, MD, MS7,8, (1)VA Center of Innovation for Complex
Chronic Healthcare, Hines, IL, (2)University of Illinois at Chicago,
Chicago, IL, (3)Loyola University, Maywood, IL, (4)VHA National
Infectious Diseases Service, Lexington, KY, (5)VA Puget Sound Health
Care System, Seattle, WA, (6)Northwestern University, Chicago, IL, (7)
Salt Lake City VA Medical Center, Salt Lake City, UT, (8)University of
Utah, Salt Lake City, UT
SCIENTIFIC
SCIENTIFIC
PROGRAM
627 Up or Across? Vertical vs Horizontal Surveillance –
Five Year Acinetobacter Screening
Peter Harvey1, Juliet G Ferrelli, MS, MT(ASCP), CIC1 and Mohamed
H Yassin, MD, PhD2, (1)UPMC Mercy, Pittsburgh, PA, (2)Univ of
Pittsburgh, Pittsburgh, PA
628 Regional Variations in Fluoroquinolone NonSusceptibility Among E.coli Bloodstream Isolates in VHA
Daniel J Livorsi, MD, MSc1,2, Michihiko Goto, MD, MSCI1,2, Margaret
Carrel, PhD1, Makoto Jones, MD, MS3,4, Jennifer S McDanel, PhD1,5,
Rajeshwari Nair, MBBS, PhD1,5, Bruce Alexander, PharmD1, Kelly K
Richardson, PhD1, Brice F Beck, MA1 and Eli N Perencevich, MD,
MS1,2, (1)Iowa City VA Medical Center, Iowa City, IA, (2)University of
Iowa Carver College of Medicine, Iowa City, IA, (3)Salt Lake City VA
Medical Center, Salt Lake City, UT, (4)University of Utah, Salt Lake
City, UT, (5)Department of Epidemiology, University of Iowa College of
Public Health, Iowa City, IA
629 Clinical Significance of Positive Admission
Surveillance Culture for CRE in Non-Outbreak Setting
Chawat Tongma, MD, Kamaljit Singh, MD and Michael Y. Lin, MD,
MPH, Rush University Medical Center, Chicago, IL
630 Secondary Bloodstream Infections; Pathogens and
Site of Primary Infection, 2010-2015
Onyekachukwu Nwankwo, MD1, David Weber, MD, MPH2, Lauren
M. DiBiase, MS3, Emily Vavalle, PhD, MS1 and William Rutala, PhD,
MPH4, (1)University of North Carolina at Chapel Hill, Chapel Hill, NC,
(2)University of North Carolina at Chapel Hill, Chapel Hill, NC, (3)
Division of Infectious Diseases, University of North Carolina School
of Medicine, Chapel Hill, NC, (4)UNC School of Medicine, Chapel
Hill, NC
631 Legionella Environmental Culture Positivity Is
Associated With Free Chlorine Concentration
SCHEDULE
632 CRE Producing Carbapenemases Other Than KPC,
Reported to CDC, 2009-2015
Debra Taylor, MPH1, Maroya Walters, PhD ScM1, David Lonsway,
MMSC2, Meghan Lyman, MD1, David Kuhar, MD1, James K.
Rasheed, PhD1, Brandi Limbago, PhD1 and Alexander J. Kallen, MD,
MPH1,3, (1)Centers for Disease Control and Prevention, Atlanta,
GA, (2)Centers For Disease Control and Prevention, Atlanta, GA, (3)
Division of Healthcare Quality Promotion, CDC, Atlanta, GA
633 Definition of Healthcare-Associated Influenza: Criteria
Considered by SRN Participants
Elodie Munier-Marion1, Thomas Bénet1,2 and Philippe
Vanhems, MD, PhD2,3, (1)Infection Control and Epidemiology Unit,
Lyon, France, (2)Emerging Pathogens Laboratory - Foundation
Mérieux, Centre International de Recherche en Infectiologie (CIRI)
Inserm U1111, CNRS UMR5308, Lyon, France, (3)Infection Control
and Epidemiology Unit, Lyon, FRANCE
634 What is an Appropriate Antibiotic Choice for
Prophylaxis in Redo –Neurosurgeries?
Bhagyashri Navalkele, MD1, Oryan Henig, MD2, Kabir
Mendiratta, MD1, Elaine Flanagan, MSA1, Paula Robinson, BSN, CIC3,
Karolina Kaser, BSN2, Keith Kaye, MD, MPH2 and Teena Chopra, MD,
MPH2, (1)Detroit Medical Center, Detroit, MI, (2)Detroit Medical Center,
Wayne State University, Detroit, MI, (3)Henry Ford Hospital Health
Systems, Detroit, MI
636 Electronic Clostridium difficile Infection Bundle
Reduces Time to Initiation of Contact Precautions
Courtney M. Dewart, MPH, RN1, Natalia Blanco, MPH1, Betsy
Foxman, PhD1 and Anurag N. Malani, MD2, (1)University of Michigan
School of Public Health, Ann Arbor, MI, (2)St. Joseph Mercy Health
System, Ann Arbor, MI
Brooke K. Decker, M.D.1, Patricia L. Harris, M.S.N., R.N.1, Diana
L. Toy, B.S.N., R.N.1, Bonnie M. Mihalchik, BS, RN, MT, CIC1, Paul
D. Wiser, BSN2, Shelia M. Cloud-Woods, M.S.N., R.N.1, Ali F. Sonel,
M.D.1 and Cornelius J. Clancy, M.D.1, (1)VA Pittsburgh Healthcare
System, Pittsburgh, PA, (2)VA Pittsburgh Healthcare Sytem,
Pittsburgh, PA
Top Poster
Abstract
32
PROGRAM
PLENARY: REACHING OUT TO NEW
PARTNERS
1:00 – 2:30 p.m.
Moderators: Matthew Linam, MD and
Thomas Talbot, MD
Speakers:
Partners in Safety - Peter Pronovost, MD
Partners of Peers: Using Collaborations to Drive
Improvement - Stephen Muething, MD
• Discuss importance of collaboration with partners to achieve
lasting HAI reductions
• Describe examples of patient safety and collaborative partners
involved with HAI reduction programs
• Discuss the benefits of collaboration as a way to catalyze
efforts to reduce healthcare associated infections
SHEA ANTIBIOTIC STEWARDSHIP
TRAINING COURSE
BREAKOUT SESSION: BEGINNING
ANTIBIOTIC STEWARDSHIP Chastain E
Speakers:
Tailoring to Your Reality: Effective Strategies for Designing a
Stewardship Program - Michael Calderwood, MD
Measurement in Antibiotic Stewardship Elizabeth Dodds-Ashley, PharmD
• Explain how to conduct a needs assessment for your institution
• Discuss specific stewardship strategies and methods, merits,
and drawbacks based on resource availability
• Identify best first steps to initiate an antibiotic stewardship
program in your institution, with emphasis on both adult and
pediatric settings
• Explain how to employ pharmacy related metrics – Days of
Therapy (DOTs) or Defined Daily Doses (DDDs) for measuring
antibiotic use
• Discuss relevant process and outcomes measures to sustain
the business case for antibiotic stewardship interventions
• Discuss methods for measuring and reporting the impact
of an antibiotic stewardship program including the National
Healthcare Safety Network’s Antibiotic Utilization Module
CPE Number: 0221-9999-16-080-L04-P
TRAINING COURSE
BREAKOUT SESSION: ADVANCED
ANTIBIOTIC STEWARDSHIP
1:00 – 2:30 p.m.
1:00 – 2:30 p.m.
SCHEDULE
Chastain F
Speakers:
Advanced Strategies for Implementation: Building Capacity
in a Health System - Whitney Buckel, PharmD
Advanced Ideas for Measurement in Antimicrobial
Stewardship - Conan MacDougall, PharmD
• Describe unique challenges and strategies for implementing antibiotic stewardship across multiple sites or within a health system
• Review approaches to implementing antibiotic stewardship
where resources are limited
• Discuss scalability - how and where to expand your program
• Describe options for antibiotic utilization measurements and
merits of each
• Examine how to use time-series analyses and other study
designs to evaluate stewardship programs
• Explain how to assess and respond to antimicrobial shortages
in an institution
CPE Number: 0221-9999-16-081-L04-P
FULL CONFERENCE
PRO/CON: TO WASH OR RUB OFF –
C. DIFFICILE AND MAKING THE MOST OF
C. DIFFICILE PCR
2:45 – 4:00 p.m.
Savannah Ballroom
Moderators: Daniel Morgan, MD and
Abhishek Deshpande, MD
Speakers:
PRO: Soap and Water Should be Used - Carolyn Gould, MD
CON: Alcohol Hand Rub is Fine - Erik Dubberke, MD
PRO: PCR - Mary Hayden, MD
CON: PCR - Curtis Donskey, MD
• Assess the pros and cons of using soap and water vs. alcoholbased hand sanitizer for patients infected with C. difficile.
• Recognize various approaches to C. difficile testing and their
implications for both patient care and infection prevention and
control
• Learn about the pros and cons of primary PCR-based testing
for C. difficile infection
THURSDAY, MAY 19
SCIENTIFIC
SCIENTIFIC
PROGRAM
FULL CONFERENCE
ORAL ABSTRACT SESSION: HAI
SURVELLIANCE
Moderator: Barbara Trautner, MD and
Rebekah Moehring, MD
2:45 – 4:00 p.m.
Chastain Room
THURSDAY, MAY 19
Carlos E. Figueroa Castro, MD1, Mary Williams, RN, BSN, CIC2,
Carrie Johnson, RN, BSN, CIC3, Mary Beth Graham, MD4 and L.
Silvia Munoz-Price, MD, PhD5, (1)Medical College of Wisconsin,
Milwaukee, WI, (2)Froedtert & The Medical College of Wisconsin,
West Bend, WI, (3)Froedtert & The Medical College of Wisconsin,
Menomonee Falls, WI, (4)Division of Infectious Diseases, Medical
College of Wisconsin, Milwaukee, WI, (5)Institute for Health and
Society/Department of Medicine Froedtert and the Medical College of
Wisconsin Health Research Center, Milwaukee, WI
8105HAI Antibiotic Resistance Patient Safety Atlas: a New
Tool for Geospatial Analysis of NHSN HAI data
Raymund B Dantes, MD, MPH1,2, Alfred Junior3, Catherine Capers,
MA3, Lindsey Weiner, MPH3, Jonathan R Edwards, MStat4 and
Scott Fridkin, MD5, (1)Division of Healthcare Quality Promotion,
CDC, Atlanta, GA, (2)Emory University Hospital, Atlanta, GA, (3)
Centers for Disease Control and Prevention, ATLANTA, GA, (4)
Centers for Disease Control and Prevention, Division of Healthcare
Quality Promotion, Atlanta, GA, (5)Centers for Disease Control and
Prevention, Atlanta, GA
7686National burden of MRSA, MSSA and CDI among
Emergency Department discharges in U.S, 2009-2012
7976Incidence of Long-Term Care Facility Onset
Clostridium difficile Infection in 10 US Sites, 2011-2014
Alice Y. Guh, MD, MPH1, James Baggs, PhD1, Yi Mu, PhD2, Wendy
Bamberg, MD3, Zintars Beldavs, MS4, Corinne M. Davis, MPH,
MS5, Monica M. Farley, MD6, Stacy M Holzbauer, DVM, MPH1,7,
Carol Lyons, MS, MPH8, Rebecca Perlmutter, MPH9, Erin C Phipps,
DVM, MPH10, Lisa Winston, MD11, Maria Karlsson, PhD12, Dale N.
Gerding, MD13 and Ghinwa Dumyati, MD, FSHEA14, (1)CDC, Atlanta,
GA, (2)Division of Healthcare Quality Promotion, CDC, Atlanta, GA, (3)
Colorado Department of Public Health & Environment, Denver, CO, (4)
Oregon Health Authority, Portland, OR, (5)Tennessee Department of
Health, Nashville, TN, (6)Emory University, Atlanta, GA, (7)Minnesota
Dept of Health, St. Paul, MN, (8)Yale School of Public Health,
Connecticut Emerging Infections Program, New Haven, CT, (9)
Maryland Department of Health and Mental Hygiene, Baltimore, MD,
(10)University of New Mexico, New Mexico Emerging Infections
Program, Albuquerque, NM, (11)University of California, San
Francisco, San Francisco, CA, (12)Centers for Disease Control and
Prevention, Atlanta, GA, (13)Hines VA Hospital and Loyola University
Medical Center, Hines, IL, (14)University of Rochester Medical Center,
Rochester, NY
8003National Trends of Severe Sepsis and Septic Shock
Using Administrative Claims Data, 2008-2015
Kelly McCormick, MSPH, James Baggs, PhD, Raymund B
Dantes, MD, MPH, Anthony E Fiore, MD, MPH, John Jernigan, MD,
MS, Shelley Magill, MD, PhD and Lauren Epstein, MD, Division of
Healthcare Quality Promotion, CDC, Atlanta, GA
UPDATES FROM THE CDC PREVENTION
EPICENTERS PROGRAM: A PUBLIC
HEALTH/ACADEMIC RESEARCH
PARTNERSHIP
4:15 – 5:45 p.m.
8087Google Fusion Tables and Data Visualization of
Regional C.difficile epidemiology
34
SCHEDULE
Chastain Room
Moderator: John Jernigan, MD
Speakers:
What makes the CDC Prevention Epicenter Program
Different? - John Jernigan, MD
Chlorhexidine Bathing, Antibiotic Resistance, and Control Mary Hayden, MD
Environmental Decontamination to Prevent Transmission Deverick Anderson, MD
Improving Surveillance and Prevention for Ventilated Patients
- Michael Klompas, MD
Protection of Healthcare Workers: Vaccines, PPE and
Aerosols - Hilary Babcock, MD
Strategies to Improve Antimicrobial Stewardship Ebbing Lautenbach, MD
• List unique features of the CDC Prevention Epicenter Program
• List ongoing lines of research being conducted by the investigators in the Program
• List high priority research topics for the field
IS THERE QUALITY IN QUALITY METRICS?
4:15 – 5:45 p.m.
Savannah Ballroom
Moderators: Neil Fishman, MD and Marci Drees, MD
Speakers:
Limitations in SSI Quality Metrics Michael Calderwood, MD
Dissonant Metrics - You Win Some, You Lose Some Raymond Chinn, MD
Penalizing Quality Hospitals for Hospital-Acquired Conditions
- Grace Lee, MD
• Discuss current hospital quality metrics for healthcare-associated infections
• Compare the advantages and disadvantages of different
quality metrics for the same healthcare-associated infection
• Recognize the limitations of current metrics and their link to
quality of care provide
PROGRAM
JOINT SESSIONS
PAC & LTC: CHANGING THE NATIONAL
LANDSCAPE & INFECTION PREVENTION
2:45 – 3:30 p.m.
Chastain F
Speaker: Nimalie Stone, MD
• Describe the differences in infrastructure for clinical care and
infection prevention in post-acute and long-term care settings
compared with acute care hospitals
• Describe the gaps and challenges in implementing infection
prevention and antibiotic stewardship programs in post-acute
and long-term care settings
• Highlight the national initiatives which are driving surveillance
and prevention activities in this setting
C O U R S E I N H O S P I TA L E P I D E M I O L O G Y
ENVIRONMENT, STERILIZATION &
DISINFECTION
WHAT EVERY STEWARD SHOULD
KNOW ABOUT PHARMACOKINETICS –
PHARMACODYNAMICS
Chastain E
Speaker: Elizabeth Dodds-Ashley, PharmD
• Review PK and PD properties of different antibiotic agents and
their application to selection of appropriate dosing based on
patient, pathogen, and syndrome characteristics
• Discuss approaches to therapeutic monitoring of antibiotics
such as vancomycin and aminoglycosides
• Review approaches for IV to PO conversion
CPE Number: 0221-9999-16-082-L01-P
ALLERGIES, INTERACTIONS AND
ADVERSE EVENTS
3:15 – 3:45 p.m.
Chastain F
Speaker: Kerri Thom, MD
Chastain E
Speaker: Jeffrey Gerber, MD
• Identify the Spaulding scheme for selection and use of
disinfectants
• Identify two control measures that can be employed to prevent
fungal transmission during construction/renovation
• Indicate when microbiologic sampling of the environment
should be done
• Perform an overview of sterilization and disinfection
SPECIAL POPULATIONS
IMMUNOCOMPROMISED, ICU, DIALYSIS
AND BURN PATIENTS
4:30 – 5:30 p.m.
TRAINING COURSE
2:45 – 3:15 p.m.
3:30 – 4:15 p.m.
SCHEDULE
Chastain F
Speaker: Deborah Yokoe, MD
• Recognize how to apply and modify healthcare epidemiology,
antibiotic stewardship, and infection prevention approaches for
immunocompromised populations
• Review the special issues associated with these populations
including increased use of invasive devices, increased use of
broad-spectrum empiric antibiotics and how intense exposure
to the healthcare system increases risks of MDRO acquisition
• List different types of allergic reactions to antibiotics and how
they may be prevented or minimized
• List common drug-drug interactions and explain strategies to
avoid them
• Discuss common adverse events associated with various
antimicrobials
CPE Number: 0221-9999-16-083-L05-P
AN UPDATE ON DURATION OF THERAPY
AND THERAPEUTIC MONITORING:
OUR ROLE AS STEWARDS
3:45 – 4:15 p.m.
Chastain E
Speaker: Kavita Trivedi, MD
• Explain the science behind duration of antibiotic therapy
• Review the uses of inflammatory biomarkers in antibiotic
stewardship programs
CPE Number: 0221-9999-16-084-L05-P
ANTIBIOTIC STEWARDSHIP: NAVIGATING
THE LIABILITY RISKS
4:30 – 5:00 p.m.
Chastain E
Speaker: Mary Ellen Nepps, Esq.
• Identify legal concepts that are applicable to the practice of
antibiotic stewardship
• Define the nature and extent of medical-legal risk in the
practice of antibiotic stewardship
• Discuss approaches for management of risk in the practice of
antibiotic stewardship
CPE Number: 0221-9999-16-085-L03-P
THURSDAY, MAY 19
SCIENTIFIC
SCIENTIFIC
PROGRAM
SCHEDULE
CASE STUDY #1: USING BENCHMARKING
TO ENHANCE ANTIBIOTIC STEWARDSHIP
SHEA EDUCATION AND RESEARCH
FOUNDATION DINNER
5:00 – 5:45 p.m.
6:00 – 9:00 p.m.
Chastain E
Speaker: Whitney Buckel, PharmD
• Describe the utility of benchmarking in antibiotic stewardship
• Discuss goals of the NHSN AUR Module
• Describe how to use data from the NHSN AUR Module to
refine stewardship interventions, highlighting the role of the
pharmacist
THURSDAY, MAY 19
CPE Number: 0221-9999-16-086-L04-P
36
Georgia Aquarium
Please note: No transportation will be provided as the
Georgia Aquarium is within walking distance to the
Westin Peachtree Plaza.
SHEA Staff and Atlanta Volunteers will be available as
guides for walking groups. Guides will depart from the
hotel lobby at 5:30 p.m. to take you to the aquarium.
If you are walking on your own, the aquarium’s Oceans
Ballroom is located on the first level of the parking deck. If
parking at the aquarium, take the elevator to level one and
follow the signs to the Oceans Ballroom.
SCIENTIFIC
PROGRAM
7:00 – 7:50 a.m.
INTERNATIONAL ATTENDEE BREAKFAST
7:00 – 7:50 a.m.
Peachtree Room
This breakfast is open only to international attendees and
SHEA Leaders.
SCHEDULE
LEADERSHIP AND COMMUNICATION
SKILLS 8:00 – 8:45 a.m.
Chastain F
Speaker: Robert Weinstein, MD
RESEARCH METHODS IN HEALTHCARE
EPIDEMIOLOGY – PRACTICAL
CONSIDERATIONS
8:00 – 9:30 a.m.
Savannah Ballroom
Moderators: Nasia Safdar, MD and
Graham Snyder, MD
Speakers:
Pearls and Pitfalls - Obs/Retro - Daniel Morgan, MD
Pearls and Pitfalls - Quasi-experimental Design Aaron Milstone, MD
Pearls and Pitfalls - Trials - Deverick Anderson, MD
• Review good methods in healthcare epidemiology research
• Learn pros and cons of using common healthcare epidemiology research methods
NOVEL ENGINEERING SOLUTIONS TO
ENVIRONMENTAL HYGIENE
8:00 – 9:30 a.m.
Chastain Room
Moderators: Leonard Mermel, DO and
Arjun Srinivasan, MD
Speakers:
The Microbiome of the Built Hospital Environment Simon Lax, PhD
Architectural Solutions to Infection Prevention James Steinberg, MD
Engineering Healthcare Workers: How Staffing Models Effect
Transmission - Sean Barnes, MS
• Discuss effective facilitation strategies to manage multidisciplinary teams and meetings including the following key
strategies:
• Agenda development, Inclusiveness, Action and follow up,
Clear responsibility and task management, and Feedback
mechanisms
• Identify the importance of collaboration with other hospital
groups/teams and stakeholders
• Recognize the basics of effective communication
• Indicate basic skills for effective negotiation
• Demonstrate how to speak to the financial impacts and
cost-effectiveness of proposed interventions
THE HOSPITAL EPIDEMIOLOGIST AS A
CLINICIAN EDUCATOR
8:45 – 9:30 a.m.
Chastain F
Speaker: Robert Weinstein, MD
• Distinguish principles of adult learning necessary to effectively
teach and to design educational interventions
• Identify varying forums and tools for effective delivery of
education including didactic lectures, small-group case-based
discussions, and one-on-one instruction
• Classify the target audience and be able to vary teaching
modalities & methods based on audience, level of training and
knowledge base
• Identify mechanisms for delivering education including
unit-level training, hands-on skills demonstration, computer-based modules, and simulation
• Assess the stage of the learner, ensure topic is meaningful and
relevant to learner’s work, articulate goals, encourage active
learner involvement, and provide feedback
• Recognize presentation tools effectively and appropriately,
develop effective written educational materials, and educate
individual HCP and other stakeholders
• Use varying teaching methods targeted at specific audience
needs and goals
• Discuss the environmental microbiome and how it can affect
disease transmission
• Propose architectural design solutions for infection prevention
and discuss how these solutions can lead to a decrease in
disease transmission
• Discuss how manipulation of healthcare worker staffing
ratios can affect transmission of disease using mathematical
modeling
FRIDAY, MAY 20
FULL CONFERENCE
SCIENTIFIC
PROGRAM
TRAINING COURSE
INTEGRATION OF THE MICROBIOLOGY
LAB & ANTIBIOTIC STEWARDSHIP:
BEGINNING CONCEPTS
8:00 – 8:45 a.m.
Chastain E
Speaker: Daniel Diekema, MD
• Describe appropriate ways to obtain a culture specimen and
other samples for microbiology testing
• Review approaches to detecting and reporting antibiotic
susceptibilities, including selective reporting
• Identify strengths and weaknesses of the antibioGram to assist
with decisions on recommendations for empirical therapy
RAPID DIAGNOSTIC TESTS AND HOW TO
IMPLEMENT THEIR USE: MINI-LECTURE &
CASE STUDY #2
Chastain E
• Describe strengths and weaknesses of common rapid
diagnostic tests and used in the microbiology lab
• Discuss how the microbiology lab and the antibiotic stewardship program can collaborate to maximize use of rapid
diagnostic tests to improve antibiotic use
FRIDAY, MAY 20
REGIONAL APPROACH TO MDRO
PREVENTION
10:00 – 12:00 p.m.
Savannah Ballroom
Moderators: Maroya Walters, PhD and
Kurt Stevenson, MD
Speakers:
Modeling the Best Approaches to Regional MDRO
Prevention - Susan Huang, MD
Challenges to Implementing Regional Programs Christopher Pfeiffer, MD
Public Health Coordination of Regional Programs Marion Kainer, MD
• Identify rationale supporting a regional approach to MDRO
control
• Describe challenges to implementing coordinated control
efforts from the state and facility perspective
• Describe potential effect of regional control efforts based on
modeling
CHALLENGING CASES AND ISSUES IN
INFECTION PREVENTION
Speaker: Shira Doron, MD
CPE Number: 0221-9999-16-088-L04-P
NETWORKING BREAK
9:30 – 10:00 a.m.
FULL CONFERENCE
CPE Number: 0221-9999-16-087-L01-P
8:45 – 9:30 a.m.
SCHEDULE
10:00 – 12:00 p.m.
Chastain Room
Moderators: Latania Logan, MD and
Robert Weinstein, MD
Speakers:
Case Presenter 1 - Latania Logan, MD
Case Presenter 2 - Robert Weinstein, MD
Panelist: Peds Perspective - Matthew Linam, MD
Panelist: University Medical Center - Laurie Conway, PhD
Panelist:Community Hospital - Raymond Chinn, MD
Panelist: Post-Acute Care - Deborah Yokoe, MD
• Discuss real-world challenges in infection prevention in various
healthcare settings
• Compare strengths and weaknesses of solutions to
challenging problems
• Formulate management strategies and discuss resources to
assist in the implementation of the solutions discussed
• Compare knowledge with other peers and assess clinical
acumen in infection prevention
38
PROGRAM
OCCUPATIONAL HEALTH ISSUES
10:00 – 11:00 a.m.
Chastain F
TRAINING COURSE
UPDATE ON THE NATIONAL
STEWARDSHIP ACTIVITIES
10:00 – 10:30 a.m.
Speaker: Thomas Talbot, MD
Chastain E
• Illustrate the role of healthcare personnel (HCP) in the transmission of healthcare-associated infections
• Identify the recommended strategies, including immunization and use of screening tests, designed to prevent
HCP-associated transmission of pathogens
• Identify the approach to HCP infected with a bloodborne virus
• Summarize the management of contagious disease exposures
among HCP, including the use of post-exposure prophylaxis
REGULATORY & EMERGENCY
PREPAREDNESS
11:00 a.m. – 12:00 p.m.
SCHEDULE
• Describe the national landscape and activities in antibiotic
stewardship
• Discuss available resources to assist with stewardship
implementation
CPE Number: 0221-9999-16-089-L04-P
HOW TO FIND RESOURCES AT YOUR
INSTITUTION OR HEALTH SYSTEM
10:30 – 11:30 a.m.
Chastain F
Speaker: Louise Dembry, MD
• State the role and functions of public health entities at local,
state, and national levels
• Review core emergency preparedness concepts, including
emergency response planning, incident command functions,
and facility response to emergent events
• Assist in policy and response plan development and evaluation
for infection-related events, such as bioterrorism or pandemic
respiratory pathogens
• Recite an overview of the system of state, federal, and accrediting organization oversight and requirements for healthcare
facilities prepare for and survive a visit from CMS, TJC, and
State DPH
Chastain E
Speaker: Mohamad Fakih, MD
• Review how your antibiotic stewardship program intersects
with the institution’s strategic plan
• Describe how to engage non-traditional stewards such as
students, quality improvement teams, and nurses
• Explain how to develop and present a business case to institutional leadership for maintenance of a program
CPE Number: 0221-9999-16-090-L04-P
ART OF ANTIBIOTIC STEWARDSHIP
11:30 – 12:00 p.m.
Chastain E
Speaker: Sara Cosgrove, MD
• Distinguish basic theories regarding patient safety, quality
science, implementation science and organizational change to
implement antibiotic stewardship interventions and to change
prescribing habits
• Review the complex interpersonal and interprofessional needs
to best develop and sustain an antibiotic stewardship program
CPE Number: 0221-9999-16-091-L04-P
FRIDAY, MAY 20
SCIENTIFIC
POSTER PRESENTATIONS: FRIDAY, MAY 20
SCIENTIFIC
PROGRAM
LUNCH WITH POSTER PRESENTATIONS
12:00 – 1:00 p.m.
501 Deploying a Novel Metric to Contextualize
Carbapenem Use at an Academic Tertiary Care
Hospital
J Daniel Markley, DO1, Anahita Molayi, MSPH2, Shaina Bernard,
Pharm D, BCPS1, Kimberly Lee, PharmD1, Kakotan Sanogo3,
Gonzalo Bearman, MD, MPH4, Amy Pakyz, Pharm D, MS, PhD3,
Michael Stevens, MD1 and Perry Taylor5, (1)Virginia Commonwealth
University Medical Center, Richmond, VA, (2)Virginia Commonwealth
University School of Medicine, Richmond, VA, (3)Virginia
Commonwealth University, Richmond, VA, (4)Medical College of
Virginia, Richmond, VA, (5)Virginia Commonwealth University Health
System, Richmond, VA
502 A Survey to Optimize the Design of an Antimicrobial
Smartphone App at an Academic Medical Center
J Daniel Markley, DO1, Gonzalo Bearman, MD, MPH2, Michael
Stevens, MD3, Amy Pakyz, Pharm D, MS, PhD4, Shaina Bernard,
Pharm D, BCPS1, Kimberly Lee, PharmD1 and Nital Appelbaum5, (1)
Virginia Commonwealth University Medical Center, Richmond, VA, (2)
Medical College of Virginia, Richmond, VA, (3)VCUHS, Richmond,
VA, (4)Virginia Commonwealth University, Richmond, VA, (5)Virginia
Commonwealth University Health System, Richmond, VA
503 Safety and Efficacy of Outpatient Parenteral Antibiotic
Therapy (OPAT) in an Infectious Disease Clinic
Geehan Suleyman, MD1, Rachel Kenney, Pharm D1, Marcus
Zervos, MD1,2 and Allison Weinmann, MD1, (1)Henry Ford Health
System, Detroit, MI, (2)Wayne State University, Detroit, MI
504 Diagnosis and Treatment of Urinary Tract Infections in
Patients Seen in the Emergency Department
Ioana Chirca, MD1, Penny Shute2, Meyer Schwartz, MD2 and
Heather J Schwartz, NP3, (1)University Hospital Augusta, Augusta,
GA, (2)University Hospital, Augusta, GA, (3)Joseph M Still Burn
Center, Augusta, GA
505 Pharmacist Managed Penicillin Skin Testing in
Hospitalized Patients
Jeff Brock, Pharm.D., MBA1, Nathan Peterson, Pharm.D.1 and
Aneesa Afroze, M.D.2, (1)Mercy Medical Center, Des Moines, IA, (2)
Chest, Infectious Diseases and Critical Care Associates, P.C., Clive, IA
506 Projecting the Impact of Reduction in Antibiotic Usage
on the Transmission of MDROs
Sean L. Barnes, PhD1, Anthony Harris, MD, MPH2, Clare Rock, MD,
MS3, Sara Cosgrove, MD, MS4, Daniel Morgan, MD, MS5 and Kerri
Thom, MD, MS2, (1)University of Maryland, College Park, MD, (2)
Department of Epidemiology and Public Health, University of
Maryland School of Medicine, Baltimore, MD, (3)Department of
Medicine, Division of Infectious Diseases, Johns Hopkins University,
Baltimore, MD, (4)Johns Hopkins University School of Medicine,
Baltimore, MD
507 The Significance of bacteriuria in Patients with ESRD
on Hemodialysis
Ibrahim Taweel, MD1, Alexsis Duarte1, Norman Beatty, MD1, David
Nix, PharmD2 and Mayar Al Mohajer, MD FACP3, (1)University of
Arizona - College of medicine, Tucson, AZ, (2)University of ArizonaCollege of Pharmacy, Tucson, AZ, (3)University of Arizona, Tucson, AZ
508 Impact of Empiric Antibiotic Likelihood of Infection
Coverage on Inpatients with UTI and ABI
Jessica P Ridgway, MD, MS1, Ari Robicsek, MD1,2, Becky
Smith, MD2, Jeffery Semel, MD2, Nirav Shah, MD, MPH1 and Lance
Peterson, MD1,2, (1)University of Chicago, Chicago, IL, (2)NorthShore
University HealthSystem, Evanston, IL
SCHEDULE
509 Impact of Antimicrobial Stewardship Program (ASP) in
a Rural Community Hospital
William L Tillett, PharmD, MPH, Mayo Clinic Health System,
Waycross, GA
510 Antimicrobial Stewardship in Critical Access Hospitals:
Fighting the Same Battle?
Gayle Allenback, MSOT, MPH, GStat1,2, Patricia Cruz, PhD3 and
David Woodard, MSc, FSHEA2, (1)University of Nevada School of
Medicine, Las Vegas, NV, (2)University of Nevada Las Vegas, Las
Vegas, NV, (3)University of Nevada, Las Vegas, Las Vegas, NV
511 Trends in Restricted and Unrestricted Gram-Positive
Antimicrobial Consumption at a Virginia Hospital
Anahita Molayi, MSPH, Virginia Commonwealth University School of
Medicine, Richmond, VA
512 The Role of Infectious Disease Consultation in
Patients with Enterococcus Bacteremia
Pryce Gaynor, MD MPH, David Nix, PharmD, Kathryn Matthias,
PharmD, Tsz Tsui, PharmD and Mayar Al Mohajer, MD FACP,
University of Arizona, Tucson, AZ
513 Patterns of Antimicrobial Prescribing in Emergency
Departments at Detroit Medical Center (DMC)
Oryan Henig, MD, Ryan P. Mynatt, PharmD, Jason Pogue,
PharmD, Leah Molloy, PharmD, Jing J. Zhao, PharmD, Kyle Murray,
PharmD, Teena Chopra, MD, MPH, Sorabh Dhar, MD, Bhagyashri
Navalkele, MD and Keith Kaye, MD, MPH, Detroit Medical Center,
Wayne State University, Detroit, MI
514 Perceptions of Use of Twitter to Promote Antibiotic
Timeouts and Education: A Pilot Study
Jordan R. Wong, PharmD1, Sheetal Kandiah, MD2, Roshan
Patel, MD3 and Mina Tadrous4,5, (1)Grady Health System, Atlanta,
Georgia, USA, Atlanta, GA, (2)Emory University, Decatur, GA, (3)
University of California San Francisco, San Francisco, CA, (4)St.
Michael’s Hospital, Toronto, ON, Canada, (5)Leslie Dan Faculty of
Pharmacy, Toronto, ON, Canada
515 Provider Prescribing Activities in the Post-Prescription
Period: Opportunities for Intervention
Kerri Thom, MD, MS1, Pranita Tamma2, Lisa Pineles, MA1, Kate
Dzintars, PharmD3, Anthony Harris, MD, MPH1, Daniel Morgan, MD,
MS4,5, Edina Avdic, Pharm, D, MBA6 and Sara Cosgrove, MD,
MS2, (1)Department of Epidemiology and Public Health, University
of Maryland School of Medicine, Baltimore, MD, (2)Johns
Hopkins University School of Medicine, Baltimore, MD, (3)Johns
Hopkins University School of Medicine Department of Medicine,
Baltimore, MD, (4)VA Maryland Healthcare System, Baltimore, MD,
(5)University of Maryland School of Medicine, Baltimore, MD, (6)The
Johns Hopkins Hospital, Baltimore, MD
516 Impact of Antimicrobial Stewardship Interventions on
Utilization and Resistance To Fluoroquinolones
Michelle T. Hecker, MD1,2, Andrea Son, PharmD2, Nina NaegerMurphy, PharmD2 and Curtis J. Donskey, MD1,3, (1)Case Western
Reserve University, Cleveland, OH, (2)MetroHealth Medical Center,
Louis Stokes Cleveland VA Medical Center, Cleveland, OH
517 City-Wide Evaluation of Urinary Tract Infection
Treatment Patterns in the Emergency Department
Christopher David Evans, PharmD1, Mary Lourdes Brundige,
PharmD2, Mary Staicu, PharmD2, Tina Khadem, PharmD3, Tuong
Diep, PharmD4, Christina B Felsen, MPH5, Maryrose LaguioVila, MD2 and Ghinwa Dumyati, MD, FSHEA5, (1)University of
Rochester Medical Center, Rochester, NY, (2)Rochester General
Hospital, Rochester, NY, (3)Highland Hospital, Rochester, NY, (4)
Unity Hospital, Rochester, NY, (5)New York Emerging Infections
Program, Rochester, NY
Top Poster
Abstract
40
PROGRAM
518 A Comparison of Antimicrobial Use Summary Measures
Using Data Reported From ICUs to NHSN, 2015
Erin N. O’Leary, MPH, Jonathan R Edwards, MStat, Katharina L. van
Santen, MSPH, Arjun Srinivasan, MD, Scott Fridkin, MD and Daniel A.
Pollock, MD, Centers for Disease Control and Prevention, Division of
Healthcare Quality Promotion, Atlanta, GA
519 Expert Consensus on Relevant and Feasible Metrics to
Demonstrate Impact of Antimicrobial Stewardship
Rebekah W. Moehring, MD, MPH1,2,3, Deverick Anderson, MD,
MPH1,4 and Elizabeth Dodds Ashley, PharmD, MHS1,5, (1)Duke
Antimicrobial Stewardship Outreach Network, Durham, NC, (2)Duke
University Medical System, Durham, NC, (3)Durham Veterans Affairs
Medical Center, Durham, NC, (4)Duke University Medical Center,
Durham, NC, (5)Duke University, Durham, NC
520 Incorporation of Antimicrobial Stewardship Into a
Hospital Committee Structure
J Ryan Bariola, MD, Katherine T Lusardi, PharmD and Robert W
Bradsher Jr, MD, University of Arkansas for Medical Sciences, Little
Rock, AR
521 Barriers and Facilitators to Implementing Antimicrobial
Stewardship in Philadelphia-Area Hospitals
Julia E. Szymczak, PhD1, Jeffrey S. Gerber, MD, PhD2 and
Keith Hamilton, MD3, (1)The Children’s Hospital of Philadelphia,
Philadelphia, PA, (2)Division of Infectious Diseases, The Children’s
Hospital of Philadelphia, Philadelphia, PA, (3)Hospital of the University
of Pennsylvania, Philadelphia, PA
522 Educational Initiative to Decrease Screening for
Asymptomatic Bacteriuria at a Community Hospital
Montgomery Ford Williams, PharmD1,2, Michael E Wright, PharmD2,
Maggie Montgomery, PharmD3, Emily P Doss, PharmD4 and Julie
Reznicek, DO5, (1)Belmont University, Nashville, TN, (2)Williamson
Medical Center, Franklin, TN, (3)Veterans Affairs New York Harbor
Healthcare System, Brooklyn, NY, (4)VA Tennessee Valley Healthcare
System, Nashville, TN, (5)VCU Health System, Richmond, VA
523 Fear of Failure: Engaging Patients to Reduce
Inappropriate Antibiotic Use after Fecal Transplants
Michelle T. Hecker, MD1,2, Edith Ho, MD1,3 and Curtis J.
Donskey, MD1,4, (1)Case Western Reserve University, Cleveland,
OH, (2)MetroHealth Medical Center, Cleveland, OH, (3)Cleveland
VA Medical Center, Cleveland, OH, (4)Geriatric Research Education
Cleveland, OH
524 Vertical Antimicrobial Stewardship to Reduce C.
difficile Colitis in Colonized Patients
Sara L Revolinski, PharmD1, Njeri Wainaina, MD2, Mary Beth
Graham, MD2 and L. Silvia Munoz-Price, MD, PhD3, (1)Froedtert
Hospital, Medical College of Wisconsin, Milwaukee, WI, (2)Division of
Infectious Diseases, Medical College of Wisconsin, Milwaukee, WI,
(3)Institute for Health and Society/Department of Medicine Froedtert
and the Medical College of Wisconsin Health Research Center,
Milwaukee, WI
525 Urinary Tract Infections: Pilot Study to Improve
Guideline Adherence
Maroun M. Sfeir, MD, MPH1,2, Alexandra Beranger, MD3 and
Thomas Hooton, MD2,3, (1)New York Presbyterian Weill Cornell
Medical Center, New York, NY, (2)University of Miami Miller School of
Medicine/ Jackson Memorial Hospital, Miami, FL, (3)Miami Veteran
Affairs Medical Center, Miami, FL
SCHEDULE
526 An Antimicrobial Stewardship Intervention for
Asymptomatic Bacteriuria Addressed Cognitive Biases
Larissa Grigoryan, MD, PhD1, Aanand D. Naik, MD1,2, Deborah
Horwitz, PA1, Jose A. Cadena-Zuluaga, MD3, Jan Patterson, MD4,
Roger Zoorob, MD, MPH1 and Barbara Trautner, MD, PhD1,5, (1)
Baylor College of Medicine, Houston, TX, (2)Health Services Research
and Development Center of Excellence, Michael E. DeBakey VA
Medical Center, Baylor College of Medicine, Houston, TX, (3)
South Texas Veterans Health Care System, Audie Murphy Division,
Pipe Creek, TX, (4)University of Texas Health Science Center at
San Antonio, San Antonio, TX, (5)Center for Innovations in Quality,
Effectiveness and Safety, Houston, TX
527 Impact of Procalcitonin (PCT) on Antimicrobial Use in
an Intensive Care Unit at a Community Hospital
Taeyong Sim, MD, Kara Brockhaus, PharmD, Curtis D Collins,
PharmD, MS, Anupam Suneja, MD and Anurag Malani, MD, St.
Joseph Mercy Health System, Ann Arbor, MI
529 Can a Patient Safety Initiative Change Outpatient
Antibiotic Prescription Practice?
Kazuaki Jindai, MD1,2, Jackson Musuuza, MD, MPH, MS3, Graeme
Forrest, MBBS1,4, Kimberly MacKay, PharmD1, Nasia Safdar, MD,
PhD5,6 and Christopher Pfeiffer, MD, MHS1,4, (1)VA Portland Health
Care System, Portland, OR, (2)School of Public Health, Oregon
Health & Science University, Portland, OR, (3)Institute for Clinical and
Translational Research, University of Wisconsin, Madison, WI, (4)
Division of Infectious Disease, Oregon Health & Science University,
Portland, OR, (5)The William S. Middleton Veterans Affairs Medical
Center, Madison, WI, (6)University of Wisconsin School of Medicine &
Public Health, Madison, WI
530 Defining Baseline Antimicrobial Utilization and
Outcomes Prior to a Stewardship Protocol for Short-C
Ethan A. Smith, PharmD, Howard S. Gold, MD, Graham M.
Snyder, MD, SM, Monica Mahoney, PharmD and Christopher McCoy,
PharmD, Beth Israel Deaconess Medical Center, Boston, MA
531 Implementing Antimicrobial Stewardship Through a
Hospital-Nursing Home Partnership
Christina B Felsen, MPH1, Gail Quinlan, RN, MS, CIC1, Elizabeth
Dodds Ashley, PharmD, MHS2 and Ghinwa Dumyati, MD, FSHEA1,
(1)University of Rochester Medical Center - Center for Community
Health, Rochester, NY, (2)Duke University, Durham, NC
532 Practical Considerations When Creating a Weighted
Incidence Syndromic Combination Antibiogram
(WISCA)
Courtney Hebert, MD1, Protiva Rahman1, Erinn Hade, PhD1,
Karri Bauer2, Mark Lustberg, MD, PhD2, Preeti Pancholi, PhD2,
Albert Lai, PhD1, Arka Pattanayak1, Po-Yin Yen, RN, PhD1 and Kurt
Stevenson, MD2, (1)The Ohio State University, Columbus, OH, (2)The
Ohio State University Wexner Medical Center, Columbus, OH
534 Clinical Guideline Adherence for Asymptomatic
Bacteriuria in Spinal Cord Injury
Felicia Skelton, MD1,2, Larissa Grigoryan, MD, PhD2, Jun Ying, MS1,
Sally Ann Holmes, MD2,3 and Barbara Trautner, MD, PhD1,2, (1)Center
for Innovations in Quality, Effectiveness and Safety, Houston, TX, (2)
Baylor College of Medicine, Houston, TX, (3)Michael E. DeBakey VA
Medical Center, Houston, TX
SCIENTIFIC
SCIENTIFIC
PROGRAM
535 What Drives Inappropriate Antibiotic Dispensing?
Pharmacist Perspectives in Haryana, India
Anna Barker, BA1, Kelli Verhoeven, MPH1, Md Muneeb Ahsan, MSc,
B Pharm2, Sazid Alam, MSc, DMLT2, Sharmila Sengupta, MBBS, MD2
and Nasia Safdar, MD, PhD3, (1)Department of Population Health
Sciences, School of Medicine and Public Health, University of
Wisconsin, Madison, WI, (2)Medanta the Medicity Hospital, Gurgaon,
India, (3)University of Wisconsin School of Medicine & Public Health,
Madison, WI
536 A Retrospective Case-Control Study to Identify Risk
Factors Associated With Clostridium difficile in a
Teaching Hospital in Saudi Arabia
Nabeela Al-Abdullah, PhD, King Abdulaziz University, Jeddah,
Saudi Arabia
537 Gastric Acid Altering Medications as a Risk for
Clostridium difficile Infection
Kerrie VerLee, MPH, CIC, Chau Nguyen, MS and Donald J Scott,
BS, PharmD, Spectrum Health, Grand Rapids, MI
SCHEDULE
544 Oral Beta-Lactamase Therapy to Prevent AntibioticInduced Disruption of the Gut Microbiome
Klaus Gotlieb, MD, Amy Sloan, John Andrew Bristol, PhD, Steven
Hubert, Olivia Coughlin, John Kokai-Kun, PhD, Heidi Whalen, Tracey
Roberts, Michael Schlosser, PhD, Sheila Connelly, PhD, Michael
Kaleko, MD, PhD and Joseph Sliman, MD, Synthetic Biologics, Inc.,
Rockville, MD
545 Effect of EMR-Based Intervention on Clostridium
difficile Standardized Infection Ratio
Raagini Jawa, MD MPH1, Deb Gregson, MSM2, Robert Burke,
RN, MA, CIC3, Pooja Phull, MD1, Matthew Bradley4, Kelly Fleming4,
Katherine Scanlon, RN5, Nancy Miller, MD6 and Cassandra
Pierre, MD, MSc3,7, (1)Internal Medicine, Boston Medical Center,
Boston, MA, (2)Quality & Patient Safety, Boston Medical Center,
Boston, MA, (3)Epidemiology, Boston Medical Center, Boston, MA,
(4)Information Technology Services, Boston Medical Center, Boston,
MA, (5)Nursing, Boston Medical Center, Boston, MA, (6)Laboratory
Medicine, Boston Medical Center, Boston, MA, (7)Infectious Diseases,
Boston University School of Medicine, Boston, MA
538 Reducing Inappropriate C. difficile Testing Using an
Electronic Laxative Alert
547 Benefits of Clostridium difficile Polymerase Chain
Reaction Screening Followed by Toxin Confirmation
539 Correlation between RT-PCR Cycle Threshold and
Clostridium difficile Infection (CDI) Outcomes
548 Time to Specimen Receipt Not Associated with
Increased Likelihood of Detecting Clostridium difficile
Stephen C Eppes, MD1, Sharon Kleban, MA2 and Marci Drees, MD,
MS1, (1)Christiana Care Health System, Newark, DE, (2)Christiana
Care Health System, New Castle, DE
Byungwoo Choi, MD1, Ken Koon Wong, MD1, Abhishek
Deshpande, MD PhD1,2, Thomas G. Fraser, MD3, Gary W.
Procop, MD4, Sandra S. Richter, MD4 and Carlos M. Isada, MD1, (1)
Department of Infectious Diseases, Medicine Institute, Cleveland
Clinic, Cleveland, OH, (2)Medicine Institute Center for Value Based
Care Research, Cleveland Clinic, Cleveland, OH, (3)Department of
Infectious Diseases, Cleveland Clinic, Cleveland, OH, (4)Department
of Laboratory Medicine, Cleveland Clinic, Cleveland, OH
540 Fecal Microbiota Transplantation by Freeze-Dried Oral
Capsules for Recurrent CDI
Michelle T. Hecker, MD1,2, Mark Obrenovich, PhD3, Jennifer
Cadnum, BS1,4, Annette Jencson, BSMT, CIC3, Alok K. Jain, MD1,2,
Edith Ho, MD1,3 and Curtis J. Donskey, MD1,4, (1)Case Western
Reserve University, Cleveland, OH, (2)MetroHealth Medical Center,
Cleveland, OH, (3)Cleveland VA Medical Center, Cleveland, OH, (4)
Geriatric Research Education and Clinical Center, Louis Stokes
541 Risk of Clostridium difficile Infection in Patients
Colonized With Toxigenic C. difficile
Cara M Cannon, University of Wisconsin Hospital, Madison, WI
University of Wisconsin School of Medicine, Madison, WI
542 Identifying Barriers and Facilitators to CDI Prevention:
Nursing and Patient-Related Factors
Caitlyn Ngam, MPH1, Nasia Safdar, MD, PhD2,3, Ann Hundt, PhD4,
Pascale Carayon, PhD4 and Nicholas Haun, MD1, (1)University of
Wisconsin School of Medicine and Public Health, Madison, WI, (2)The
William S. Middleton Veterans Affairs Medical Center, Madison, WI, (3)
University of Wisconsin School of Medicine & Public Health, Madison,
WI, (4)University of Wisconsin-Madison College of Engineering Center
for Quality & Productivity Improvement, Madison, WI
543 Cost-effectiveness Analysis of Treatment Strategies
for C. difficile infection: a Systematic Review
Phuc Le, MPH, PhD1, Van T Nghiem, MSPH2, Michael B Rothberg,
MPH, MD1 and Abhishek Deshpande, MD PhD1,3, (1)Medicine Institute
Center for Value Based Care Research, Cleveland Clinic, Cleveland,
OH, (2)Center for Health Promotion and Prevention Research, The
University of Texas School of Public Health, Houston, TX, (3)Department
of Infectious Diseases, Cleveland Clinic, Cleveland, OH
Philip A. Robinson, MD, Barbara Goss-Bottorff, MPH, MSN, William
Griffith, CLS, MT(ASCP) and Sherry Etoch, CLS, MT(ASCP), Hoag
Memorial Hospital Presbyterian, Newport Beach, CA
Andrew J Barros, MD, Kyle Enfield, MD, MS and Costi Sifri, MD,
University of Virginia Health System, Charlottesville, VA
549 A Cross-Sectional Survey of Clostridium difficile
Diagnostic Testing and Management in India
Anubhav Kanwar, MBBS1 and Curtis J. Donskey, MD2,3, (1)University
Hospitals Case Medical Center, Cleveland, OH, (2)Case Western
Reserve University, Cleveland, OH, (3)Geriatric Research Education
Cleveland, OH
550 Rotating Mini-Cohorts of Hospitalized Patients with
Clostridium difficile Infection
Lisa Saidel-Odes, MD1, Gal Ifergane, MD1, Ronit Nativ, RN, MPH2,
Seada Eskira, RN, MPH2, Batya Shterer, RN, MA2, Alex Goshansky,
RN, MA2, Lea Cohen, BSN, MHA2 and Abraham Borer, MD1, (1)
Soroka University Medical Center and Ben-Gurion University of the
Negev, Beer-Sheva, Israel, (2)Soroka University Medical Center,
Beer-Sheva, Israel
551 Efficacy of Two Hand Hygiene Methods for Clostridium
difficile Spore Removal
Caroline Zellmer1, Megan Duster, MT2, Marc Oliver Wright, MT,
MS3 and Nasia Safdar, MD, PhD4,5, (1)William S. Middleton Veterans
Hospital, and Section of Infectious Diseases, Department of Medicine
and Department of Infection Control, University of Wisconsin,
Madison, WI, Madison, WI, (2)School of Medicine and Public Health,
University of Wisconsin, Madison, WI, (3)University of Wisconsin
Hospital and Clinics, Infection Control, Madison, WI, (4)The William S.
552 Successful Implementation of Rectal Route Fecal
Microbiota Transplantation (FMT) in High Risk Patient
Suganya Chandramohan, MD1, Pranatharthi Chandrasekar, MD2,
Bicky Thapa, MD2, Babbaljeet Kaur2 and Teena Chopra, MD, MPH2,
(1)Wayne State University,Department of Infectious disease, Detroit,
MI, (2)Detroit Medical Center, Wayne State University, Detroit, MI
Top Poster
Abstract
42
PROGRAM
553 Persistence of Clostridium difficile Colonization in
Long-Term Care Facility Residents
Venkata Sunkesula, MD, MS1,2, Sirisha Kundrapu, MD, MS1,2
and Curtis Donskey, MD3, (1)Case Western Reserve University,
Cleveland, OH, (2)Cleveland VA Medical Center, Cleveland, OH, (3)
554 Investigating the Relationship between Hospital and
Nursing Home C. difficile Infection Rates
Ghinwa Dumyati, MD, FSHEA1, Rebecca Tsay, MPH2, Deborah
Nelson, MSN RN2, Anita Gellert, RN2, Gail Quinlan, RN, MS, CIC1
and Dwight Hardy, PhD3, (1)University of Rochester Medical Center
- Center for Community Health, Rochester, NY, (2)University of
Rochester, Rochester, NY, (3)University of Rochester Medical Center,
Microbiology & Immunology, Rochester, NY
556 Hospital-Onset Clostridium difficile Clusters: Are Index
Cases Hospital Onset or Community Onset?
J Bradford Bertumen, MD1,2 and Christopher W. Woods, MD1,2, (1)
Durham VA Medical Center, Durham, NC, (2)Duke University Medical
Center, Durham, NC
557 Results of a Pilot Screening Program for Clostridium
difficile among Inpatients
Jessica P Ridgway, MD, MS, Cynthia Murillo, M(ASCP), CIC,
Sylvia Garcia-Houchins, RN, MBA CIC, Rachel Marrs, MSN, RN
CIC, Kathleen G Beavis, MD, Angella Charnot-Katsikas, MD, Vera
Tesic, MD, Allison Bartlett, MD, MS and Emily Landon, MD, University
of Chicago, Chicago, IL
558 Time for a Patient-Centered Approach to Clostridium
difficile Infections
Megan E. Meller, MS1,2, Daniel M. Bolt, PhD1, Bruce P. Barrett, MD,
Phd1,2, Ajay K. Sethi, Phd, MHS1 and Nasia Safdar, MD, PhD3,4, (1)
University of Wisconsin-Madison, Madison, WI, (2)University of
Wisconsin Hospitals and Clinics, Madison, WI, (3)The William S.
559 Colonization and Atb Exposure as Time Dependent
Factors in Development of C.difficile Colitis
Javeria Haque, MD1, Rossana Rosa, MD2, Nathan A Ledeboer,
PhD3, Laura Michaelis, MD4, Mary Beth Graham, MD1, Parameswaran
Hari, MD, MRCP, MS4, Tami-Lea Mackey3, Kelly Acker5, Ricka
Long5, Njeri Wainaina, MD1, Sara L Revolinski, PharmD5, Bronwen
Shaw, MD, PhD4, Mary Horowitz, MD, MS4 and L. Silvia MunozPrice, MD, PhD1, (1)Division of Infectious Diseases, Medical College
of Wisconsin, Milwaukee, WI, (2)Division of Infectious Diseases,
University of Miami Miller School of Medicine, Miami, FL, (3)
Department of Pathology, Medical College of Wisconsin, Milwaukee,
WI, (4)Department of Hematology and Oncology, Medical College of
Wisconsin, Milwaukee, WI, (5)Froedtert Hospital, Medical College of
Wisconsin, Milwaukee, WI
560 Discordance in CLSI Standards Amongst the
Carbapenem Producing Enterobacteriaceae
David R. Woodard, MSc1, Fidelis Uzoma Enyinnaya, MPH1,2,
Mark P. Buttner, PhD1, Patricia Cruz, PhD1 and Chad Cross, PhD3,
(1)University of Nevada, Las Vegas, Las Vegas, NV, (2)Le Moyne
College, Syracuse, NY, (3)PaLS-Mathemetics, Nevada State College,
Henderson, NV
561 How Well Does Transfer Of Bacterial Pathogens by
Culture Swabs Correlate With Transfer by Hands?
Anubhav Kanwar, MBBS1, Jennifer Cadnum, BS2,3, Heba
Alhmidi, MD4, Sreelatha Koganti, MD4 and Curtis J. Donskey, MD2,3,
(1)University Hospitals Case Medical Center, Cleveland, OH, (2)
Cleveland VA Medical Center, Cleveland, OH, (3)Case Western
Reserve University, Cleveland, OH, (4)Louis Stokes Cleveland VA
SCHEDULE
562 Current Epidemiology, Risk Factors and Outcomes of
Non-albicans Candidemia at a Tertiary-care Center
Woo Jeong Choi, MD1, Odaliz Abreu-Lanfranco, MD1, Linoj Samuel,
PhD1, Robert Tibbetts, PhD1, Norman Markowitz, MD1, Marcus
Zervos, MD1,2 and George Alangaden, MD1,2, (1)Henry Ford Health
System, Detroit, MI, (2)Wayne State University, Detroit, MI
563 Impact of a Testing Algorithm in the Evaluation of
Diarrhea in Hospitalized Patients
Chad Tewell, M.D.1, James Chappell, M.D., Ph.D.1, Bryan D
Harris, MD1, Whitney Jones, PharmD1, George E Nelson, MD1,
Thomas Talbot III, MD, MPH2 and Patty W Wright, MD1, (1)Vanderbilt
University School of Medicine, Nashville, TN, (2)Vanderbilt University
Medical Center, Nashville, TN
564 Survival of Healthcare-Associated Pathogens on Dry
Versus Moist Surfaces
Jennifer L. Cadnum, BS1,2 and Curtis J. Donskey, MD1,2, (1)Case
Western Reserve University, Cleveland, OH, (2)Geriatric Research
Education and Clinical Center, Louis Stokes Cleveland VA Medical
565 Blogging in Infectious Diseases and Clinical
Microbiology: Assessment of the ‘Blogosphere’
Content
Rachael E Troughton, MSc, Gabriel Birgand, PharmD, PhD, Luke
SP Moore, MBChB, MRCP, FRCPath, MSc, MPH, DTM&H, Enrique
Castro-Sanchez, PhD, MPH, RGN, DipTropNurs, PgDip, DLSHTM,
Esmita Charani, MSc, Timothy M Rawson, MBBS, BSc, PgD
MedEd and Alison Holmes, MA, MD, MPH, FRCP, Health Protection
Research Unit in Healthcare Associated Infections and Antimicrobial
Resistance, Imperial College London, London, United Kingdom
566 A Low-Cost Method for Diagnosis of Clostridium
difficile Infection in the Developing World
Jennifer L. Cadnum, BS1,2, Annette Jencson, BSMT, CIC3,
Michelle Nerandzic, BS3, Anubhav Kanwar, MBBS4 and Curtis J.
Donskey, MD1,2, (1)Case Western Reserve University, Cleveland, OH,
(2)Geriatric Research Education and Clinical Center, Louis Stokes
Cleveland VA Medical Center, Cleveland, OH, (3)Cleveland VA Medical
Center, Cleveland, OH, (4)University Hospitals Case Medical Center,
Cleveland, OH
567 Comparing ESwab™ and RODAC™ Plates for
Detection of Multidrug-Resistant Organisms (MDRO)
on Surfaces
Koh Okamoto, MD1, Yoona Rhee, MD, ScM1, Michael Schoeny,
PhD1, Karen Lolans, BS1, Jennifer Cheng, MD1, Shivani Reddy, MD1,
Efrain Salzar1, Melanie Carr1, Patricia Mangan1, Grace McIlroy1, Robert
A Weinstein, MD1,2, Mary K. Hayden, MD1 and Kyle J Popovich, MD
MS1,2, (1)Rush University Medical Center, Chicago, IL, (2)Cook County
Health and Hospitals System, Chicago, IL
568 A “Virtual Clinic” Improves Pneumococcal Vaccinations
Among Patients With HIV at a VA Medical Center
Richard Banks, AS1, Brigid Wilson, PhD1, Rebecca Carter, BA2,
Michelle Montpetite, MBA1, Federico Perez, MD1,2 and Robin
Jump, MD, PhD1,2, (1)Louis Stokes Cleveland Veterans Aff Med Ctr,
Cleveland, OH, (2)Case Western Reserve University, Cleveland, OH
569 Comparison of 2% Chlorhexidine Gluconate (CHG)Impregnated Cloth vs. 4% Liquid Cleansing
Yoona Rhee, MD, ScM1, Koh Okamoto, MD1, Sarah K.
Kemble, MD1,2, Karen Lolans, BS1, Michael Lin, MD, MPH1, Louis
Fogg, PhD1, Robert A. Weinstein, MD1,3 and Mary K. Hayden, MD1, (1)
Rush University Medical Center, Chicago, IL, (2)Chicago Department
of Public Health, Chicago, IL, (3)Cook County Health and Hospitals
System, Chicago, IL
SCIENTIFIC
PROGRAM
570 The Role of Ethnography in Preventing HealthcareAssociated Infections: A Narrative Review
Nasia Safdar, MD, PhD1,2, Kevin Thomas3 and Mary Jo Knobloch,
MPH4,5, (1)The William S. Middleton Veterans Affairs Medical Center,
Madison, WI, (2)University of Wisconsin School of Medicine & Public
Health, Madison, WI, (3)Washington University, St. Louis, MO, (4)
University of Wisconsin, Madison, WI, (5)William S. Middleton
Memorial Veterans Hospital, Madison, WI
571 Using National Healthcare Safety Network Data to
Select Hospitals for Infection Control Assessments
Gwendolyn D. Holman, MPH, Ashley Fell, MPH, Katherine Buechel,
BSN CIC, Karen Toungett, RN BSN and Marion A. Kainer, MD, MPH,
Tennessee Department of Health, Nashville, TN
573 Exploring Implementation in Infection Prevention: the
Novel Use of Normalisation Process Theory
Lisa Hall, PhD1, Brett G. Mitchell, RN, PhD2, Sally M. Havers, RN,
MPH1, Monika Pogorzelska-Maziarz, MPH, PhD3, Anne Gardner, RN,
PhD4 and Patricia W. Stone, RN, PhD5, (1)Queensland University of
Technology, Brisbane, Qld, Australia, (2)Avondale College of Higher
Education, Sydney, NSW, Australia, (3)Thomas Jefferson University,
Philadelphia, PA, (4)Australian Catholic University, ACT, Australia, (5)
Columbia University, New York, NY
574 Sustainability of Daily Chlorhexidine Bathing in the
Intensive Care Unit of a Veterans Hospital
Jackson Musuuza, MD, MPH, MS1, Nasia Safdar, MD, PhD2,3 and
Tonya Roberts, PhD, RN4, (1)Institute for Clinical and Translational
Research, University of Wisconsin, Madison, WI, (2)The William S.
of Wisconsin School of Medicine & Public Health, Madison, WI, (4)
School of Nursing, University of Wisconsin-Madison, Madison, WI
575 Use of an Interferon-gamma Release Assay for
Tuberculosis Screening in a Children’s Hospital System
Amelia B. Thompson, MD, MPH1, Nikki Mattick, RN2, Trisha E.
Hardy, MPH, RD2, Nancy E. Lloyd, MS, RN2 and Andi Shane, MD,
MPH, MSc1,2, (1)Emory University School of Medicine, Atlanta, GA, (2)
Children’s Healthcare of Atlanta, Atlanta, GA
576 Acceptability and Necessity of Training for Optimal
Personal Protective Equipment (PPE) Use
Michelle Doll, MD1, Moshe Feldman, PhD2, Sarah Hartigan, MD1,2,
Kakotan Sanogo, MS1, Mike Stevens, MD, MPH1,2, Myriah
McReynolds, BS1, Nadia Masroor, BS1, Kaila Cooper, MSN, RN,
CIC1 and Gonzalo Bearman, MD, MPH1,2, (1)VCU Health, Richmond,
VA, (2)Virginia Commonwealth University School of Medicine,
Richmond, VA
578 Impact of Cross-Coverage on Antibiotic Prescribing in
Nursing Homes
Miranda McElligott, MS, BSN1, Christopher Crnich, MD, PhD2,3,
Ajay K. Sethi4, Mari Palta, PhD1 and Mozhdeh Bahrainian, MS2, (1)
University of Wisconsin - Madison, Madison, WI, (2)University of
Wisconsin School of Medicine & Public Health, Madison, WI, (3)
William S. Middleton Memorial VA Hospital, Madison, WI, (4)University
of Wisconsin-Madison, Madison, WI
580 An Outbreak of Pseudomonas aeruginosa from the
tracheal aspirates in the NICU of a tertiary hospital
Nimfa L. Dagunton, BSN, RN1, Dr. Saif Al Saif, MD1, Noura Shami,
Diploma in Nursing2, Marissa Alarcon, BSN, RN1, Joseph Tannous,
BSMT1 and Dr. Hanan Balkhy, MD1, (1)King Abdulaziz Medical City
Ministry of National Guard, Riyadh, Saudi Arabia, (2)King Abdulaziz
Medical City Ministry of National Guard, Riyadh, Saudi Arabia
581 Risk Factors for Carbapenem Resistance in Klebsiella
pneumoniae Bloodstream Infection
Gregory Weston, MD1 and Belinda Ostrowsky, MD, MPH2,
(1)Montefiore Medical Center, Albert Einstein College of Medicine,
Bronx, NY, (2)Montefiore Medical Center, Bronx, NY
44
SCHEDULE
582 The Influence of Hospital-Onset Escherichia coli
Bacteremia and Multidrug-Resistant Phenotype on
Mor
SCIENTIFIC
Michihiko Goto, MD, MSCI1,2, Daniel Livorsi, MD, MSc3,4, Makoto
Jones, MD, MS5,6, Jennifer McDanel, PhD1,2, Rajeshwari Nair, MBBS,
PhD1,2, Bruce Alexander, PharmD1, Brice F Beck, MA1, Kelly K
Richardson, PhD1 and Eli Perencevich, MD, MS1,2, (1)Iowa City VA
Medical Center, Iowa City, IA, (2)University of Iowa Carver College of
Medicine, Iowa City, IA, (3)University of Iowa Hospitals & Clinics, Iowa
City, IA, (4)Iowa City VAMC, Iowa City, IA, (5)Salt Lake City VA Medical
Center, Salt Lake City, UT, (6)University of Utah, Salt Lake City, UT
583 Phenotypic Confirmatory of extended-spectrum
β-lactamases (ESBLs) production in Enterobacteriacea
Sujan Babu Marahatta, Ph.D1, PR Khanal, M.Sc2 and P Maharjan,
B.Sc3, (1)Manmohan Memorial Medical College and Teaching
Hospital, Kathmandu, Nepal, (2)Manmohan Memorial Institute of
health Sciences, Kathmandu, Nepal, (3)Manmohan Memorial Institute
of Health Sciences, Kathmandu, Nepal
584 Severe Infections Caused by Multidrug-Resistant NonFermentative Bacilli in Southern Poland
Jadwiga Wojkowska-Mach, dr1, Agnieszka Chmielarczyk2, Monika
Pobiega2, Grzegorz Ziolkowski3, Monika Pomorska-Wesolowska4
and Dorota Romaniszyn2, (1)Jagiellonian University Medical School,
Krakow, POLAND, (2)Chair of Microbiology Jagiellonian University
Medical College, Kraków, Poland, (3)Higher School of Medicine
in Sosnowie, Sosnowiec, Poland, (4)Department of Microbiology,
Analytical and Microbiological Laboratory of Ruda Slaska, KORLAB
NZOZ, Ruda Slaska, Poland
585 Effectiveness of Daily Chlorhexidine Bathing for
Reducing Gram-negative Infections: a Meta-analysis
Abhishek Deshpande, MD PhD1,2, Aditi Patel, MD1, Parth
Parikh, MD1, Jon Otter, PhD3, Priyaleela Thota, MD4, Curtis J.
Donskey, MD5,6 and Thomas G. Fraser, MD2, (1)Medicine Institute
Center for Value Based Care Research, Cleveland Clinic, Cleveland,
OH, (2)Department of Infectious Diseases, Cleveland Clinic,
Cleveland, OH, (3)Imperial College Healthcare NHS Trust, London,
United Kingdom, (4)Vancive Medical Technologies, Avery Dennison
Business, Mentor, OH, (5)Geriatric Research, Education, and Clinical
586 Hypervirulent Hypermucoviscous CarbapenemResistant K. pneumoniae: An Infection Prevention
Challenge
Melanie S Curless, RN MPH CIC1, Patricia J Simner, PhD, D(ABMM)2,
Jennifer Andonian, MPH1, Donna Fellerman, RN, BA, CIC1, Karen C
Carroll, MD2, Lisa L K Maragakis, MD, MPH3 and Clare Rock, MD,
MS3, (1)The Johns Hopkins Hospital, Baltimore, MD, (2)School of
Medicine, Division of Medical Microbiology, Johns Hopkins University,
Baltimore, MD, (3)Department of Medicine, Division of Infectious
Diseases, Johns Hopkins University, Baltimore, MD
587 Increasing Resistance Among Gram-Negative Bacteria
in Veterans with Spinal Cord Injury
Margaret Fitzpatrick, MD, MS1,2, Katie J. Suda, PharmD, MS1,3,
Stephen Burns, MD4, Makoto Jones, MD, MS5,6, Linda Poggensee,
MS1, Swetha Ramanathan, MPH1 and Charlesnika T. Evans, PhD,
MPH1,7, (1)VA Center of Innovation for Complex Chronic Healthcare,
Hines, IL, (2)Loyola University, Maywood, IL, (3)University of Illinois
at Chicago, Chicago, IL, (4)VA Puget Sound Health Care System,
Seattle, WA, (5)Salt Lake City VA Medical Center, Salt Lake City, UT,
(6)University of Utah, Salt Lake City, UT, (7)Northwestern University,
Chicago, IL
589 Control of a Novel Extended-spectrum β-lactamase
(ESBL) Salmonella Isangi Outbreak
Geehan Suleyman, MD1, Eman Chami, BS, MHA1, Patricia Starr,
RN, MPH, CIC1, Jennifer Pietsch, RN, MSN1, Katherine Reyes, MD,
MPH1, Marcus Zervos, MD1,2 and George Alangaden, MD1,2, (1)Henry
Ford Health System, Detroit, MI, (2)Wayne State University, Detroit, MI
PROGRAM
590 Nosocomial Outbreak of a Novel Extended-spectrum
β-lactamase-producing Salmonella Isangi
Geehan Suleyman, MD1, Robert Tibbetts, PhD1, Mary Perri, BS1,
Dora Vager, MLT1, Linoj Samuel, PhD1, Yuan Xin, MPH1, Eman
Chami, BS, MHA1, Patricia Starr, RN, MPH, CIC1, Jennifer Pietsch,
RN, MSN1, Katherine Reyes, MD, MPH1, Marcus Zervos, MD1,2 and
George Alangaden, MD1,2, (1)Henry Ford Health System, Detroit, MI,
(2)Wayne State University, Detroit, MI
591 Characterization of Salmonella Isangi Possessing
CTX-M15 ESBL Associated with an Outbreak in a US
Hospital
Geehan Suleyman, MD1, Mary Perri, BS1, Dora Vager, MLT1, Linoj
Samuel, PhD1, Marcus Zervos, MD1,2, George Alangaden, MD1,2 and
Robert Tibbetts, PhD1, (1)Henry Ford Health System, Detroit, MI, (2)
592 Citrobacter freundii blaKPC Producer Outbreak at a
Tertiary Acute Care Facility in Miami, FL
Adriana Jimenez, MPH, BSMT.1,2, Jose Guillermo Castro, MD.3,
Yohei Doi, MD, PhD.4, Luis Shimose, MD.5, Dennise De Pascale,
BSMT.1 and Caressa Spychala, BS.4, (1)Jackson Memorial Hospital Department of Infection Prevention and Control, Miami, FL, (2)Florida
International University Robert Stempel College of Public Health &
Social Work, Miami, FL, (3)Division of Infectious Diseases University of
Miami Miller School of Medicine, Miami, FL, (4)University of Pittsburgh,
Pittsburgh, PA, (5)University of Miami Miller School of Medicine,
Miami, FL
593 Use of Antibiotics with Activity Against CarbapenemResistant Enterobacteriaceae in Pediatrics
Kathleen Chiotos, MD1,2, Rachael K. Ross, MPH2, Jeffrey S.
Gerber, MD, PhD1,2,3, Matthew Miller, BS2 and Jennifer Han, MD,
MSCE3,4, (1)Division of Infectious Diseases, The Children’s Hospital
of Philadelphia, Philadelphia, PA, (2)Center for Pediatric Clinical
Effectiveness, The Children’s Hospital of Philadelphia, Philadelphia,
PA, (3)Center for Clinical Epidemiology and Biostatistics, University
of Pennsylvania Perelman School of Medicine, Philadelphia, PA, (4)
Division of Infectious Diseases, Department of Medicine, Perelman
University School of Medicine, Philadelphia, PA
594 Surveillance and Inter-Facility Communication for
Carbapenem-Resistant Enterobacteriaceae (CRE)
Julie Kim, BS, John Segreti, MD, Alexander Tomich, DNP, RN, CIC,
Chawat Tongma, MD, Mary K. Hayden, MD and Michael Y. Lin, MD,
MPH, Rush University Medical Center, Chicago, IL
595 A Contaminated Ice Machine as a Potential Source for
Transmission of Carbapenem-Resistant Acenitobac
Anubhav Kanwar, MBBS1, T Nicholas Domitrovic, BA2,3, Sreelatha
Koganti, MD4, Peter Fuldauer, BSMT3, Jennifer Cadnum, BS5, Robert
A. Bonomo, MD6 and Curtis Donskey, MD6, (1)University Hospitals
Case Medical Center, Cleveland, OH, (2)Case Western Reserve
University, Cleveland, OH, (3)Cleveland VA Medical Center, Cleveland,
OH, (4)Louis Stokes Cleveland VA Medical Center, Cleveland, OH,
(5)Geriatric Research Education and Clinical Center, Louis Stokes
Cleveland VA Medical Center, Cleveland, OH, (6)Geriatric Research,
Education, and Clinical Center, Louis Stokes Cleveland VA Medical
596 Emergence of Community-Onset Multi-Resistant E.coli
ST131 Bloodstream Infections in Singapore
Yin Mo, MBBS1, Patrick N A Harris, MBBS, FRACP2, Roland Jureen,
PhD1, Paul Tambyah, MBBS, MD1, David Lye, MBBS, FRACP3
and David L. Paterson, MD, PhD2, (1)National University Hospital,
Singapore, Singapore, (2)University of Queensland Centre for Clinical
Research, Brisbane, Australia, (3)Tan Tock Seng Hospital, Singapore,
Singapore
SCHEDULE
597 Surveillance for CRE Colonization Yields Detection of
Unexpected Resistance Patterns
Rebecca Linfield, Medical Student1, Shelley Miller, PhD1, Patil
Injean, Medical Student1, Aric Gregson, MD1, Fady Kaldas, MD1,
Zachary Rubin, MD1, Tae Kim, MS, MPH1, Samantha J Eells, PhD1,
Romney Humphries, PhD1 and James A McKinnell, MD2, (1)David
Geffen School of Medicine at UCLA, Los Angeles, CA, (2)Infectious
Disease Clinical Outcomes Research Unit (ID-CORE), Division of
Infectious Disease, Los Angeles Biomedical Research Institute at
Harbor-University of California Los Angeles (UCLA) Medical Center,
Torrance, CA
598 Risk Factors for Invasive Infection with CarbapenemResistant Enterobacteriaceae (CRE)
Mary Elizabeth Sexton, MD1,2, Christopher Bower, MPH2,3,4 and
Jesse Jacob, MD1,2, (1)Emory University School of Medicine, Division
of Infectious Diseases, Atlanta, GA, (2)Georgia Emerging Infections
Program, Decatur, GA, (3)Atlanta Veterans Affairs Medical Center,
Decatur, GA, (4)Atlanta Research and Education Foundation,
Atlanta, GA
599 Risk Factors of Acquiring Carbapenem-Resistant
Acinetobacter Baumannii (CRAb): A Prospective Study
Norihisa Yamamoto, MD1, Shigeto Hamaguchi, MD, PhD1, Yukihiro
Akeda, PhD1, Pitak Santanirand, PhD2, Kumthorn Malathum, MD2 and
Kazunori Tomono, MD, PhD1, (1)Osaka University Graduate School of
Medicine, Suita, Japan, (2)Faculty of Medicine Ramathibodi Hospital,
Mahidol University, Bangkok, Thailand
600 Alarming Rates of Co-Colonization With MDROS
Among Patients With CRE Carriage
Kamaljit Singh, MD1, Kody Wyant1, Kathy A Mangold, PhD2, Donna
Schora, MT2 and Lance Peterson, MD2, (1)Rush University Medical
Center, Chicago, IL, (2)NorthShore University HealthSystem,
Evanston, IL
12:00 – 1:00 p.m. 7th Floor: Augusta Room
601 Treatment Duration for Uncomplicated MethicillinResistant Staphylococcus aureus Bacteremia
Khulood Rizvi, MD1, Ana C Bardossy, MD2, Daniela Moreno, BS3,
Pamela Hartman, BS3, Mary Perri, BS2, Mahan Meredith, MS1 and
Marcus Zervos, MD2, (1)Henry Ford hospital, Detroit, MI, (2)Henry
Ford Health System, Detroit, MI, (3)Henry Ford Hospital, Detroit, MI
602 Longevity and Hospitalization as a Risk Factor of
MRSA Infections in Southern Poland
Jadwiga Wojkowska-Mach, dr1, Joanna Natkaniec2, Monika
Pobiega2, Monika Pomorska-Wesolowska3, Barbara Gryglewska,
PhD4, Anna Rozanska, PhD2, Dorota Romaniszyn2 and Agnieszka
Chmielarczyk2, (1)Jagiellonian University Medical School, Krakow,
POLAND, (2)Chair of Microbiology Jagiellonian University Medical
College, Kraków, Poland, (3)Department of Microbiology, Analytical
and Microbiological Laboratory of Ruda Slaska, KORLAB NZOZ,
Ruda Slaska, Poland, (4)Jagiellonian University Medical School,
Kraków, Poland
603 Risk Factors Associated with VRE and MRSA
Colonization
Helina M Misikir, MPH1, Ana C Bardossy, MD1, Pamela Hartman,
BS1, Daniela Moreno, BS1, Geehan Suleyman, MD2, Mary Perri, BS2,
Katherine Reyes, MD, MPH1 and Marcus Zervos, MD1,3, (1)Henry Ford
Hospital, Detroit, MI, (2)Henry Ford Health System, Detroit, MI, (3)
Top Poster
Abstract
SCIENTIFIC
SCIENTIFIC
PROGRAM
604 Incidence and Outcomes Associated with Methicillinresistant Staphylococcus aureus Infections
Rajeshwari Nair, MBBS, PhD1,2, Eli N Perencevich, MD, MS1,2,3,
Hsiu-Yin Chiang, PhD, MS2, Stacey M Hockett Sherlock, MAA1,2,
Erin C Balkenende, MPH1,2, Jennifer S McDanel, PhD1,2,3, Richard
E Nelson, PhD4,5, Matthew H Samore, MD4,5, Karim Khader, PhD5,
Amy E Blevins, MALS6, Melissa A Ward, MS2 and Marin L Schweizer,
PhD1,2,3, (1)Iowa City VA Medical Center, Iowa City, IA, (2)University
of Iowa Carver College of Medicine, Iowa City, IA, (3)Department of
Epidemiology, University of Iowa College of Public Health, Iowa City,
IA, (4)VA Salt Lake City Health Care System IDEAS Center, Salt Lake
City, UT, (5)University of Utah School of Medicine, Salt Lake City, UT,
(6)Ruth Lilly Medical Library, Indiana University School of Medicine,
Indianapolis, IN
605 Impact of Active MRSA Surveillance on Vancomycin
Use Among Inpatients
Carlos Acuna-Villaorduna, MD1,2, Judith Strymish, MD2,3 and
Kalpana Gupta, MD, MPH4, (1)Boston Medical Center, Boston, MA,
(2)VA Boston HCS, West Roxbury, MA, (3)Harvard Medical School,
Boston, MA, (4)VA Boston and Boston University School of Medicine,
West Roxbury, MA
606 Beliefs and Emotional Response of Patients Colonised
With MRSA
Toney Poovelikunnel Thomas, PG DipIC. MBA.1, Georgina
Gethin, Dr2, Mary Codd, Dr3 and Hilary Humphreys, MD4, (1)Royal
College of Surgeons Ireland, Dublin, Ireland, (2)National University of
Ireland, Galway, Galway, Ireland, (3)UCD-CSTAR, School of Public
Health, Physiotherapy & Sports Science, UCD, Dublin, Ireland, (4)
Royal College of Surgeons of Ireland and Beaumont Hospital, Dublin,
IRELAND
607 Comparison of Contact Precautions Based on MDRO
Status vs. Transmission Risk in a Community Hospital
Emily J Cooper, RN, MS, CIC, WellSpan Health, York, PA
608 Perceptions and Use of Gowns and Gloves in Nursing
Homes
Jennifer S Albrecht, PhD, Lindsay D. Croft, MS, PhD, Daniel
Morgan, MD, MS and Mary-Claire Roghmann, MD, MS, University
of Maryland School of Medicine, Baltimore, MD
609 Universal Screening and Decolonization for Control of
MRSA in Nursing Homes: Follow-up to a RCT
Delphine Héquet, MD1, Valentin Rousson, PhD1, Dominique
S. Blanc, PhD1, Christophe Büla, MD1, Laetitia Qalla-Widmer1,
Eric Masserey, MD2, Giorgio Zanetti, MD, MS1 and Christiane
Petignat, MD1, (1)University Hospital, Lausanne, Switzerland, (2)Public
Health Canton Vaud, Lausanne, Switzerland
SCHEDULE
611 Effect of Mupirocin Prophylaxis on Mupirocin
Susceptibility in MRSA Isolates in a NICU
Elizabeth Ristagno, MD1, Kristina Bryant, MD1, Lynette Boland,
RNC, BSN, CIC2, Gordon Stout, BS1, Alan Junkins, PhD3, Charles
Woods, MD, MS1 and Claudia Espinosa, MD, MSc1, (1)University of
Louisville, Louisville, KY, (2)Kosair Children’s Hospital, Louisville, KY, (3)
Norton Healthcare, Louisville, KY
612 Molecular Characterization of Staphylococcus aureus
Strains Isolated From Surgical Site
Jadwiga Wojkowska-Mach, dr1, Monika Pomorska-Wesolowska2,
Katarzyna Małyszek3, Dorota Romaniszyn4, Monika Pobiega4, Anna
Szczypta5, Agnieszka Chmielarczyk4 and Anna Rozanska, PhD4,
(1)Jagiellonian University Medical School, Krakow, POLAND, (2)
Department of Microbiology, Analytical and Microbiological Laboratory
of Ruda Slaska, KORLAB NZOZ, Ruda Slaska, Poland, (3)Arcana
Institute Ltd, Krakow, Poland, (4)Chair of Microbiology Jagiellonian
University Medical College, Kraków, Poland, (5)Faculty of Health and
Medical Science, Andrzej Frycz Modrzewski University,
KrakÃ³w, Poland
613 Invasive USA100 vs USA300 Methicillin-Resistant
Staphylococcus Aureus Infections in 5 states—2013
Isaac See1, Valerie Albrecht, MPH1, Joelle Nadle2, Wendy
Bamberg, MD3, Susan Ray, MD4, Mackenzie Koeck, MPH5, Ruth
Lynfield, MD5, Ghinwa Dumyati, MD6, William Schaffner, MD7 and
Alexander J. Kallen, MD, MPH1, (1)Centers for Disease Control and
Prevention, Atlanta, GA, (2)California Emerging Infections Program,
Oakland, CA, (3)Colorado Department of Public Health & Enviroment,
Denver, CO, (4)Emory University School of Medicine, Atlanta, GA,
(5)Minnesota Department of Health, Saint Paul, MN, (6)University
of Rochester, Department of Health, Rochester, NY, (7)Vanderbilt
University School of Medicine, Nashville, TN
614 Using a Regional Approach to Combat the Spread of
Antibiotic-Resistant Organisms
Rebecca A. Meyer, MPH1, Shannon M. Harney, MPH2, Raphaelle
H. Beard, MPH2 and Marion A. Kainer, MD, MPH2, (1)Tennessee
Dept. of Health, Nashville, TN, (2)Tennessee Department of Health,
Nashville, TN
615 Improved VRE Surveillance Detects Patients at Risk
for Subsequent VRE Infection
Rebecca Linfield, Medical Student1, Patil Injean, Medical
Student1, Shelley Miller, PhD1, Fady Kaldas, MD1, Zachary
Rubin, MD1, Tae Kim, MS, MPH1, Samantha J Eells, PhD1,
Aric Gregson, MD1, Romney Humphries, PhD1 and James A
McKinnell, MD2, (1)David Geffen School of Medicine at UCLA, Los
Angeles, CA, (2)Infectious Disease Clinical Outcomes Research Unit
(ID-CORE), Division of Infectious Disease, Los Angeles Biomedical
Research Institute at Harbor-University of California Los Angeles
(UCLA) Medical Center, Torrance, CA
616 The Impact of Discontinuing Routine Contact
Precautions for Endemic MRSA and VRE on Adverse
Events
Elise M Martin, MD1, Brandy Bryant, MPH2, Dana Russell2, David
Elashoff, PhD3, Romney Humphries, PhD1 and Daniel Uslan, MD1,
(1)David Geffen School of Medicine at UCLA, Los Angeles, CA, (2)
UCLA, Los Angeles, CA, (3)Department of Medicine Statistics Core,
David Geffen School of Medicine at UCLA, Los Angeles, CA
617 Daptomycin and Linezolid Non Susceptible
Vancomycin Resistant Enterococcus (DLVRE)
Matthew H Greene, MD, Bryan D Harris, MD, Whitney Jones,
PharmD, Marley A Linder, PharmD, Patty W Wright, MD, Thomas
Talbot III, MD, MPH and George E Nelson, MD, Vanderbilt University
School of Medicine, Nashville, TN
Top Poster
Abstract
46
PROGRAM
618 Methicillin Resistant Staphylococcus Aureus Nasal
Carriage in Homeless Persons, Boston, MA
Jessica H Leibler, DrPH1, Casey Leon2, Lena Cardoso2 and Jessie
M. Gaeta, MD2,3, (1)Boston University School of Public Health,
Boston, MA, (2)Boston Health Care for the Homeless Program,
Boston, MA, (3)Boston University School of Medicine, Boston, MA
619 Beginning to See the Light: Simulation Effectively
Identifies Safety Gaps in Ebola PPE Training
Judith Guzman-Cottrill, DO, Molly Hale, MPH, CIC, Lauren Ogden,
MPH and Jeffrey Gold, MD, Oregon Health and Science University,
Portland, OR
620 Comparison of Two Interferon-Gamma Release Assays
for Screening of Japanese Healthcare Workers
Masaki Tanabe, MD, PhD, Akiko Nakamura, Akie Arai, RN, Daisuke
Yamasaki, Pharm. D, Kyoko Hirano, Tetsu Kobayashi, MD, PhD,
Osamu Taguchi, MD, PhD and Toshihiro Kaneko, MD, PhD, Mie
University Hospital, Tsu, Japan
622 Effectiveness of Isolation Gowns in Reducing Clothing
Contamination and Pathogen Transmission
Heba Alhmidi, MD1, Sreelatha Koganti, MD1, Myreen E. Tomas, MD2,
Jennifer Cadnum, BS2,3, Thriveen Sankar Chittoor Mana, MS, MBA3,
Annette Jencson, BSMT, CIC4 and Curtis J. Donskey, MD2, (1)Louis
Stokes Cleveland VA Medical Center, Cleveland, OH, (2)Geriatric
Research Education and Clinical Center, Louis Stokes Cleveland VA
623 Don’t forget the mask! Skin and Facemask
Contamination due to Incorrect PPE Technique
Sreelatha Koganti, MD1, Heba Alhmidi, MD1, Myreen E. Tomas, MD2,
Jennifer Cadnum, BS2,3, Thriveen Sankar Chittoor Mana, MS, MBA3,
Annette Jencson, BSMT, CIC4 and Curtis J. Donskey, MD2, (1)Louis
Stokes Cleveland VA Medical Center, Cleveland, OH, (2)Geriatric
Research Education and Clinical Center, Louis Stokes Cleveland VA
624 Use of Fluorescent Lotion in Patient Care Simulations
to Illustrate Pathogen Dissemination
Heba Alhmidi, MD1, Sreelatha Koganti, MD1, Myreen E. Tomas, MD2,
Jennifer Cadnum, BS2,3, Annette Jencson, BSMT, CIC4, Thriveen
Sankar Chittoor Mana, MS, MBA3 and Curtis J. Donskey, MD2,3,
(1)Louis Stokes Cleveland VA Medical Center, Cleveland, OH, (2)
Cleveland VA Medical Center, Cleveland, OH, (3)Case Western
Reserve University, Cleveland, OH, (4)Cleveland VA Medical Center,
Cleveland, OH
625 Predictors of Healthcare Personnel SelfContamination During Removal of PPE
Myreen E. Tomas, MD1, Sirisha Kundrapu, MD, MS2,3, Priyaleela
Thota, MD3, Venkata Sunkesula, MD, MS2,3, Jennifer Cadnum, BS1,2,
Thriveen Sankar Chittoor Mana, MS, MBA2, Annette Jencson, BSMT,
CIC3, Michelle T. Hecker, MD2,4, Amy Ray, MD2,5, Brigid Wilson, PhD1
and Curtis J. Donskey, MD1,2, (1)Geriatric Research Education and
OH, (2)Case Western Reserve University, Cleveland, OH, (3)
Cleveland VA Medical Center, Cleveland, OH, (4)MetroHealth Medical
Center, Cleveland, OH, (5)University Hospitals Case Medical Center,
Cleveland, OH
626 Nurses’ Adherence and Related Factors of Wearing
Gloves in Peripheral Intravenous Catheter Insertion
SCHEDULE
627 Do Medical Students Receive Training in Correct Use
of Personal Protective Equipment?
Amrita Rebecca John, MBBS1, Myreen E. Tomas, MD2, Thriveen
Sankar Chittoor Mana, MS, MBA3, Adithya Hari, MBBS3 and Curtis
J. Donskey, MD2,3, (1)University Hospitals Case Medical Center,
Louis Stokes Cleveland VA Medical Center, Cleveland, OH, (3)Case
Western Reserve University, Cleveland, OH
628 Simulations Using Surrogate Viruses to Evaluate SelfContamination During Doffing of Ebola PPE
Lisa M. Casanova, Ph.D.1, Lisa Teal, BSN2, Emily Sickbert-Bennett,
PhD, MS2, William Rutala, PhD, MPH3 and David Weber, MD, MPH4,
(1)Georgia State University, Atlanta, GA, (2)Hospital Epidemiology,
UNC Medical Center, Chapel Hill, NC, (3)UNC School of Medicine,
Chapel Hill, NC, (4)University of North Carolina at Chapel Hill School
of Medicine, UNC Health Care, Chapel Hill, NC
629 Survival and Disinfection of Bacteriophage Φ6 on
Tyvek Suits
Travis W. Brown, MPH, Weiyu Chen, MPH and Lisa M. Casanova,
Ph.D., Georgia State University, Atlanta, GA
630 Aerosol Generation During Patient Care Activities
Jiayu Li, BS1, Anna Leavey, PhD1, Yang Wang, BS1, Matthew
Hink2, Caroline O’Neil, MPH2, Meghan Wallace, BS1, Carey-Ann D.
Burnham, PhD3, Pratim Biswas, PhD1 and Hilary Babcock, MD,
MPH4, (1)Washington University, Saint Louis, MO, (2)Washington
University School of Medicine, St Louis, MO, (3)Washington University
School of Medicine, St. Louis, MO, (4)Washington University School
of Medicine, Saint Louis, MO
632 U.S. Health Care Personnel Working While Having
Influenza-Like Illness, 2014-15 Influenza Season
Sophia K. Chiu, MD, MPH1,2, Carla L. Black, PhD3, Xin Yue, MPS,
MS3, Marie A. de Perio, MD1, A. Scott Laney, PhD4 and Stacie M.
Greby, DVM, MPH3, (1)National Institute for Occupational Safety
and Health, Centers for Disease Control and Prevention, Cincinnati,
OH, (2)Epidemic Intelligence Service, Centers for Disease Control
and Prevention, Cincinnati, OH, (3)Immunization Services Division,
National Center for Immunization and Respiratory Diseases, Centers
for Disease Control and Prevention, Atlanta, GA, (4)Respiratory
Health Division, National Institute for Occupational Safety and Health,
Centers for Disease Control and Prevention, Morgantown, WV
633 Varicella Exposure Investigation Takes an
Unexpected Turn
Oryan Henig, MD, Samyah F Mogalli, MHSA MT(ASCP)CM, Karolina
Kaser, BSN, Bhagyashri Navalkele, MD, Elaine Flanagan, MSA,
Sorabh Dhar, MD, Marilynn R. Fairfax, MD, PhD, Mark Upfal, MD,
MPH, Jim Russell, RN, Keith Kaye, MD, MPH and Teena Chopra, MD,
MPH, Detroit Medical Center, Wayne State University, Detroit, MI
634 Double Whammy: Mixed Genotype Norovirus Outbreak
in an Adult Psychiatric Unit
Michelle T Flood, MSN, RN, CIC1 and Mamta Sharma, MD2, (1)
St John Hospital and Medical Center, Grosse Point Woods, MI, (2)St
John Hospital & Medical Center, Grosse Pointe Woods, MI
635 An Outbreak of Clostridium difficile Infection
Associated with Use of a Defective Commercial Surface
Jennifer Cadnum, BS1,2, Michelle Nerandzic, BS3, Annette Jencson,
BSMT, CIC3 and Curtis Donskey, MD2, (1)Case Western Reserve
University, Cleveland, OH, (2)Geriatric Research, Education, and
OH, (3)Cleveland VA Medical Center, Cleveland, OH
YeongSeo Ahn, RN1, Hye-Ran Choi, RN, MPH1, Jae Sim Jeong, RN,
MPH, PhD2 and Jeong Hye Kim, RN, PhD1, (1)University of Ulsan,
Seoul, Korea, The Republic of, (2)Department of Nursing, University of
Ulsan, Seoul, South Korea
SCIENTIFIC
SCIENTIFIC
PROGRAM
636 Using Human Factors Engineering to Improve
Guideline Compliance: The Case of Ebola
Ayse P Gurses, PhD, MPH1, Nancy Edwards-Molello, MBA2, Jen Di
Mattina, MS3, Polly Trexler, MS, CIC4, Peter Pronovost, MD, PhD,
FCCM5, Lee Jenkins6, Susan Peterson6, Mike Rosen7, Anping
Xie, PhD1, Aaron Dietz8, Lauren Benishek8, Myles Leslie8, Trish
M Perl, MD, MSc9,10,11, Pete Doyle12, Christina S Halligan8, Sallie
Weaver8, Meredith Black, MPH13, JoEllen Harris14, Paula Justice6,
Paula Neira12, Tina Tolson12, Kerri Huber12, Glenn Platt15, Pamela
Falk, MPH16,17, Jonathan Teter, MS11, Rita Tonner18, Lisa Tomlinson16,
Tina Hoang, MHE19, Chelsea Lynch20, Malorie Givan, MPH21, Simone
Almeida22 and Lisa L K Maragakis, MD, MPH12, (1)Armstrong
Institute for Patient Safety and Quality, Johns Hopkins University,
Baltimore, MD, (2)Johns Hopkins Amnstrong Institute, Baltimore, MD,
(3)Johns Hopkins Armstrong Institute, Baltimore, MD, (4)The Johns
Hopkins Hospital, Baltimore, MD, (5)Johns Hopkins University,
Baltimore, MD, (6)JHU, Baltimore, MD, (7)Johns Hopkins Armstrong
Institute, Baltimore, MD, (8)Johns Hopkins Armstrong Institute,
Baltimore, MD, (9)The Johns Hopkins University, Baltimore, MD, (10)
Johns Hopkins Medical Institutions and University, Baltimore, MD, (11)
Johns Hopkins University School of Medicine, Baltimore, MD, (12)
Johns Hopkins Hospital, Baltimore, MD, (13)John Hopkins Hospital,
Baltimore, MD, (14)Johns Hopkins Medicine, SAINT PETERSBURG,
FL, (15)Miami University, Oxford, OH, (16)APIC, Washington, DC, (17)
Baylor Univerisity Medical Center, Dallas, TX, (18)Suburban Hospital,
Bethesda, MD, (19)Johns Hopkins University, baltimore, MD, (20)
Veterans Affairs Maryland Health Care System, Baltimore, MD, (21)
Sibley Memorial Hospital, Washington, DC, (22)Johns Hopkins Sibley
Memorial, Washington, DC
637 Paramyxovirus Outbreak in a Long-Term Care Facility
S Shaefer Spires, MD1, H Keipp Talbot, MD, MPH2, Carol Pope,
RN3 and Thomas Talbot III, MD, MPH2, (1)VANDERBILT UNIVERSITY
SCHOOL OF MEDICINE, Franklin, TN, (2)Vanderbilt University School
of Medicine, Nashville, TN, (3)Tennessee Valley Healthcare System,
Nashville, TN
638 VIM-Producing Carbapenem-Resistant
Enterobacteriaceae in a Neonatal and Adult Intensive
Care Unit
Anna Quay Yaffee1,2, Lynn Roser1, Kimberly Daniels1, Tom de Man2,
Kraig Humbaugh1, Robert Brawley1, Douglas Thoroughman1,2 and
Andrea Flinchum1, (1)Kentucky Department for Public Health, Frankfort,
KY, (2)Centers for Disease Control and Prevention, Atlanta, GA
639 Carbapenem-Resistant Klebsiella Pneumoniae
Outbreak: A Resource Limited Nation’s Response
Corey A Forde, MBBS, DM, Queen Elizabeth Hospital, Bridgetown,
Barbados
SCHEDULE
642 Water Sample Cultures Are More Sensitive Than
Swabs in the Detection of Environmental Legionella
Spe
Brooke K. Decker, M.D., Patricia L. Harris, M.S.N., R.N., Diana
L. Toy, B.S.N., R.N., Robert R. Muder, M.D., Ali F. Sonel, M.D.
and Cornelius J. Clancy, M.D., VA Pittsburgh Healthcare System,
Pittsburgh, PA
643 Ebola Virus Disease Preparation Costs for Acute Care
Hospitals in the United States
Michael A Smit, MD, MSPH1,2, Leonard A Mermel, DO, ScM, AM
(Hon)1,2, Kenneth A Rasinski, PhD3, Barbara I Braun, PhD3, Linda L
Kusek, MPH, RN, CIC3, Aaron M Milstone, MD MHS4 and Daniel J
Morgan, MD, MS5,6, (1)Brown University, Providence, RI, (2)Rhode
Island Hospital, Providence, RI, (3)The Joint Commission, Oakbrook
Terrace, IL, (4)Johns Hopkins Hospital, Baltimore, MD, (5)VA Maryland
Healthcare System, Baltimore, MD, (6)University of Maryland,
Baltimore, MD
644 Evolving Use of Patient Notifications for
Communicating Risks Following Infection Control
Breaches
Kiran Perkins, MD, MPH, Kathy Seiber, MS and Joseph Perz, DrPH,
Centers for Disease Control and Prevention, Atlanta, GA
645 Healthcare-Associated Legionella Outbreak : A
Collaborative Response
Siru Prasai, MD, MPH1, Eugene Livar, MD2, Ronald Klein, RN, BSN1,
Jigna Narang, MPH1, Ken Komatsu, MPH2 and Tammy Sylvester, RN,
MSN1, (1)Maricopa County Department of Public Health, Phoenix, AZ,
(2)Arizona Department of Health Services, Phoenix, AZ
646 Identifying Potential Outbreaks of Clostridium difficile
Infections
Chelsea Foo, MPH1,2, Kelsey OYong1, L’Tanya D. English, RN, PHN,
MPH1, Patricia Marquez, MPH1, Dawn Terashita, MD, MPH1 and
Laurene Mascola, MD, MPH1, (1)Los Angeles County Department of
Public Health, Los Angeles, CA, (2)CDC/CSTE Applied Epidemiology
Fellowship Program, Atlanta, GA
647 Perceived Benefits of EVD Preparation Compared to
Cost: A US Nationwide Sample
Barbara I Braun, PhD1, Linda L Kusek, MPH, RN, CIC1, Kenneth A
Rasinski, PhD1, Leonard A Mermel, DO, ScM, AM (Hon)2,3, Michael
A Smit, MD, MSPH2,3, Aaron M Milstone, MD MHS4 and Daniel J
Morgan, MD, MS5, (1)The Joint Commission, Oakbrook Terrace,
IL, (2)Brown University, Providence, RI, (3)Rhode Island Hospital,
Providence, RI, (4)Johns Hopkins Hospital, Baltimore, MD, (5)
University of Maryland School of Medicine, Baltimore, MD
640 Costs Associated with Ebola Preparedness at a
Pediatric Assessment Center
Kari Simonsen, MD1, Amber R. Phipps, MBA2, Mel Hall2, Brenda
Heybrock, RN, CIC2, Lindsay Hegemann, BSN, RN, CPN2 and Debra
Arnow, DNP, RN, NE-BC2, (1)University of Nebraska Medical Center,
Omaha, NE, (2)Children’s Hospital and Medical Center, Omaha, NE
641 Legionnaires’ Disease Outbreak in Outpatients Using a
Healthcare Facility Swimming Pool for Aquatic
Curtis Donskey, MD1 and Trina F. Zabarsky, RN. MSN, CIC2, (1)
Cleveland VA Medical Center, Cleveland, OH, (2)Louis Stokes
Top Poster
Abstract
48
PROGRAM
SCHEDULE
PLENARY: TELLING STORIES: USING
NARRATIVE TO EXPAND AWARENESS OF
INFECTION PREVENTION
ROLE OF THE MICROBIOME IN
RESISTANCE AGAINST HEALTHCARE
ASSOCIATED INFECTIONS
1:00 – 2:30 p.m.
2:45 – 3:45 p.m.
Moderators: Arjun Srinivasan, MD and
Daniel Diekema, MD
Speakers:
When Antibiotics Fail: A Science Journalist’s Perspective Maryn McKenna, MSJ
Patient Advocate Prospective - Victoria Nahum and
Armando Nahum
• Identify methods for improving communication around antibiotic resistance
• Describe the patient perspective of HAI
FULL CONFERENCE
DEVICE-ASSOCIATED INFECTIONS: CAN
SCIENCE BRING US TO ZERO?
2:45 – 4:00 p.m.
Savannah Ballroom
Moderators: Heather Gilmartin, PhD and
Shruti Gohil, MD
Speakers:
CLABSI: The Post-Bundle Frontier - Leonard Mermel, DO
VAC: Does Preventing VAC Demand Different Strategies than
the VAP Bundle? - Grace Lee, MD
CAUTI: Does the CAUTI Bundle Target Patients at Highest
Risk for CAUTI Sepsis? - Laurie Conway, PhD
• Describe the current epidemiology of device-associated infections in light of recent progress toward national targets for HAI
reduction
• Identify the strengths and limitations of existing bundle
elements for addressing “irreducible minimum” device-associated infections
• Select strategies beyond the bundle for preventing device-associated infections
Chastain Room
Moderators: Silvia Munoz-Price, MD and
Clifford McDonald, MD
Speaker: Eric Pamer, MD
• Review the human microbiota and microbiome
• Discuss the impact of antibiotics and cancer treatment on the
human microbiome
• Identify the ability of a diverse microbiota to confer resistance
against antibiotic-resistant bacterial pathogens and Clostridium
difficile
A HUMAN FACTORS AND SYSTEMS
ENGINEERING APPROACH TO INFECTION
PREVENTION
4:15 – 5:45 p.m.
Savannah Ballroom
Moderators: Michael Rubin, MD and Sarah Krein, PhD
Speakers:
Basic Concepts in Human Factors Design for Infection
Prevention - Sarah Krein, PhD
Application of Adherence Engineering to Improve Central Line
Maintenance Procedures- Frank Drews, PhD
Preventing Clostridium difficile Infection: A Human Factors
and Systems Engineering Approach - Nasia Safdar, MD
• Identify key concepts in human factors engineering
• Describe the application of human factors and systems
engineering to improve the use of infection prevention practices
• Recognize how human factors and systems engineering
approaches can be used to improve patient care and healthcare worker safety
FRIDAY, MAY 20
SCIENTIFIC
SCIENTIFIC
PROGRAM
ORAL ABSTRACT SESSION:
TOP ABSTRACT
4:15 – 5:45 p.m.
Chastain Room
Moderators: Susan Huang, MD and Thomas Talbot, MD
7677Comparing Hospital Compare Ranking With HospitalAcquired Condition Reduction Program Penalty Status
Kathleen Gase, MPH, CIC1, Kathleen McMullen, MPH, CIC2 and
Hilary Babcock, MD, MPH3, (1)BJC HealthCare, Saint Louis, MO, (2)
Christian Hospital, Saint Louis, MO, (3)Washington University School of
Medicine, Saint Louis, MO
8039Evaluation of Diagnosis Codes Used to Identify
Candidate SSI Events During CMS Validation
Michael S. Calderwood, MD, MPH1, Ken Kleinman, ScD2, Christina
B. Bruce, BA3, Lauren Shimelman, BA3, Rebecca E. Kaganov, BA3,
Richard Platt, MD, MSc3 and Susan S. Huang, MD, MPH4, (1)Brigham
and Women’s Hospital, Boston, MA, (2)University of Massachusetts
Amherst School of Public Health and Health Sciences, Amherst,
MA, (3)Department of Population Medicine, Harvard Medical School
and Harvard Pilgrim Health Care Institute, Boston, MA, (4)Division of
Infectious Diseases and Health Policy Research Institute, University of
California, Irvine School of Medicine, Irvine, CA
8064Elimination of MRSA and VRE Contact Precautions is
Associated with a Reduction in Antimicrobial Use
Brandy Bryant, MPH1, Elise M Martin, MD2 and Daniel Uslan, MD2, (1)
UCLA, Los Angeles, CA, (2)David Geffen School of Medicine at UCLA,
Los Angeles, CA
FRIDAY, MAY 20
7716Measuring Antibiotic Appropriateness for Urinary Tract
Infections in Nursing Home Residents
Taniece Eure, MPH1,2, Nicola Thompson, PhD1,2, Nimalie
Stone, MD1,2, Lisa L LaPlace, MPH1,2, Richard Melchreit, MD3,
Meghan Maloney, MPH3, Ruth Lynfield, MD4, Tory Whitten4, Linn
Warnke4, Ghinwa Dumyati, MD5, Gail Quinlan, RN, MS, CIC5, Cathleen
Concannon, MPH5 and Deborah Thompson, MD6,7, (1)Centers for
Disease Control and Prevention, Atlanta, GA, (2)Division of Healthcare
Quality Promotion, Atlanta, GA, (3)Connecticut Department of Public
Health, Hartford, CT, (4)Minnesota Department of Health, Saint Paul,
MN, (5)University of Rochester, Department of Health, Rochester, NY,
(6)New Mexico Department of Health, Santa Fe, NM, (7)Presbyterian
Healthcare Services, Albuquerque, NM
8126Two-State Collaborative Cohort Study of an
Intervention to Decrease Ventilator-Associated Events
Nishi Rawat, MD, Ting Yang, PhD, MHS, Kisha Jezel Ali, MS,
Kathleen Speck, MPH and Sean Berenholtz, MD, MHS, FCCM, Johns
Hopkins Medicine Armstrong Institute for Patient Safety and Quality,
Baltimore, MD
8159Distribution of Carbapenem-Resistant Gram-Negative
Rods — National Healthcare Safety Network, 2014
Maroya Walters, PhD ScM1, Jonathan R Edwards, MStat2, Scott
Fridkin, MD2 and Alexander J. Kallen, MD, MPH3, (1)Centers for
Disease Control and Prevention, Atlanta, GA, (2)Centers for Disease
Control and Prevention, Division of Healthcare Quality Promotion,
Atlanta, GA, (3)Division of Healthcare Quality Promotion, CDC, Atlanta,
GA
50
SCHEDULE
HOW TO READ A STUDY AND PERFORM
RESEARCH
2:45 – 3:30 p.m.
Chastain F
Speaker: Anthony Harris, MD
• Examine concepts of study design, implementation of a study
infrastructure, analytic methods, data needs and interpretation
of data for observational and intervention studies
• Distinguish approaches to evaluate the impact of an
intervention, including:
−− Decreases in rates of HAIs
−− Changes in prevalence or incidence of resistant organisms
−− Reductions in inappropriate device use
−− Reductions in antimicrobial use
−− Reductions in length of hospitalization
−− Decreases in cost
• Assess when to use various study designs such as beforeafter and cluster randomized trials, and when to use various
analyses such as time-series analysis
• Calculate p values, confidence intervals and effect estimates/
odds ratios to evaluate data for identification of epidemiologic
trends, analysis of outbreaks and in the conduct of formal
epidemiologic studies
• Assess the process for presentation of analytic study data in
varying formats, including summary presentations
BUSINESS OF INFECTION PREVENTION:
PROMOTING GROWTH OF A PROGRAM
3:30 – 4:10 p.m.
Chastain F
Speaker: Sarah Haessler, MD
• Explain the importance of physician and administrative leader
buy in for an infection prevention Program
• Indicate how to write and present to institutional leadership a
strategic plan and business case for instituting, maintaining,
and expanding of an infection control program
• Learn how to successfully recruit physician and administrative
champions for planned programs
• Discuss how to develop and present a report detailing the
rationale and proposed benefits of a Program or intervention,
including financial analysis, improvement in patient safety, and
justification for funding of proposed team members
• Demonstrate how to develop and present annual reports
detailing interventions, cost-savings/maintenance, improved
patient safety
SCIENTIFIC
PROGRAM
SCHEDULE
TRAINING COURSE
THE ROLE OF THE LABORATORY IN
HEALTHCARE EPIDEMIOLOGY
INFORMATICS AND STEWARDSHIP
4:15 – 5:00 p.m.
Speaker: Jerod Nagel, PharmD
Chastain F
Speaker: Daniel Diekema, MD
Chastain E
• Discuss the major roles of the clinical laboratory in infection
prevention, outbreak response, and antibiotic stewardship
• Identify promising developments in rapid and/or molecular
diagnostic testing in the microbiology lab, including when and
how such testing should be incorporated into infection prevention efforts
• Assess test characteristics (e.g. sensitivity, specificity, positive
and negative predictive value) and that a change in testing
methodology may result in an apparent change in incidence or
prevalence of an infection or pathogen
• Develop and interpret an antibioGram that is consistent
with Clinical and Laboratory Standards Institute (CLSI)
recommendations
• Know when to utilize molecular typing methods for infection
prevention and outbreak response, and describe the strengths
and limitations of existing typing methods
PUTTING IT ALL TOGETHER: LEADING
YOUR HEALTHCARE FACILITY THROUGH A
MASSIVE EXPOSURE SITUATION
Chastain F
Speaker: Sarah Haessler, MD
• Review an interactive case which leads course participants
through the work up of a massive exposure in their healthcare
facility
• Identify skills learned to identify which pathogen is responsible,
and the mode of transmission
• Identify which healthcare workers and patients were exposed
and who needs prophylaxis and/or isolation.
• Apply communication skills to effectively convey information
within the healthcare organization and to the media
• List leadership skills to help respond, organize, and manage
the massive exposure.
• Identify how information technology infrastructure may assist
stewardship programs
• Describe how to assess IT resources and external proprietary
software programs
• List examples of how information technology has assisted
successful stewardship programs in various settings
CPE Number: 0221-9999-16-092-L04-P
MANAGEMENT OF RESISTANT GRAM
POSITIVE INFECTIONS
3:30 – 4:00 p.m.
Chastain E
Speaker: Deverick Anderson, MD
• Identify common mechanisms of resistance for different bug/
drug combinations including Gram-positive organisms
• Discuss therapeutic options for highly resistant organisms
• Discuss MICs and breakpoints and their role in determining
appropriate therapy
CPE Number: 0221-9999-16-093-L01-P
MANAGEMENT OF RESISTANT GRAM
NEGATIVE INFECTIONS
4:15 – 4:45 p.m.
Chastain E
Speaker: Christopher Pfeiffer, MD
• Identify common mechanisms of resistance for different bug/
drug combinations including Gram-negative organisms
• Discuss therapeutic options for highly resistant organisms
• Discuss MICs and breakpoints and their role in determining
appropriate therapy
CPE Number: 0221–9999–16–094–L01–P
FRIDAY, MAY 20
5:00 – 5:45 p.m.
2:45 – 3:30 p.m.
SCIENTIFIC
PROGRAM
TRAINING COURSE
CASE STUDY #3: STEWARDSHIP AND
C. DIFFICILE INFECTION
4:45 – 5:45 p.m.
Chastain E
Speaker: Belinda Ostrowsky, MD
• Define laboratory approaches to testing for C. difficile testing
and interpret results
• Review the association between use of antimicrobials and the
development of C. difficile infections
• Identify strategies to decrease C. difficile infection rates that
include improving antibiotic use and understand how to
implement them in a collaborative group including infection
prevention
FRIDAY, MAY 20
CPE Number: 0221-9999-16-095-L05-P
52
SCHEDULE
PROGRAM
7:00 – 7:50 a.m.
SCHEDULE
ORAL ABSTRACT SESSION: ANTIBIOTIC
AND TEST STEWARDSHIP
8:00 – 9:30 a.m.
FULL CONFERENCE
Moderators: Trevor Van Schooneveld, MD and
Matthew Linam, MD
PRO/CON: UNIVERSAL PPE
8:00 – 9:30 a.m.
Savannah Ballroom
Moderators: Ann-Christine Nyquist, MD and
Leonard Mermel, DO
Speakers:
Pro - Anthony Harris, MD
Con - Gonzalo Bearman, MD
Enduring Competency in PPE - Kari Simonsen, MD
• Discuss the evidence supporting universal approaches to PPE
in healthcare settings
• Describe the potential advantages to universal PPE
approaches and highlight disadvantages to pathogen-specific
approaches to PPE
• Discuss the evidence supporting individualized and pathogen-specific approaches to PPE use in healthcare settings
• Discuss potential advantages to pathogen-specific/individualized approaches and disadvantages to universal approaches
to PPE
• Describe the role of planning, preparedness, and competency
with a chosen PPE approach
• Discuss the evidence supporting the need for demonstrating
competency in PPE utilization
CROSSING THE STEWARDSHIP
CONTINUUM
8:00 – 9:30 a.m.
Chastain Room
Chastain F
Moderators: Neil Fishman, MD and Waleed Javaid, MD
Speakers:
Not the Usual Suspects - Prescribing in Community Lauri Hicks, DO
Breaking the Cycle: Collaborative Antibiotic Use Across the
Continuum - Robin Jump, MD
Academic and Community Hospital Partnerships in ASP Elizabeth Dodds-Ashley, PharmD
• Discuss antibiotic stewardship priorities, interventions, implementation and successes across the spectrum of healthcare
facilities
• Discuss prescribing and antibiotic stewardship initiatives in
non-acute care settings, e.g., outpatient offices, pediatrics,
urgent care centers
• Discuss prescribing challenges and antibiotic stewardship
initiatives in long-term care, long-term acute care and chronic
facilities, including continuity of prescribing between facilities
• Discuss delivery of antibiotic stewardship in different acute
care settings including smaller hospital, community settings,
large networks.
7883A New Measure of Antimicrobial Use: the NHSN
Standardized Antimicrobial Administration Ratio
Katharina L. van Santen, MSPH, Jonathan R Edwards, MStat, Arjun
Srinivasan, MD, Scott Fridkin, MD and Daniel A. Pollock, MD, Centers
for Disease Control and Prevention, Division of Healthcare Quality
Promotion, Atlanta, GA
7894Effective Antibiotic Conservation by Emergency
Antimicrobial Stewardship During a Drug Shortage
Michael Durkin, MD, MPH1,2,3, Maria Reyes, MD1, Tamara Krekel,
PharmD2, Ed Casabar, PharmD2, David Ritchie, PharmD2,4, Amanda
Hays, PharmD, MHA5, Michael A. Lane, MD, MPH, MSc1,5 and Kevin
Hsueh, MD1,2, (1)Washington University School of Medicine, St.
Louis, MO, (2)Barnes-Jewish Hospital, St. Louis, MO, (3)Washington
University Institute of Public Health, St. Louis, MO, (4)St. Louis
College of Pharmacy, St. Louis, MO, (5)BJC HealthCare, St. Louis,
MO
7924Impact of Clinical Decision Support Tool on
Antimicrobial Stewardship in a Large Health System
Roy Guharoy, Pharm.D., MBA1,2, Mylinda Dill, PharmD1, Karen
Smethers, Pharm.D.1, Florian Daragjati, Pharm.D.1 and Mohamad
Fakih, MD, MPH3, (1)Ascension Health, St. Louis, MO, (2)University of
Massachusetts Medical School, Worcester, MA, (3)Care Excellence,
Ascension Health, St. Louis, MO
8274IRobot vs. ID: Personalizing Initial Antibiotic Therapy
for Patients Hospitalized with Infections
Becky Smith, MD1,2, Jessica P Ridgway, MD, MS2, Nirav
Shah, MD1,2, Jeffery Semel, MD1,2, Ari Robicsek, MD1,2 and Lance
Peterson, MD1,2, (1)NorthShore University HealthSystem, Evanston,
IL, (2)University of Chicago, Chicago, IL
7555Evaluating an Antibiotic Stewardship Intervention in
Rural China
Yanhong Hu, 1B, winter drive1,2, Xiaolin Wei, PhD3,4, Martin Wong,
M.D PHD5, Joseph D Tucker, M.D PHD6, Zhitong Zhang, MPH7,
Yuanyuan Huang, MPH8 and Simin Deng, MPH9, (1)University of North
Carolina, Chapel Hill, NC, (2)The chinese university of HongKong,
HongKong, Hong Kong, (3)The chinese university of HongKong,
HongKong, China, (4)University of Toronto, Toronto, ON, Canada, (5)
Family Medicine and Primary Healthcare, JC School of Public Health
and Primary Care, HongKong, China, (6)UNC Chapel Hill Institute
for Global Health & Infectious Diseases, Chapel Hill, NC, (7)Nuffield
Centre for International Health and Development, University of Leeds,
UK (Based in China), Shenzhen, China, (8)Shenzhen CDC, Shenzhen,
China, (9)Nuffield Centre for International Health and Development,
University of Leeds, UK (Based in China),, Shenzhen, China
7811National Prevalence and Appropriateness of Urine
Culture Testing
Molly Horstman, MD1, Andrew Spiegelman, PhD2, Aanand
Naik, MD1 and Barbara Trautner, MD, PhD3,4, (1)Center for Innovations
in Quality, Effectiveness, and Safety, Houston, TX, (2)The Advisory
Board Company, Washington, DC, (3)Baylor College of Medicine,
Houston, TX, (4)Center for Innovations in Quality, Effectiveness and
Safety, Houston, TX
SATURDAY, MAY 21
SCIENTIFIC
SCIENTIFIC
PROGRAM
NETWORKING BREAK
9:30 – 10:00 a.m.
CLOSING PLENARY: CREATING A
CULTURE OF ACCOUNTABILITY
AND PROFESSIONALISM TO DRIVE
IMPROVEMENT
10:00 – 12:00 p.m.
Moderators: Silvia Munoz-Price, MD and
Robert Duncan, MD
Speakers:
Professional Accountability in Pursuit of a Culture of Safety Gerald Hickson, MD
Utilizing Shared Accountability in Infection Prevention: The
Vanderbilt Hand Hygiene Adventure - Thomas Talbot, MD
Peer to Peer Stewardship and SSI Prevention Daniel Raymond, MD
SATURDAY, MAY 21
• Discuss the importance of a standardized accountability
process to address variability in performance
• Describe the use of such a process to improve clinician
behaviors in terms of hand hygiene compliance, antibiotic
stewardship, and adherence to Hai prevention bundles
54
SCHEDULE
NOTES
NOTES
56
SEE YOU NEXT YEAR!
March 29-31, 2017, St. Louis, MO
Break
Root Cause Analysis
Practical Session
3:45 - 4:15 PM
Change Management
and the Science of
Safety
2:45 - 3:45 PM
The Compendium
Strategies for
Preventing HAIs
1:45 - 2:30 PM
Practical Strategies for
Surveillance
1:00 - 1:45 PM
Strategies to
Prevent Infections &
MDROs
4:15 - 5:30 PM
Overview of Antibiotic
Stewardship
4:30 - 5:30 PM
Changing
Approaches in
Surveillance
2:30 - 4:00 PM
Managing
Outbreaks
1:00 - 2:15 PM
Transmission of Infectious Agents in
Healthcare Settings
11:15 - 12:00 AM
Introduction to Healthcare Epidemiology
10:15 - 11:15 AM
Course Overview
10:00 - 10:15 AM
The Possibilities of
Innovative Automated
Tools in Hand Hygiene
Compliance
Measurement
11:00 - 12:00 PM
Breakout:
Advanced AS
1:00 - 2:30 PM
What Every Steward Should Know
About Pharmacokinetics Pharmacodynamics
2:45 - 3:15 PM
Breakout:
Beginning AS
1:00 - 2:30 PM
AS in Skilled Nursing Facilities &
Long Term Care
11:00 - 12:00 PM
Challenging Situations
10:00 - 11:00 AM
CDI Management
8:45 - 9:30 AM
Occupational Health & Safety
8:00 - 8:45 AM
Choosing Wisely
Co-Organized by The
Society of Infectious
Diseases Pharmacists
(SIDP)
4:15 - 5:45 PM
4:15 - 5:45 PM
Oral Abstract Session:
Innovation In Infection
Prevention
Break
Case Study #1: Using
Benchmarking to Enhance
Antibiotic Stewardship
5:00 - 5:45 PM
Antibiotic Stewardship: Navigating
the Liability Risks
4:30 - 5:00 PM
Break
An Update on Duration of Therapy
and Therapeutic Monitoring: Our
Role as
Stewards
3:45 - 4:15 PM
Pediatric Infection
Prevention: Focus on
Outbreaks
Allergies, Interactions and Adverse
Guideline Implementation
2:45 - 3:30 PM
Events
2:45 - 4:00 PM
3:15 - 3:45 PM
Implementation Academy:
Turning Science into
MDROs
Improved Practice
1:00 - 2:30 PM
1:00 - 2:30 PM
Creating a Level Playing
Field with PublicallyReported HAI Data
10:00 - 12:00 PM
Are there Global
Standards for
Endoscope
Reprocessing
Methods?
10:00 - 11:00 AM
Opening Plenary: CDC and Healthcare Associated Infections:
Prevention in the Past, the Present, and the Future
8:00 - 9:30 AM
Wednesday, May 18
Surgical Site Infection
Prevention: Where Do
we SCIP and HOP from
Here?
10:00 - 12:00 PM
Special Populations:
Immunocompromised, ICU,
Dialysis & Burn Patients
4:30 - 5:30 PM
Environment, Sterilization &
Disinfection
3:30 - 4:15 PM
PAC&LTC: Changing the
National Landscape and
2:45 - 3:30 PM
Updates from the CDC
Prevention Epicenters
Program: A Public
Health/Academic
Research Partnership
4:15 - 5:45 PM
Is There Quality in
Quality Metrics?
4:15 - 5:45 PM
Pro/Con: To Wash or
Rub Off C. Difficile
and Making the Most of
C. Difficile PCR
2:45 - 4:00 PM
Break
HAI Surveillance
2:45 - 4:00 PM
Movement Break
Plenary: Reaching out to New Partners
1:00 - 2:30 PM
Practical
Considerations in HAI
Research
10:00 - 12:00 PM
Networking Break (9:30 - 10:00 AM)
Selling Your Reults:
To Suits, Scientists and
Society
8:00 - 9:30 PM
Breakfast (7:00 - 7:50 AM)
Environmental
Disinfection
8:00 - 9:30 PM
Lunch (12:00 - 1:00 PM)
Problem Session:
Outbreak in the OR
11:30 - 12:00 PM
Approach to
Epidemic/Outbreak
Investigation
10:45 - 11:30 AM
Unique Aspects of Pediatric
Infection Control
10:00 - 10:45 AM
CDC Problem Sessions
8:00 - 9:30 AM
Thursday, May 19
Art of Antibiotic Stewardship
11:30 - 12:00 PM
How to Find Resources at your
Institution or Health System
10:30 - 11:30 AM
Update on National Stewardship
Activities
10:00 - 10:.30 AM
Rapid Diagnostic Tests and How
to Implement their Use: Minilecture & Case Study #2
8:45 - 9:30 AM
Integration of the Microbiology
Lab & Antibiotic Stewardship:
Beginning Concepts
8:00 - 8:45 AM
Regional Approach to
MDRO Prevention
10:00 - 12:00 PM
Challenging Cases and
Issues in Infection
Prevention
10:00 - 12:00 PM
Research Methods in
Novel Engineering
Healthcare
Solutions to
Epidemiology:
Environmental Hygiene
Practical
8:00 - 9:30 PM
Considerations
8:00 - 9:30 PM
Putting it all Together
5:00 - 5:45 PM
The Role of the
Laboratory in
Healthcare
Epidemiology
4:15 - 5:00 PM
Break
Business of Infection
Prevention: Promoting
Growth of a Program
3:30 - 4:10 PM
How to Read a Study &
Perform Research
2:45 - 3:30 PM
Case Study #3: Stewardship and
C. Difficile Infection
4:45- 5:45 PM
Management of Resistant
Gram Negative Infections
4:15 - 4:45 PM
Management of Resistant Gram
Positive Infections
3:30 - 4:00 PM
Informatics and Stewardship
2:45 - 3:30 PM
A Human Factors and
Systems Engineering
Approach to Infection
Prevention
4:15 - 5:45 PM
Break
Device-Associated
Infections: Can
Science Bring us to
Zero?
2:45 - 4:00 PM
Top Oral Abstract
Session
4:15 - 5:45 PM
Role of the Microbiome
in Resistance Against
Healthcare Associated
Infections
2:45 - 3:45 PM
Plenary: Telling Stories: Using Narrative to Expand Awareness of Infection
Prevention
1:00 - 2:30 PM
Regulatory &
Emergency
Preparedness
11:00 - 12:00 PM
Occupational Health
Issues
10:00 - 11:00 AM
The Hospital
Epidemiologist as a
Clinician Educator
8:45 - 9:30 AM
Leadership and
Communication Skills
8:00 - 8:45 AM
Friday, May 20
CONFERENCE AGENDA — View inside Schedule at a Glance
Crossing the
Stewardship
Continuum
8:00 - 9:30 PM
Oral Abstract
Session: Antibiotic
and Test
Stewardship
8:00 - 9:30 AM
Closing Plenary:
Creating a Culture of Accountability and
Professionalism to Drive Improvement
10:00 - 12:00 PM
Pro/Con:
Universal PPE
8:00 - 9:30 PM
Saturday, May 21

the Final Program Book

Transcription

Similar documents

Untitled

press kit (pdf download)

October Newsletter - Cleveland Metropolitan School District

Ward 10 News - Cleveland City Council

Ward 10 News - Cleveland City Council

HoneyPOP Border Instructions

January Le Sabre PDF - Cleveland Charter High School

Frédéric Fekkai - Institut Karité

Annual Report 2015 - HFLA of Northeast Ohio

online auction – bindery equipment